data_6urs_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6urs _Structure_validation_residue.Date_analyzed 2020-10-30 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 73.3 tp60 . . . . . 0 CA--C 1.505 -0.762 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -65.82 -38.46 88.97 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 122.726 0.411 . . . . 0.0 110.824 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.3 tp -67.1 -41.09 86.84 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 123.639 0.776 . . . . 0.0 109.037 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -62.38 -42.61 99.55 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 124.631 1.172 . . . . 0.0 109.595 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -65.18 -41.79 94.28 Favored 'General case' 0 CA--C 1.496 -1.119 0 C-N-CA 123.256 0.622 . . . . 0.0 111.122 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -64.44 -41.11 96.75 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 123.078 0.551 . . . . 0.0 111.57 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.9 mm -67.35 -45.83 85.04 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 CA-C-O 118.602 -0.714 . . . . 0.0 110.24 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.72 -37.12 79.2 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 C-N-CA 123.54 0.736 . . . . 0.0 111.166 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -64.38 -43.75 93.51 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 118.584 0.629 . . . . 0.0 110.514 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.0 mt -67.57 -38.7 84.47 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 123.63 0.772 . . . . 0.0 110.886 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -61.68 -46.65 88.8 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.806 2.042 . . . . 0.0 110.035 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -74.21 -37.36 63.89 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.2 p -80.93 -42.18 21.75 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 117.575 2.435 . . . . 0.0 117.575 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.14 -113.14 1.09 Allowed Glycine 0 CA--C 1.485 -1.84 0 C-N-CA 121.488 -0.386 . . . . 0.0 112.652 -177.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.9 t -66.4 122.9 18.56 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 121.9 0.857 . . . . 0.0 110.747 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 73.4 m -91.72 -57.55 2.71 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 113.801 -1.545 . . . . 0.0 113.135 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.7 mt -98.92 -16.91 18.61 Favored 'General case' 0 CA--C 1.487 -1.455 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.721 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.21 -38.56 72.12 Favored Glycine 0 C--N 1.354 1.557 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.62 -38.84 84.5 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 123.486 0.715 . . . . 0.0 111.001 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -72.37 -47.09 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.967 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.7 m -63.23 -37.96 89.28 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 124.035 0.934 . . . . 0.0 112.988 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -75.79 -46.01 33.04 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -86.74 -54.99 4.06 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.9 mt -81.42 -31.44 33.17 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 123.772 0.829 . . . . 0.0 112.949 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 77.44 -67.35 0.2 Allowed 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 128.26 2.624 . . . . 0.0 111.052 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.2 t -113.48 117.29 45.21 Favored Pre-proline 0 N--CA 1.44 -0.948 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -67.33 -38.64 14.68 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 123.197 2.598 . . . . 0.0 114.241 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 56.67 -173.03 0.07 Allowed 'General case' 0 C--N 1.36 1.06 0 C-N-CA 124.863 1.265 . . . . 0.0 113.376 -172.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.3 p -66.1 -29.99 70.42 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 124.618 1.167 . . . . 0.0 110.721 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.3 m -61.07 -48.86 79.77 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.425 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.0 t -81.33 -38.26 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 118.901 0.773 . . . . 0.0 109.71 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -61.33 -38.86 88.43 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 97.7 m -68.12 -41.87 81.08 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 119.268 0.94 . . . . 0.0 109.901 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.3 mt -66.35 -43.78 91.2 Favored 'Isoleucine or valine' 0 C--N 1.356 0.888 0 C-N-CA 123.767 0.827 . . . . 0.0 109.734 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . 0.264 33.0 m -70.18 -32.49 51.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 CA-C-O 117.743 -1.122 . . . . 0.0 113.323 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -62.53 -41.55 98.94 Favored 'General case' 0 C--N 1.362 1.111 0 CA-C-N 119.22 0.918 . . . . 0.0 111.616 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -70.48 -44.45 67.69 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 124.443 1.097 . . . . 0.0 109.192 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -66.13 -32.16 73.45 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.79 -39.42 90.95 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -64.3 -42.68 96.24 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 123.61 0.764 . . . . 0.0 109.531 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -70.24 -33.51 71.72 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.93 -31.12 67.24 Favored Glycine 0 C--N 1.355 1.588 0 C-N-CA 124.527 1.061 . . . . 0.0 110.857 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.0 m -78.94 -60.33 2.42 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.1 m . . . . . 0 C--N 1.358 0.975 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.754 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 . . . . . 0 CA--C 1.493 -1.221 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -57.77 -32.94 67.99 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.8 mt -64.19 -40.84 96.94 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 123.013 0.525 . . . . 0.0 111.789 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.75 -37.99 67.51 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 124.622 1.169 . . . . 0.0 109.915 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -61.33 -35.45 77.43 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 123.658 0.783 . . . . 0.0 111.691 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -65.47 -29.03 69.65 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 93.5 mt -74.81 -47.59 37.13 Favored 'Isoleucine or valine' 0 C--N 1.356 0.881 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.282 31.9 m -67.42 -25.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.36 1.062 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -63.9 -32.99 74.71 Favored 'General case' 0 C--N 1.358 0.962 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.91 -37.84 79.2 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 124.247 1.019 . . . . 0.0 108.478 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -62.98 -42.05 99.73 Favored 'General case' 0 C--N 1.363 1.158 0 C-N-CA 124.238 1.015 . . . . 0.0 109.404 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -68.48 -37.62 80.29 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.207 1.003 . . . . 0.0 110.512 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.0 m -69.81 -29.86 67.25 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 123.655 0.782 . . . . 0.0 111.671 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.15 109.96 0.53 Allowed Glycine 0 CA--C 1.482 -2.025 0 N-CA-C 106.268 -2.733 . . . . 0.0 106.268 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.9 t -79.26 114.57 18.3 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.851 0.834 . . . . 0.0 108.877 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.6 m -104.27 115.58 30.64 Favored 'General case' 0 N--CA 1.431 -1.412 1 N-CA-C 97.568 -4.975 . . . . 0.0 97.568 176.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.0 mt -67.31 -35.89 80.36 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.43 -38.41 86.86 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.5 -41.82 54.36 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.1 mt -68.95 -38.99 79.27 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 CA-C-O 118.619 -0.705 . . . . 0.0 111.961 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.5 m -65.47 -38.17 89.01 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 118.621 0.646 . . . . 0.0 111.591 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.22 -37.19 74.97 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 118.106 0.412 . . . . 0.0 111.863 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.75 -46.4 63.03 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.94 -41.77 22.39 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 75.6 -67.95 0.22 Allowed 'General case' 0 C--N 1.355 0.846 0 C-N-CA 127.63 2.372 . . . . 0.0 107.2 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.2 t -127.88 102.93 21.67 Favored Pre-proline 0 C--N 1.358 0.949 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.11 -32.69 42.85 Favored 'Trans proline' 0 CA--C 1.499 -1.235 0 C-N-CA 123.986 3.124 . . . . 0.0 114.577 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 65.04 174.39 0.21 Allowed 'General case' 0 C--N 1.355 0.836 0 C-N-CA 125.789 1.635 . . . . 0.0 112.969 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.9 m -64.34 -35.31 80.47 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 124.484 1.114 . . . . 0.0 112.819 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.7 m -63.69 -48.53 76.78 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 77.0 t -71.65 -38.69 67.73 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 73.3 tp60 -60.26 -35.84 76.42 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 123.176 0.59 . . . . 0.0 112.431 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 99.2 m -67.44 -39.44 85.42 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.391 0.541 . . . . 0.0 110.282 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.4 mt -71.77 -36.64 59.49 Favored 'Isoleucine or valine' 0 C--N 1.359 1.015 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.39 -40.3 85.77 Favored 'Isoleucine or valine' 0 C--N 1.362 1.126 0 C-N-CA 125.26 1.424 . . . . 0.0 108.471 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 -63.72 -36.6 84.4 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 123.343 0.657 . . . . 0.0 112.104 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.89 -44.39 93.18 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -68.3 -36.04 78.75 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.88 -39.25 93.74 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 124.953 1.301 . . . . 0.0 109.619 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -63.45 -43.6 96.91 Favored 'General case' 0 C--N 1.357 0.927 0 C-N-CA 123.768 0.827 . . . . 0.0 110.275 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -81.62 -22.7 37.49 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.15 -11.57 85.42 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-O 118.783 -1.009 . . . . 0.0 112.426 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.0 m -72.25 -60.79 2.05 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 118.123 0.961 . . . . 0.0 108.851 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 80.6 m . . . . . 0 C--N 1.362 1.13 0 CA-C-N 119.093 0.86 . . . . 0.0 108.768 179.023 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 . . . . . 0 CA--C 1.496 -1.126 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.6 -35.08 79.34 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.739 1.216 . . . . 0.0 110.628 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.3 tp -65.83 -43.03 89.8 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.7 mtp85 -65.18 -38.6 91.01 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 122.845 0.458 . . . . 0.0 111.049 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.46 -41.8 96.31 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 92.4 mtm-85 -67.24 -29.35 68.96 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 123.962 0.905 . . . . 0.0 113.048 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -70.05 -46.32 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 119.29 0.95 . . . . 0.0 109.0 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.7 t -68.48 -44.33 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 124.634 1.174 . . . . 0.0 111.344 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -68.79 -40.13 79.77 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 124.072 0.949 . . . . 0.0 112.555 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.5 mt -67.22 -33.27 75.0 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 118.836 -0.602 . . . . 0.0 110.817 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -62.49 -42.07 99.24 Favored 'General case' 0 C--N 1.362 1.12 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -66.32 -36.66 83.48 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 123.971 0.908 . . . . 0.0 109.978 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.8 m -70.72 -16.97 62.82 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 124.906 1.282 . . . . 0.0 112.978 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.53 1.16 3.52 Favored Glycine 0 C--N 1.36 1.901 0 N-CA-C 117.866 1.907 . . . . 0.0 117.866 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.6 m -77.18 154.77 32.8 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 119.972 1.886 . . . . 0.0 111.721 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.7 p -80.83 164.67 22.52 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 125.307 1.443 . . . . 0.0 112.623 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 86.2 mt -68.94 -22.45 64.13 Favored 'General case' 0 C--N 1.361 1.073 0 C-N-CA 124.07 0.948 . . . . 0.0 110.61 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.98 -35.66 92.28 Favored Glycine 0 C--N 1.359 1.861 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.11 -37.01 75.26 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 123.644 0.778 . . . . 0.0 110.184 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.3 mt -66.41 -43.15 91.3 Favored 'Isoleucine or valine' 0 C--N 1.365 1.244 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.2 m -63.09 -37.14 86.02 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.65 1.18 . . . . 0.0 110.498 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.68 -46.88 67.89 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -74.44 -49.28 23.04 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.4 mt -77.36 -33.72 55.27 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 115.721 1.748 . . . . 0.0 115.721 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 74.76 -68.3 0.22 Allowed 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 126.186 1.795 . . . . 0.0 111.527 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.6 t -122.48 94.7 47.53 Favored Pre-proline 0 C--N 1.36 1.061 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -70.77 -27.83 21.15 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 123.578 2.852 . . . . 0.0 113.328 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 60.31 -175.57 0.11 Allowed 'General case' 0 C--N 1.359 1.02 0 C-N-CA 124.846 1.258 . . . . 0.0 112.548 -170.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 92.8 p -67.98 -37.44 81.52 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 123.775 0.83 . . . . 0.0 112.821 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.7 m -63.86 -47.47 80.55 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -177.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.4 t -71.45 -37.92 66.42 Favored 'Isoleucine or valine' 0 C--N 1.359 0.981 0 CA-C-O 118.535 -0.745 . . . . 0.0 109.29 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -62.3 -37.77 86.81 Favored 'General case' 0 C--N 1.362 1.12 0 CA-C-N 118.573 0.624 . . . . 0.0 112.334 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 97.7 m -66.84 -41.39 87.48 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 123.346 0.658 . . . . 0.0 109.581 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.4 mt -66.4 -41.92 89.58 Favored 'Isoleucine or valine' 0 C--N 1.358 0.953 0 C-N-CA 123.495 0.718 . . . . 0.0 110.01 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.7 t -62.9 -40.13 87.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 C-N-CA 124.127 0.971 . . . . 0.0 110.744 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -65.53 -40.1 92.53 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.45 0.568 . . . . 0.0 112.245 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -68.29 -40.25 81.84 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 124.155 0.982 . . . . 0.0 109.783 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -66.62 -40.14 88.64 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.246 1.018 . . . . 0.0 110.317 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.0 -41.51 86.58 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -60.76 -28.74 68.94 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 125.941 1.696 . . . . 0.0 112.463 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -60.1 -27.94 67.43 Favored 'General case' 0 C--N 1.361 1.104 0 N-CA-C 112.71 0.634 . . . . 0.0 112.71 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.83 -28.87 71.43 Favored Glycine 0 C--N 1.359 1.854 0 CA-C-O 119.483 -0.62 . . . . 0.0 111.818 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.0 m -83.1 -58.36 2.89 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 81.6 m . . . . . 0 C--N 1.359 1.02 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -179.439 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 . . . . . 0 N--CA 1.439 -0.998 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -65.43 -40.09 92.89 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 119.278 0.945 . . . . 0.0 111.478 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.3 tp -66.79 -41.66 87.28 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -63.26 -41.89 99.09 Favored 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 123.596 0.758 . . . . 0.0 110.14 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.37 -42.86 95.97 Favored 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 123.963 0.905 . . . . 0.0 111.334 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -64.26 -41.89 96.72 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 123.557 0.743 . . . . 0.0 110.46 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.6 mt -68.72 -46.51 79.53 Favored 'Isoleucine or valine' 0 C--N 1.358 0.966 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.407 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.96 -39.97 87.48 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 C-N-CA 124.039 0.935 . . . . 0.0 112.039 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -62.82 -43.4 98.9 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 118.297 0.498 . . . . 0.0 110.692 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.9 mt -70.63 -37.79 73.83 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 123.068 0.547 . . . . 0.0 111.77 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -60.92 -44.92 96.51 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 126.724 2.01 . . . . 0.0 109.687 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -74.77 -40.31 61.26 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.9 p -80.88 -43.51 19.79 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.27 -115.31 1.38 Allowed Glycine 0 CA--C 1.487 -1.691 0 CA-C-O 121.158 0.31 . . . . 0.0 112.835 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.0 t -66.66 122.27 17.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-O 122.203 1.001 . . . . 0.0 110.691 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.1 m -93.65 -54.99 3.42 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 113.126 -1.852 . . . . 0.0 111.298 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.0 mt -87.96 -29.07 21.06 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.81 -36.45 91.17 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-O 119.656 -0.524 . . . . 0.0 112.525 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.81 -40.85 79.34 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 117.06 0.43 . . . . 0.0 111.0 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -71.02 -45.39 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 118.955 -0.545 . . . . 0.0 109.778 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.7 m -62.7 -38.32 89.95 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 124.143 0.977 . . . . 0.0 113.149 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -72.7 -48.4 39.21 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -83.69 -55.81 4.07 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.98 -33.43 24.6 Favored 'General case' 0 CA--C 1.494 -1.208 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 78.82 -66.08 0.2 Allowed 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 128.011 2.524 . . . . 0.0 108.653 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.6 t -115.75 118.97 38.25 Favored Pre-proline 0 C--N 1.357 0.911 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -66.76 -38.44 17.84 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 123.849 3.033 . . . . 0.0 114.967 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 55.82 -171.98 0.07 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 125.501 1.521 . . . . 0.0 113.532 -172.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 89.0 p -63.79 -32.32 73.78 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 124.897 1.279 . . . . 0.0 111.872 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.6 m -59.81 -47.09 87.1 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 124.325 1.05 . . . . 0.0 112.757 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 77.0 t -82.46 -38.02 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-O 118.873 -0.584 . . . . 0.0 110.459 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -60.62 -38.98 86.54 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 98.6 m -65.76 -42.93 90.27 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-N 118.803 0.729 . . . . 0.0 109.939 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.1 mt -67.11 -45.93 85.55 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 123.985 0.914 . . . . 0.0 110.176 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . 0.266 33.9 m -69.18 -33.52 58.7 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.388 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -64.58 -36.71 85.1 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 119.179 0.9 . . . . 0.0 113.158 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -71.47 -44.98 63.77 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -66.74 -30.56 70.82 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -65.85 -37.27 85.73 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.611 1.565 . . . . 0.0 108.762 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -65.75 -41.55 91.98 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -70.25 -32.49 70.36 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 122.755 0.422 . . . . 0.0 111.4 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.86 -34.05 59.49 Favored Glycine 0 C--N 1.356 1.668 0 C-N-CA 123.878 0.752 . . . . 0.0 111.424 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.7 m -74.94 -61.05 2.02 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 79.1 m . . . . . 0 C--N 1.362 1.12 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.298 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 . . . . . 0 N--CA 1.431 -1.378 0 CA-C-O 118.383 -0.818 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -60.15 -39.99 88.29 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 123.866 0.867 . . . . 0.0 112.932 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.15 -39.79 82.53 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -65.3 -39.61 92.72 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 123.397 0.679 . . . . 0.0 109.659 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.07 -40.09 95.51 Favored 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 124.684 1.193 . . . . 0.0 109.043 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.66 -39.03 93.31 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.949 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.36 -45.42 85.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.2 t -63.74 -46.23 95.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 C-N-CA 124.792 1.237 . . . . 0.0 111.318 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -65.25 -42.07 93.65 Favored 'General case' 0 CA--C 1.488 -1.422 0 C-N-CA 123.853 0.861 . . . . 0.0 111.546 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.9 mt -66.24 -38.7 88.51 Favored 'General case' 0 CA--C 1.496 -1.104 0 O-C-N 123.514 0.509 . . . . 0.0 110.521 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -60.84 -45.33 94.92 Favored 'General case' 0 C--N 1.361 1.087 0 CA-C-O 118.965 -0.54 . . . . 0.0 110.678 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.04 -38.25 82.29 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.874 1.27 . . . . 0.0 111.587 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.4 m -69.79 -28.68 65.94 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 124.161 0.985 . . . . 0.0 112.538 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.54 78.22 0.44 Allowed Glycine 0 CA--C 1.482 -2.002 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.6 p -96.01 -20.32 18.79 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.462 -0.869 . . . . 0.0 110.576 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.8 t 57.96 -119.23 1.12 Allowed 'General case' 0 C--N 1.368 1.376 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.3 mt -123.12 -31.89 3.54 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 119.187 0.903 . . . . 0.0 109.785 177.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.52 -40.19 94.19 Favored Glycine 0 C--N 1.358 1.767 0 N-CA-C 117.925 1.93 . . . . 0.0 117.925 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.88 -41.59 82.54 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 118.424 1.112 . . . . 0.0 110.96 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.0 mt -67.28 -40.46 84.95 Favored 'Isoleucine or valine' 0 C--N 1.362 1.109 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.2 m -61.59 -37.01 82.32 Favored 'General case' 0 C--N 1.359 1.009 0 CA-C-N 118.612 0.642 . . . . 0.0 112.563 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.62 -40.14 88.63 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 119.217 -0.421 . . . . 0.0 110.984 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 62.7 ttm-85 -72.16 -52.63 15.74 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-O 119.157 -0.449 . . . . 0.0 111.534 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.8 mt -142.0 110.17 5.94 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.34 -49.84 4.78 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.1 t -73.45 -52.72 4.94 Favored Pre-proline 0 C--N 1.356 0.888 0 CA-C-O 115.457 -2.211 . . . . 0.0 112.818 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.56 75.83 4.69 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 CA-C-N 124.321 2.579 . . . . 0.0 112.09 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 55.6 mmm-85 -93.53 -10.99 32.98 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.3 m -61.27 -43.42 98.9 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.8 p -72.13 -39.36 68.88 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 123.705 0.802 . . . . 0.0 110.976 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 78.3 t -62.3 -40.25 87.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.834 0 C-N-CA 125.39 1.476 . . . . 0.0 110.353 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.36 -38.34 89.17 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.652 0.781 . . . . 0.0 111.867 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 94.9 m -71.28 -45.57 62.83 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 123.858 0.863 . . . . 0.0 110.571 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.41 -43.66 97.03 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 C-N-CA 124.869 1.268 . . . . 0.0 111.618 -177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.5 m -65.48 -36.83 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.128 0 CA-C-O 118.284 -0.865 . . . . 0.0 113.188 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -68.52 -44.51 74.46 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.14 -45.53 76.84 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 123.113 0.565 . . . . 0.0 111.417 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -69.97 -30.65 68.05 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -65.39 -39.81 92.7 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -63.27 -40.11 96.48 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.746 0.818 . . . . 0.0 109.82 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -69.69 -38.53 77.01 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 118.955 -0.545 . . . . 0.0 111.905 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.5 -32.89 61.57 Favored Glycine 0 C--N 1.358 1.754 0 CA-C-O 119.825 -0.431 . . . . 0.0 113.868 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.3 m -82.19 -48.06 11.75 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 117.208 0.504 . . . . 0.0 111.719 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.9 m . . . . . 0 N--CA 1.436 -1.161 0 N-CA-C 119.518 3.155 . . . . 0.0 119.518 -175.484 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 . . . . . 0 N--CA 1.437 -1.096 0 CA-C-O 119.313 -0.375 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -66.27 -38.96 89.05 Favored 'General case' 0 C--N 1.361 1.083 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.9 mt -66.91 -38.94 87.18 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 78.1 mtt85 -61.98 -37.24 84.07 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 123.223 0.609 . . . . 0.0 111.176 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -60.52 -42.23 96.02 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 124.405 1.082 . . . . 0.0 109.391 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -69.71 -41.87 74.79 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.907 1.283 . . . . 0.0 110.387 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 88.9 mt -64.13 -38.1 81.6 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 125.9 1.68 . . . . 0.0 111.812 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.4 -40.53 88.36 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -69.53 -40.25 77.0 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 123.528 0.517 . . . . 0.0 109.848 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.6 mt -60.7 -30.35 69.89 Favored 'General case' 0 CA--C 1.496 -1.126 0 C-N-CA 125.229 1.412 . . . . 0.0 112.774 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -56.16 -44.04 78.94 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 124.351 1.06 . . . . 0.0 110.16 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -84.75 -36.85 21.49 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 117.903 0.32 . . . . 0.0 111.156 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.8 m -60.54 -36.62 78.89 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 176.89 -176.05 47.87 Favored Glycine 0 CA--C 1.49 -1.517 0 C-N-CA 119.469 -1.348 . . . . 0.0 113.217 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.6 t 56.93 -149.67 0.46 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 128.242 2.617 . . . . 0.0 111.37 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.8 m -132.99 155.4 49.23 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.637 0.732 . . . . 0.0 109.14 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.7 tp -65.02 -32.07 73.61 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.473 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.15 -35.69 92.02 Favored Glycine 0 C--N 1.358 1.751 0 CA-C-O 119.275 -0.736 . . . . 0.0 111.51 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.9 -40.92 62.83 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-N 118.077 0.938 . . . . 0.0 111.303 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.59 -41.96 86.22 Favored 'Isoleucine or valine' 0 C--N 1.358 0.951 0 C-N-CA 123.776 0.83 . . . . 0.0 109.515 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.3 m -65.04 -38.85 92.2 Favored 'General case' 0 CA--C 1.496 -1.126 0 C-N-CA 124.397 1.079 . . . . 0.0 111.083 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.36 -39.07 85.69 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 92.0 mtm-85 -66.8 -42.41 85.98 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 122.599 0.36 . . . . 0.0 111.305 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.2 mt -73.09 -26.41 61.24 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 124.793 1.237 . . . . 0.0 111.993 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 79.49 -63.34 0.26 Allowed 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 128.212 2.605 . . . . 0.0 108.197 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.0 t -115.97 105.45 51.19 Favored Pre-proline 0 C--N 1.36 1.024 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -71.85 -27.02 18.31 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 123.762 2.975 . . . . 0.0 113.639 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 64.89 167.34 0.17 Allowed 'General case' 0 C--N 1.359 1.006 0 C-N-CA 125.949 1.699 . . . . 0.0 112.505 -166.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 88.8 p -77.2 -26.77 53.15 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 124.997 1.319 . . . . 0.0 110.338 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.2 m -61.56 -44.72 96.51 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.827 1.251 . . . . 0.0 113.421 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.0 t -67.16 -36.91 78.12 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.59 -40.36 95.38 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 123.549 0.74 . . . . 0.0 110.947 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 95.8 m -68.44 -41.84 79.73 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 123.548 0.739 . . . . 0.0 110.062 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.8 mt -67.52 -42.36 86.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.968 0 C-N-CA 122.927 0.491 . . . . 0.0 109.993 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.8 m -66.36 -33.31 62.67 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 CA-C-N 118.468 0.576 . . . . 0.0 111.753 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -64.04 -39.2 93.57 Favored 'General case' 0 C--N 1.359 0.988 0 CA-C-N 118.321 0.509 . . . . 0.0 110.932 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -67.68 -39.6 84.44 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 124.201 1.0 . . . . 0.0 109.613 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -66.49 -37.22 84.61 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 124.249 1.019 . . . . 0.0 109.823 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -67.99 -41.2 82.67 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 124.907 1.283 . . . . 0.0 109.097 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -63.98 -35.03 79.36 Favored 'General case' 0 C--N 1.36 1.025 0 C-N-CA 124.617 1.167 . . . . 0.0 109.401 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -66.16 -25.46 66.97 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 123.812 0.845 . . . . 0.0 111.606 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.99 -35.02 77.85 Favored Glycine 0 C--N 1.36 1.88 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 84.8 m -79.28 -52.6 7.91 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.8 m . . . . . 0 C--N 1.359 1.004 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -179.713 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 . . . . . 0 N--CA 1.441 -0.91 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -65.77 -43.38 89.03 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 118.757 0.708 . . . . 0.0 110.213 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.3 tp -64.3 -45.59 87.29 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.706 1.202 . . . . 0.0 109.169 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.88 -38.14 87.99 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.951 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -65.25 -37.06 86.06 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-N 118.513 0.597 . . . . 0.0 112.28 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -66.25 -37.19 84.9 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 122.912 0.485 . . . . 0.0 109.754 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.7 mt -69.13 -40.19 80.31 Favored 'Isoleucine or valine' 0 C--N 1.356 0.859 0 C-N-CA 123.722 0.809 . . . . 0.0 109.734 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.5 t -66.08 -34.45 70.28 Favored 'Isoleucine or valine' 0 C--N 1.356 0.863 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -64.13 -39.13 93.36 Favored 'General case' 0 C--N 1.358 0.95 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.0 mt -66.4 -38.43 87.47 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 123.934 0.894 . . . . 0.0 109.825 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -60.2 -46.15 90.72 Favored 'General case' 0 C--N 1.364 1.204 0 C-N-CA 125.114 1.366 . . . . 0.0 108.097 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.91 -33.83 76.46 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 123.527 0.731 . . . . 0.0 111.271 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.4 m -74.95 -12.69 60.4 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 124.217 1.007 . . . . 0.0 112.972 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.61 -15.42 12.79 Favored Glycine 0 C--N 1.358 1.783 0 N-CA-C 116.76 1.464 . . . . 0.0 116.76 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.8 t -91.84 87.17 6.15 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 100.924 -3.732 . . . . 0.0 100.924 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.4 m -95.66 -73.43 0.59 Allowed 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 115.138 1.532 . . . . 0.0 115.138 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.2 mt -81.22 -24.03 37.69 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-O 119.555 -0.259 . . . . 0.0 111.572 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.78 -20.94 78.98 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.6 -49.45 4.01 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 117.901 0.851 . . . . 0.0 112.456 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.96 -48.81 84.46 Favored 'Isoleucine or valine' 0 C--N 1.358 0.974 0 CA-C-N 118.44 0.564 . . . . 0.0 111.865 -176.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.2 m -70.2 -35.1 73.69 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.87 -50.23 9.44 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -73.16 -51.09 19.17 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 94.8 mt -87.83 -55.99 3.53 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.978 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 66.65 -67.02 0.17 Allowed 'General case' 0 C--N 1.356 0.862 0 C-N-CA 125.853 1.661 . . . . 0.0 114.909 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.6 t -69.48 -53.79 12.19 Favored Pre-proline 0 C--N 1.358 0.967 0 CA-C-O 114.549 -2.643 . . . . 0.0 114.713 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -81.8 46.08 2.13 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 CA-C-N 126.132 3.226 . . . . 0.0 114.441 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -70.68 -35.08 72.64 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 118.962 -0.542 . . . . 0.0 110.892 -174.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.5 m -65.0 -43.31 92.98 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 93.0 p -67.47 -39.34 85.27 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 78.3 t -67.69 -36.33 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 117.862 -1.066 . . . . 0.0 109.31 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.62 -36.75 84.84 Favored 'General case' 0 C--N 1.361 1.082 0 CA-C-N 119.656 1.116 . . . . 0.0 110.923 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 95.3 m -65.4 -40.95 94.05 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 123.351 0.66 . . . . 0.0 109.23 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.87 -40.78 81.63 Favored 'Isoleucine or valine' 0 C--N 1.356 0.889 0 C-N-CA 124.687 1.195 . . . . 0.0 110.08 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.1 t -61.6 -39.56 83.54 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 C-N-CA 125.773 1.629 . . . . 0.0 110.149 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -62.23 -38.85 90.78 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 118.424 0.556 . . . . 0.0 111.127 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -68.8 -42.45 77.29 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 123.921 0.888 . . . . 0.0 108.922 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . 0.259 28.8 m-85 -70.42 -23.2 62.7 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -66.3 -38.88 88.75 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -65.34 -42.69 92.63 Favored 'General case' 0 C--N 1.363 1.153 0 C-N-CA 124.404 1.082 . . . . 0.0 108.414 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -70.63 -25.04 62.85 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.31 -32.34 68.55 Favored Glycine 0 C--N 1.356 1.657 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.9 m -78.46 -50.01 12.41 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 83.3 m . . . . . 0 C--N 1.359 1.003 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 -179.148 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 . . . . . 0 CA--C 1.496 -1.113 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -67.41 -41.36 85.03 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 118.797 0.726 . . . . 0.0 111.629 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.05 -42.4 76.33 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 123.922 0.889 . . . . 0.0 110.345 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -66.7 -37.74 85.33 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-O 118.675 -0.678 . . . . 0.0 111.091 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -65.47 -34.7 78.89 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 119.018 -0.515 . . . . 0.0 111.476 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -66.51 -38.72 87.83 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.3 mt -67.65 -40.05 83.33 Favored 'Isoleucine or valine' 0 C--N 1.359 1.003 0 C-N-CA 123.851 0.86 . . . . 0.0 109.505 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.5 -36.48 77.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.826 0 C-N-CA 124.197 0.999 . . . . 0.0 108.985 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.06 -37.29 87.07 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.17 -36.37 79.53 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 123.66 0.784 . . . . 0.0 110.15 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -61.09 -45.38 94.97 Favored 'General case' 0 C--N 1.367 1.341 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.64 -36.44 84.28 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 125.262 1.425 . . . . 0.0 110.546 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.2 m -74.12 -18.26 60.82 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.226 1.011 . . . . 0.0 113.326 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.28 -14.34 8.85 Favored Glycine 0 C--N 1.357 1.704 0 CA-C-O 118.255 -1.303 . . . . 0.0 116.057 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.9 m -91.74 82.74 5.23 Favored 'General case' 0 C--N 1.356 0.853 1 N-CA-C 100.194 -4.002 . . . . 0.0 100.194 177.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.4 m -94.72 -81.01 0.4 Allowed 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 -175.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.3 mt -79.46 -23.66 42.94 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 118.371 0.532 . . . . 0.0 111.867 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.18 -25.48 75.41 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.74 -46.84 6.43 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 117.668 0.734 . . . . 0.0 112.707 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -66.62 -46.69 85.42 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 CA-C-N 118.124 0.42 . . . . 0.0 111.614 -177.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.8 m -69.25 -34.57 74.99 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -82.62 -47.25 12.29 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -74.69 -52.52 11.39 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 93.3 mt -84.33 -54.06 5.04 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 119.46 -0.305 . . . . 0.0 111.797 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 67.08 -66.92 0.18 Allowed 'General case' 0 C--N 1.358 0.969 0 C-N-CA 126.238 1.815 . . . . 0.0 115.328 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.8 t -72.91 -52.77 5.59 Favored Pre-proline 0 N--CA 1.442 -0.86 0 CA-C-O 114.963 -2.446 . . . . 0.0 114.764 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -81.51 43.92 1.63 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 125.789 3.103 . . . . 0.0 115.101 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -67.95 -33.38 74.55 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-O 118.55 -0.738 . . . . 0.0 112.803 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.3 m -65.72 -43.43 89.08 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 123.291 0.637 . . . . 0.0 111.683 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.8 m -66.42 -41.95 88.49 Favored 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 123.646 0.778 . . . . 0.0 109.657 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 78.9 t -67.34 -40.48 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-O 117.82 -1.086 . . . . 0.0 109.927 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -64.22 -30.81 71.85 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 119.652 1.115 . . . . 0.0 112.955 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 97.5 m -66.34 -40.51 89.89 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.3 mt -71.58 -40.68 71.56 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 C-N-CA 125.145 1.378 . . . . 0.0 109.511 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.73 -37.22 77.53 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 C-N-CA 125.754 1.621 . . . . 0.0 111.057 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 95.5 mtm-85 -63.33 -39.59 94.95 Favored 'General case' 0 C--N 1.357 0.926 0 CA-C-N 119.605 1.093 . . . . 0.0 110.91 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -68.6 -41.04 80.13 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 123.501 0.72 . . . . 0.0 109.071 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -69.98 -25.09 63.45 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -66.85 -38.13 85.78 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -65.41 -41.17 93.91 Favored 'General case' 0 C--N 1.362 1.122 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -69.55 -26.38 64.46 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.07 -31.03 71.93 Favored Glycine 0 C--N 1.357 1.704 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.2 m -75.34 -52.99 9.5 Favored 'General case' 0 C--N 1.359 1.008 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 76.8 m . . . . . 0 C--N 1.36 1.063 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -179.958 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 123.297 1.522 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.3 p -110.59 -22.8 11.45 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.375 -1.739 . . . . 0.0 114.801 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 78.2 mtm -72.41 -24.97 61.31 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.24 -125.0 5.4 Favored Glycine 0 C--N 1.355 1.637 0 N-CA-C 108.29 -1.924 . . . . 0.0 108.29 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . 0.271 99.1 mttt 58.31 106.35 0.02 OUTLIER 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 57.6 m 53.34 52.1 14.16 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -71.99 124.54 25.14 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 81.07 130.56 0.05 Allowed 'General case' 0 C--N 1.358 0.968 0 C-N-CA 127.149 2.18 . . . . 0.0 106.067 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.71 -41.78 93.63 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 124.702 1.201 . . . . 0.0 110.729 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.6 p -76.98 -9.49 58.73 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 73.3 tp60 -60.73 -39.98 90.67 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -65.82 -38.46 88.97 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 122.726 0.411 . . . . 0.0 110.824 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.3 tp -67.1 -41.09 86.84 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 123.639 0.776 . . . . 0.0 109.037 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -62.38 -42.61 99.55 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 124.631 1.172 . . . . 0.0 109.595 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -65.18 -41.79 94.28 Favored 'General case' 0 CA--C 1.496 -1.119 0 C-N-CA 123.256 0.622 . . . . 0.0 111.122 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -64.44 -41.11 96.75 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 123.078 0.551 . . . . 0.0 111.57 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.9 mm -67.35 -45.83 85.04 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 CA-C-O 118.602 -0.714 . . . . 0.0 110.24 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.72 -37.12 79.2 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 C-N-CA 123.54 0.736 . . . . 0.0 111.166 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -64.38 -43.75 93.51 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 118.584 0.629 . . . . 0.0 110.514 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.0 mt -67.57 -38.7 84.47 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 123.63 0.772 . . . . 0.0 110.886 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -61.68 -46.65 88.8 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.806 2.042 . . . . 0.0 110.035 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -74.21 -37.36 63.89 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.2 p -80.93 -42.18 21.75 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 117.575 2.435 . . . . 0.0 117.575 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.14 -113.14 1.09 Allowed Glycine 0 CA--C 1.485 -1.84 0 C-N-CA 121.488 -0.386 . . . . 0.0 112.652 -177.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.9 t -66.4 122.9 18.56 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 121.9 0.857 . . . . 0.0 110.747 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 73.4 m -91.72 -57.55 2.71 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 113.801 -1.545 . . . . 0.0 113.135 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.7 mt -98.92 -16.91 18.61 Favored 'General case' 0 CA--C 1.487 -1.455 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.721 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.21 -38.56 72.12 Favored Glycine 0 C--N 1.354 1.557 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.62 -38.84 84.5 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 123.486 0.715 . . . . 0.0 111.001 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -72.37 -47.09 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.967 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.7 m -63.23 -37.96 89.28 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 124.035 0.934 . . . . 0.0 112.988 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -75.79 -46.01 33.04 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -86.74 -54.99 4.06 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.9 mt -81.42 -31.44 33.17 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 123.772 0.829 . . . . 0.0 112.949 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 77.44 -67.35 0.2 Allowed 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 128.26 2.624 . . . . 0.0 111.052 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.2 t -113.48 117.29 45.21 Favored Pre-proline 0 N--CA 1.44 -0.948 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -67.33 -38.64 14.68 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 123.197 2.598 . . . . 0.0 114.241 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 56.67 -173.03 0.07 Allowed 'General case' 0 C--N 1.36 1.06 0 C-N-CA 124.863 1.265 . . . . 0.0 113.376 -172.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.3 p -66.1 -29.99 70.42 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 124.618 1.167 . . . . 0.0 110.721 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.3 m -61.07 -48.86 79.77 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.425 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.0 t -81.33 -38.26 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 118.901 0.773 . . . . 0.0 109.71 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -61.33 -38.86 88.43 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 97.7 m -68.12 -41.87 81.08 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 119.268 0.94 . . . . 0.0 109.901 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.3 mt -66.35 -43.78 91.2 Favored 'Isoleucine or valine' 0 C--N 1.356 0.888 0 C-N-CA 123.767 0.827 . . . . 0.0 109.734 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . 0.264 33.0 m -70.18 -32.49 51.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 CA-C-O 117.743 -1.122 . . . . 0.0 113.323 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -62.53 -41.55 98.94 Favored 'General case' 0 C--N 1.362 1.111 0 CA-C-N 119.22 0.918 . . . . 0.0 111.616 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -70.48 -44.45 67.69 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 124.443 1.097 . . . . 0.0 109.192 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -66.13 -32.16 73.45 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.79 -39.42 90.95 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -64.3 -42.68 96.24 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 123.61 0.764 . . . . 0.0 109.531 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -70.24 -33.51 71.72 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.93 -31.12 67.24 Favored Glycine 0 C--N 1.355 1.588 0 C-N-CA 124.527 1.061 . . . . 0.0 110.857 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.0 m -78.94 -60.33 2.42 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.1 m -153.27 108.1 3.17 Favored 'General case' 0 C--N 1.358 0.975 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -89.4 126.0 35.38 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -98.9 139.9 33.87 Favored 'General case' 0 CA--C 1.498 -1.03 0 C-N-CA 124.453 1.101 . . . . 0.0 110.593 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 56.9 m80 . . . . . 0 C--O 1.259 1.554 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 179.899 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.278 0 CA-C-O 121.65 0.738 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.9 t -80.94 137.96 36.11 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.205 -1.361 . . . . 0.0 109.409 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 99.1 mmm -104.76 -28.03 11.43 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.11 -141.6 9.79 Favored Glycine 0 CA--C 1.488 -1.632 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 72.93 -52.83 0.71 Allowed 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 127.394 2.278 . . . . 0.0 112.013 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.1 t -70.83 125.1 25.9 Favored 'General case' 0 C--N 1.36 1.03 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -122.48 161.07 24.26 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.05 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.4 mp0 54.76 40.62 32.03 Favored 'General case' 0 C--N 1.36 1.025 0 C-N-CA 127.275 2.23 . . . . 0.0 113.245 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.35 -47.21 90.57 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.0 p -80.07 -39.19 30.24 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 123.902 0.881 . . . . 0.0 113.092 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -61.61 -27.9 68.98 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -57.77 -32.94 67.99 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.8 mt -64.19 -40.84 96.94 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 123.013 0.525 . . . . 0.0 111.789 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.75 -37.99 67.51 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 124.622 1.169 . . . . 0.0 109.915 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -61.33 -35.45 77.43 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 123.658 0.783 . . . . 0.0 111.691 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -65.47 -29.03 69.65 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 93.5 mt -74.81 -47.59 37.13 Favored 'Isoleucine or valine' 0 C--N 1.356 0.881 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.282 31.9 m -67.42 -25.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.36 1.062 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -63.9 -32.99 74.71 Favored 'General case' 0 C--N 1.358 0.962 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.91 -37.84 79.2 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 124.247 1.019 . . . . 0.0 108.478 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -62.98 -42.05 99.73 Favored 'General case' 0 C--N 1.363 1.158 0 C-N-CA 124.238 1.015 . . . . 0.0 109.404 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -68.48 -37.62 80.29 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.207 1.003 . . . . 0.0 110.512 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.0 m -69.81 -29.86 67.25 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 123.655 0.782 . . . . 0.0 111.671 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.15 109.96 0.53 Allowed Glycine 0 CA--C 1.482 -2.025 0 N-CA-C 106.268 -2.733 . . . . 0.0 106.268 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.9 t -79.26 114.57 18.3 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.851 0.834 . . . . 0.0 108.877 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.6 m -104.27 115.58 30.64 Favored 'General case' 0 N--CA 1.431 -1.412 1 N-CA-C 97.568 -4.975 . . . . 0.0 97.568 176.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.0 mt -67.31 -35.89 80.36 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.43 -38.41 86.86 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.5 -41.82 54.36 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.1 mt -68.95 -38.99 79.27 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 CA-C-O 118.619 -0.705 . . . . 0.0 111.961 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.5 m -65.47 -38.17 89.01 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 118.621 0.646 . . . . 0.0 111.591 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.22 -37.19 74.97 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 118.106 0.412 . . . . 0.0 111.863 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.75 -46.4 63.03 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.94 -41.77 22.39 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 75.6 -67.95 0.22 Allowed 'General case' 0 C--N 1.355 0.846 0 C-N-CA 127.63 2.372 . . . . 0.0 107.2 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.2 t -127.88 102.93 21.67 Favored Pre-proline 0 C--N 1.358 0.949 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.11 -32.69 42.85 Favored 'Trans proline' 0 CA--C 1.499 -1.235 0 C-N-CA 123.986 3.124 . . . . 0.0 114.577 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 65.04 174.39 0.21 Allowed 'General case' 0 C--N 1.355 0.836 0 C-N-CA 125.789 1.635 . . . . 0.0 112.969 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.9 m -64.34 -35.31 80.47 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 124.484 1.114 . . . . 0.0 112.819 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.7 m -63.69 -48.53 76.78 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 77.0 t -71.65 -38.69 67.73 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 73.3 tp60 -60.26 -35.84 76.42 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 123.176 0.59 . . . . 0.0 112.431 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 99.2 m -67.44 -39.44 85.42 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.391 0.541 . . . . 0.0 110.282 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.4 mt -71.77 -36.64 59.49 Favored 'Isoleucine or valine' 0 C--N 1.359 1.015 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.39 -40.3 85.77 Favored 'Isoleucine or valine' 0 C--N 1.362 1.126 0 C-N-CA 125.26 1.424 . . . . 0.0 108.471 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 -63.72 -36.6 84.4 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 123.343 0.657 . . . . 0.0 112.104 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.89 -44.39 93.18 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -68.3 -36.04 78.75 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.88 -39.25 93.74 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 124.953 1.301 . . . . 0.0 109.619 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -63.45 -43.6 96.91 Favored 'General case' 0 C--N 1.357 0.927 0 C-N-CA 123.768 0.827 . . . . 0.0 110.275 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -81.62 -22.7 37.49 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.15 -11.57 85.42 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-O 118.783 -1.009 . . . . 0.0 112.426 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.0 m -72.25 -60.79 2.05 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 118.123 0.961 . . . . 0.0 108.851 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 80.6 m -133.94 -69.05 0.54 Allowed 'General case' 0 C--N 1.362 1.13 0 CA-C-N 119.093 0.86 . . . . 0.0 108.768 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 67.34 -72.77 0.09 Allowed 'General case' 0 C--N 1.364 1.223 0 C-N-CA 128.079 2.552 . . . . 0.0 111.59 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -77.03 135.88 38.67 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 123.645 0.778 . . . . 0.0 112.786 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 . . . . . 0 C--O 1.26 1.645 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 179.872 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.1 m -85.62 -44.47 12.58 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.695 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.6 ttm -62.06 124.37 20.63 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 123.766 0.826 . . . . 0.0 111.776 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.04 -12.97 62.54 Favored Glycine 0 C--N 1.352 1.43 0 CA-C-N 114.482 -1.236 . . . . 0.0 112.552 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -114.72 2.61 14.5 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.12 0.968 . . . . 0.0 109.411 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.5 m -66.66 -25.82 66.75 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 126.945 2.098 . . . . 0.0 111.535 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.31 166.99 22.13 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 127.36 2.264 . . . . 0.0 112.778 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -67.5 169.03 9.82 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.876 1.67 . . . . 0.0 112.13 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.5 mt 81.96 -19.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.089 0 C-N-CA 128.89 2.876 . . . . 0.0 111.143 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 75.5 m -67.55 -48.99 65.35 Favored 'General case' 0 C--N 1.357 0.929 0 CA-C-N 119.25 0.932 . . . . 0.0 110.674 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -75.11 -36.24 61.67 Favored 'General case' 0 CA--C 1.496 -1.126 0 C-N-CA 124.466 1.106 . . . . 0.0 110.007 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.6 -35.08 79.34 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.739 1.216 . . . . 0.0 110.628 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.3 tp -65.83 -43.03 89.8 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.7 mtp85 -65.18 -38.6 91.01 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 122.845 0.458 . . . . 0.0 111.049 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.46 -41.8 96.31 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 92.4 mtm-85 -67.24 -29.35 68.96 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 123.962 0.905 . . . . 0.0 113.048 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -70.05 -46.32 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 119.29 0.95 . . . . 0.0 109.0 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.7 t -68.48 -44.33 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 124.634 1.174 . . . . 0.0 111.344 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -68.79 -40.13 79.77 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 124.072 0.949 . . . . 0.0 112.555 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.5 mt -67.22 -33.27 75.0 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 118.836 -0.602 . . . . 0.0 110.817 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -62.49 -42.07 99.24 Favored 'General case' 0 C--N 1.362 1.12 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -66.32 -36.66 83.48 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 123.971 0.908 . . . . 0.0 109.978 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.8 m -70.72 -16.97 62.82 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 124.906 1.282 . . . . 0.0 112.978 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.53 1.16 3.52 Favored Glycine 0 C--N 1.36 1.901 0 N-CA-C 117.866 1.907 . . . . 0.0 117.866 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.6 m -77.18 154.77 32.8 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 119.972 1.886 . . . . 0.0 111.721 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.7 p -80.83 164.67 22.52 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 125.307 1.443 . . . . 0.0 112.623 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 86.2 mt -68.94 -22.45 64.13 Favored 'General case' 0 C--N 1.361 1.073 0 C-N-CA 124.07 0.948 . . . . 0.0 110.61 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.98 -35.66 92.28 Favored Glycine 0 C--N 1.359 1.861 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.11 -37.01 75.26 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 123.644 0.778 . . . . 0.0 110.184 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.3 mt -66.41 -43.15 91.3 Favored 'Isoleucine or valine' 0 C--N 1.365 1.244 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.2 m -63.09 -37.14 86.02 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.65 1.18 . . . . 0.0 110.498 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.68 -46.88 67.89 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -74.44 -49.28 23.04 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.4 mt -77.36 -33.72 55.27 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 115.721 1.748 . . . . 0.0 115.721 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 74.76 -68.3 0.22 Allowed 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 126.186 1.795 . . . . 0.0 111.527 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.6 t -122.48 94.7 47.53 Favored Pre-proline 0 C--N 1.36 1.061 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -70.77 -27.83 21.15 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 123.578 2.852 . . . . 0.0 113.328 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 60.31 -175.57 0.11 Allowed 'General case' 0 C--N 1.359 1.02 0 C-N-CA 124.846 1.258 . . . . 0.0 112.548 -170.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 92.8 p -67.98 -37.44 81.52 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 123.775 0.83 . . . . 0.0 112.821 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.7 m -63.86 -47.47 80.55 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -177.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.4 t -71.45 -37.92 66.42 Favored 'Isoleucine or valine' 0 C--N 1.359 0.981 0 CA-C-O 118.535 -0.745 . . . . 0.0 109.29 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -62.3 -37.77 86.81 Favored 'General case' 0 C--N 1.362 1.12 0 CA-C-N 118.573 0.624 . . . . 0.0 112.334 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 97.7 m -66.84 -41.39 87.48 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 123.346 0.658 . . . . 0.0 109.581 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.4 mt -66.4 -41.92 89.58 Favored 'Isoleucine or valine' 0 C--N 1.358 0.953 0 C-N-CA 123.495 0.718 . . . . 0.0 110.01 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.7 t -62.9 -40.13 87.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 C-N-CA 124.127 0.971 . . . . 0.0 110.744 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -65.53 -40.1 92.53 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.45 0.568 . . . . 0.0 112.245 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -68.29 -40.25 81.84 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 124.155 0.982 . . . . 0.0 109.783 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -66.62 -40.14 88.64 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.246 1.018 . . . . 0.0 110.317 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.0 -41.51 86.58 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -60.76 -28.74 68.94 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 125.941 1.696 . . . . 0.0 112.463 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -60.1 -27.94 67.43 Favored 'General case' 0 C--N 1.361 1.104 0 N-CA-C 112.71 0.634 . . . . 0.0 112.71 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.83 -28.87 71.43 Favored Glycine 0 C--N 1.359 1.854 0 CA-C-O 119.483 -0.62 . . . . 0.0 111.818 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.0 m -83.1 -58.36 2.89 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 81.6 m -150.57 110.44 4.09 Favored 'General case' 0 C--N 1.359 1.02 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -82.52 -49.61 9.71 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.005 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -110.09 130.5 55.53 Favored 'General case' 0 CA--C 1.49 -1.336 0 CA-C-O 120.734 0.302 . . . . 0.0 110.626 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.1 m80 . . . . . 0 C--O 1.26 1.639 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 -179.525 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.146 0 CA-C-O 121.415 0.626 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.4 p -103.53 -3.14 25.69 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 125.179 1.392 . . . . 0.0 113.21 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 97.8 mmm -66.93 -31.61 72.31 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.79 -90.78 2.19 Favored Glycine 0 C--N 1.354 1.556 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . 0.279 95.7 mttt 56.23 56.82 5.46 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 117.129 2.27 . . . . 0.0 117.129 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.279 59.2 m 54.91 69.74 0.7 Allowed 'General case' 0 C--N 1.362 1.118 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 89.2 tttt -63.55 131.86 49.42 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 80.9 133.94 0.06 Allowed 'General case' 0 C--N 1.359 0.984 0 C-N-CA 128.604 2.762 . . . . 0.0 107.161 -177.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.44 -41.35 90.85 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 C-N-CA 124.037 0.935 . . . . 0.0 109.468 -178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 98.6 p -66.58 -21.44 66.14 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 126.06 1.744 . . . . 0.0 115.259 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -59.02 -38.05 78.35 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -65.43 -40.09 92.89 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 119.278 0.945 . . . . 0.0 111.478 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.3 tp -66.79 -41.66 87.28 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -63.26 -41.89 99.09 Favored 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 123.596 0.758 . . . . 0.0 110.14 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.37 -42.86 95.97 Favored 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 123.963 0.905 . . . . 0.0 111.334 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -64.26 -41.89 96.72 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 123.557 0.743 . . . . 0.0 110.46 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.6 mt -68.72 -46.51 79.53 Favored 'Isoleucine or valine' 0 C--N 1.358 0.966 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.407 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.96 -39.97 87.48 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 C-N-CA 124.039 0.935 . . . . 0.0 112.039 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -62.82 -43.4 98.9 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 118.297 0.498 . . . . 0.0 110.692 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.9 mt -70.63 -37.79 73.83 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 123.068 0.547 . . . . 0.0 111.77 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -60.92 -44.92 96.51 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 126.724 2.01 . . . . 0.0 109.687 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -74.77 -40.31 61.26 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.9 p -80.88 -43.51 19.79 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.27 -115.31 1.38 Allowed Glycine 0 CA--C 1.487 -1.691 0 CA-C-O 121.158 0.31 . . . . 0.0 112.835 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.0 t -66.66 122.27 17.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-O 122.203 1.001 . . . . 0.0 110.691 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.1 m -93.65 -54.99 3.42 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 113.126 -1.852 . . . . 0.0 111.298 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.0 mt -87.96 -29.07 21.06 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.81 -36.45 91.17 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-O 119.656 -0.524 . . . . 0.0 112.525 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.81 -40.85 79.34 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 117.06 0.43 . . . . 0.0 111.0 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -71.02 -45.39 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 118.955 -0.545 . . . . 0.0 109.778 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.7 m -62.7 -38.32 89.95 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 124.143 0.977 . . . . 0.0 113.149 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -72.7 -48.4 39.21 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -83.69 -55.81 4.07 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.98 -33.43 24.6 Favored 'General case' 0 CA--C 1.494 -1.208 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 78.82 -66.08 0.2 Allowed 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 128.011 2.524 . . . . 0.0 108.653 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.6 t -115.75 118.97 38.25 Favored Pre-proline 0 C--N 1.357 0.911 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -66.76 -38.44 17.84 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 123.849 3.033 . . . . 0.0 114.967 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 55.82 -171.98 0.07 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 125.501 1.521 . . . . 0.0 113.532 -172.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 89.0 p -63.79 -32.32 73.78 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 124.897 1.279 . . . . 0.0 111.872 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.6 m -59.81 -47.09 87.1 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 124.325 1.05 . . . . 0.0 112.757 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 77.0 t -82.46 -38.02 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-O 118.873 -0.584 . . . . 0.0 110.459 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -60.62 -38.98 86.54 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 98.6 m -65.76 -42.93 90.27 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-N 118.803 0.729 . . . . 0.0 109.939 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.1 mt -67.11 -45.93 85.55 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 123.985 0.914 . . . . 0.0 110.176 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . 0.266 33.9 m -69.18 -33.52 58.7 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.388 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -64.58 -36.71 85.1 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 119.179 0.9 . . . . 0.0 113.158 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -71.47 -44.98 63.77 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -66.74 -30.56 70.82 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -65.85 -37.27 85.73 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.611 1.565 . . . . 0.0 108.762 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -65.75 -41.55 91.98 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -70.25 -32.49 70.36 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 122.755 0.422 . . . . 0.0 111.4 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.86 -34.05 59.49 Favored Glycine 0 C--N 1.356 1.668 0 C-N-CA 123.878 0.752 . . . . 0.0 111.424 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.7 m -74.94 -61.05 2.02 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 79.1 m -154.55 106.92 2.77 Favored 'General case' 0 C--N 1.362 1.12 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -85.81 131.93 34.22 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -84.22 140.64 31.56 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 124.54 1.136 . . . . 0.0 110.945 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 47.5 m80 . . . . . 0 C--O 1.261 1.672 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 179.595 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.173 0 CA-C-O 121.176 0.512 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.7 t -76.51 132.43 39.56 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.869 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 97.4 mmm -105.32 120.3 41.22 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.7 174.08 46.98 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -134.05 148.45 51.06 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 121.428 0.633 . . . . 0.0 111.969 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.1 p -90.7 168.17 11.96 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 124.85 1.26 . . . . 0.0 107.61 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt 58.27 60.21 2.73 Favored 'General case' 0 C--N 1.365 1.245 0 C-N-CA 124.56 1.144 . . . . 0.0 112.9 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -85.44 7.1 23.94 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.361 1.064 . . . . 0.0 113.622 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.2 mt -58.38 -41.19 80.78 Favored 'Isoleucine or valine' 0 C--N 1.357 0.921 0 C-N-CA 125.111 1.364 . . . . 0.0 111.27 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 88.6 p -66.84 -38.89 87.28 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 123.97 0.908 . . . . 0.0 111.96 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -67.41 -31.94 72.49 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 125.588 1.555 . . . . 0.0 110.853 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -60.15 -39.99 88.29 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 123.866 0.867 . . . . 0.0 112.932 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.15 -39.79 82.53 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -65.3 -39.61 92.72 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 123.397 0.679 . . . . 0.0 109.659 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.07 -40.09 95.51 Favored 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 124.684 1.193 . . . . 0.0 109.043 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.66 -39.03 93.31 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.949 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.36 -45.42 85.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.2 t -63.74 -46.23 95.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 C-N-CA 124.792 1.237 . . . . 0.0 111.318 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -65.25 -42.07 93.65 Favored 'General case' 0 CA--C 1.488 -1.422 0 C-N-CA 123.853 0.861 . . . . 0.0 111.546 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.9 mt -66.24 -38.7 88.51 Favored 'General case' 0 CA--C 1.496 -1.104 0 O-C-N 123.514 0.509 . . . . 0.0 110.521 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -60.84 -45.33 94.92 Favored 'General case' 0 C--N 1.361 1.087 0 CA-C-O 118.965 -0.54 . . . . 0.0 110.678 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.04 -38.25 82.29 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.874 1.27 . . . . 0.0 111.587 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.4 m -69.79 -28.68 65.94 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 124.161 0.985 . . . . 0.0 112.538 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.54 78.22 0.44 Allowed Glycine 0 CA--C 1.482 -2.002 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.6 p -96.01 -20.32 18.79 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.462 -0.869 . . . . 0.0 110.576 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.8 t 57.96 -119.23 1.12 Allowed 'General case' 0 C--N 1.368 1.376 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.3 mt -123.12 -31.89 3.54 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 119.187 0.903 . . . . 0.0 109.785 177.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.52 -40.19 94.19 Favored Glycine 0 C--N 1.358 1.767 0 N-CA-C 117.925 1.93 . . . . 0.0 117.925 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.88 -41.59 82.54 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 118.424 1.112 . . . . 0.0 110.96 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.0 mt -67.28 -40.46 84.95 Favored 'Isoleucine or valine' 0 C--N 1.362 1.109 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.2 m -61.59 -37.01 82.32 Favored 'General case' 0 C--N 1.359 1.009 0 CA-C-N 118.612 0.642 . . . . 0.0 112.563 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.62 -40.14 88.63 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 119.217 -0.421 . . . . 0.0 110.984 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 62.7 ttm-85 -72.16 -52.63 15.74 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-O 119.157 -0.449 . . . . 0.0 111.534 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.8 mt -142.0 110.17 5.94 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.34 -49.84 4.78 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.1 t -73.45 -52.72 4.94 Favored Pre-proline 0 C--N 1.356 0.888 0 CA-C-O 115.457 -2.211 . . . . 0.0 112.818 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.56 75.83 4.69 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 CA-C-N 124.321 2.579 . . . . 0.0 112.09 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 55.6 mmm-85 -93.53 -10.99 32.98 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.3 m -61.27 -43.42 98.9 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.8 p -72.13 -39.36 68.88 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 123.705 0.802 . . . . 0.0 110.976 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 78.3 t -62.3 -40.25 87.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.834 0 C-N-CA 125.39 1.476 . . . . 0.0 110.353 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.36 -38.34 89.17 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.652 0.781 . . . . 0.0 111.867 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 94.9 m -71.28 -45.57 62.83 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 123.858 0.863 . . . . 0.0 110.571 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.41 -43.66 97.03 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 C-N-CA 124.869 1.268 . . . . 0.0 111.618 -177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.5 m -65.48 -36.83 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.128 0 CA-C-O 118.284 -0.865 . . . . 0.0 113.188 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -68.52 -44.51 74.46 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.14 -45.53 76.84 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 123.113 0.565 . . . . 0.0 111.417 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -69.97 -30.65 68.05 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -65.39 -39.81 92.7 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -63.27 -40.11 96.48 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.746 0.818 . . . . 0.0 109.82 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -69.69 -38.53 77.01 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 118.955 -0.545 . . . . 0.0 111.905 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.5 -32.89 61.57 Favored Glycine 0 C--N 1.358 1.754 0 CA-C-O 119.825 -0.431 . . . . 0.0 113.868 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.3 m -82.19 -48.06 11.75 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 117.208 0.504 . . . . 0.0 111.719 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.9 m -99.18 -52.81 3.42 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 119.518 3.155 . . . . 0.0 119.518 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -82.15 -55.6 4.45 Favored 'General case' 0 C--N 1.356 0.859 1 N-CA-C 122.874 4.398 . . . . 0.0 122.874 -174.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 66.9 m170 -78.39 144.98 35.45 Favored 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 125.163 1.385 . . . . 0.0 113.386 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 . . . . . 0 C--O 1.259 1.584 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 179.591 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 121.555 0.693 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.7 m -81.75 -40.47 22.62 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.762 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 76.8 mtm -60.97 138.78 58.15 Favored 'General case' 0 CA--C 1.497 -1.067 0 C-N-CA 125.554 1.541 . . . . 0.0 115.074 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.75 -175.57 43.27 Favored Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -86.73 -10.73 53.0 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.7 m -61.95 124.0 19.59 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.61 111.09 23.51 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 103.146 -2.909 . . . . 0.0 103.146 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . 0.314 96.0 mt-10 52.9 -106.61 0.3 Allowed 'General case' 0 C--N 1.357 0.93 0 C-N-CA 124.188 0.995 . . . . 0.0 112.888 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 86.9 mt 73.93 -64.59 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.324 0 C-N-CA 128.036 2.534 . . . . 0.0 109.325 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 98.7 p -64.8 -33.9 77.09 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 125.047 1.339 . . . . 0.0 111.055 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -63.65 -35.54 80.86 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 123.831 0.853 . . . . 0.0 111.144 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -66.27 -38.96 89.05 Favored 'General case' 0 C--N 1.361 1.083 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.9 mt -66.91 -38.94 87.18 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 78.1 mtt85 -61.98 -37.24 84.07 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 123.223 0.609 . . . . 0.0 111.176 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -60.52 -42.23 96.02 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 124.405 1.082 . . . . 0.0 109.391 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -69.71 -41.87 74.79 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.907 1.283 . . . . 0.0 110.387 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 88.9 mt -64.13 -38.1 81.6 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 125.9 1.68 . . . . 0.0 111.812 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.4 -40.53 88.36 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -69.53 -40.25 77.0 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 123.528 0.517 . . . . 0.0 109.848 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.6 mt -60.7 -30.35 69.89 Favored 'General case' 0 CA--C 1.496 -1.126 0 C-N-CA 125.229 1.412 . . . . 0.0 112.774 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -56.16 -44.04 78.94 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 124.351 1.06 . . . . 0.0 110.16 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -84.75 -36.85 21.49 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 117.903 0.32 . . . . 0.0 111.156 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.8 m -60.54 -36.62 78.89 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 176.89 -176.05 47.87 Favored Glycine 0 CA--C 1.49 -1.517 0 C-N-CA 119.469 -1.348 . . . . 0.0 113.217 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.6 t 56.93 -149.67 0.46 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 128.242 2.617 . . . . 0.0 111.37 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.8 m -132.99 155.4 49.23 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.637 0.732 . . . . 0.0 109.14 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.7 tp -65.02 -32.07 73.61 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.473 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.15 -35.69 92.02 Favored Glycine 0 C--N 1.358 1.751 0 CA-C-O 119.275 -0.736 . . . . 0.0 111.51 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.9 -40.92 62.83 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-N 118.077 0.938 . . . . 0.0 111.303 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.59 -41.96 86.22 Favored 'Isoleucine or valine' 0 C--N 1.358 0.951 0 C-N-CA 123.776 0.83 . . . . 0.0 109.515 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.3 m -65.04 -38.85 92.2 Favored 'General case' 0 CA--C 1.496 -1.126 0 C-N-CA 124.397 1.079 . . . . 0.0 111.083 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.36 -39.07 85.69 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 92.0 mtm-85 -66.8 -42.41 85.98 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 122.599 0.36 . . . . 0.0 111.305 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.2 mt -73.09 -26.41 61.24 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 124.793 1.237 . . . . 0.0 111.993 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 79.49 -63.34 0.26 Allowed 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 128.212 2.605 . . . . 0.0 108.197 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.0 t -115.97 105.45 51.19 Favored Pre-proline 0 C--N 1.36 1.024 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -71.85 -27.02 18.31 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 123.762 2.975 . . . . 0.0 113.639 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 64.89 167.34 0.17 Allowed 'General case' 0 C--N 1.359 1.006 0 C-N-CA 125.949 1.699 . . . . 0.0 112.505 -166.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 88.8 p -77.2 -26.77 53.15 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 124.997 1.319 . . . . 0.0 110.338 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.2 m -61.56 -44.72 96.51 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.827 1.251 . . . . 0.0 113.421 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.0 t -67.16 -36.91 78.12 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.59 -40.36 95.38 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 123.549 0.74 . . . . 0.0 110.947 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 95.8 m -68.44 -41.84 79.73 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 123.548 0.739 . . . . 0.0 110.062 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.8 mt -67.52 -42.36 86.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.968 0 C-N-CA 122.927 0.491 . . . . 0.0 109.993 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.8 m -66.36 -33.31 62.67 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 CA-C-N 118.468 0.576 . . . . 0.0 111.753 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -64.04 -39.2 93.57 Favored 'General case' 0 C--N 1.359 0.988 0 CA-C-N 118.321 0.509 . . . . 0.0 110.932 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -67.68 -39.6 84.44 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 124.201 1.0 . . . . 0.0 109.613 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -66.49 -37.22 84.61 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 124.249 1.019 . . . . 0.0 109.823 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -67.99 -41.2 82.67 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 124.907 1.283 . . . . 0.0 109.097 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -63.98 -35.03 79.36 Favored 'General case' 0 C--N 1.36 1.025 0 C-N-CA 124.617 1.167 . . . . 0.0 109.401 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -66.16 -25.46 66.97 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 123.812 0.845 . . . . 0.0 111.606 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.99 -35.02 77.85 Favored Glycine 0 C--N 1.36 1.88 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 84.8 m -79.28 -52.6 7.91 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.8 m -147.49 108.09 4.14 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -85.31 -50.7 7.12 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.152 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 49.3 p-80 -142.08 153.61 44.3 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 121.167 0.508 . . . . 0.0 111.437 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 31.2 m80 . . . . . 0 C--O 1.257 1.48 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.715 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.232 0 CA-C-O 121.45 0.643 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 72.3 m -71.47 121.61 18.95 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.249 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.7 mmm -123.22 -21.41 5.4 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.483 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.62 -95.46 1.64 Allowed Glycine 0 CA--C 1.484 -1.894 0 N-CA-C 106.096 -2.802 . . . . 0.0 106.096 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -89.9 96.95 10.91 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 102.43 -3.174 . . . . 0.0 102.43 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.1 t -85.75 -54.22 4.66 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.477 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -142.68 154.81 44.67 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 117.78 2.511 . . . . 0.0 117.78 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -81.86 155.09 25.52 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 127.328 2.251 . . . . 0.0 108.123 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -82.2 -38.41 15.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.829 0 C-N-CA 124.754 1.221 . . . . 0.0 111.303 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 97.9 p -59.21 -23.62 62.44 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 117.031 2.234 . . . . 0.0 117.031 -177.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -57.89 -37.85 74.74 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.515 1.526 . . . . 0.0 112.927 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -65.77 -43.38 89.03 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 118.757 0.708 . . . . 0.0 110.213 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.3 tp -64.3 -45.59 87.29 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.706 1.202 . . . . 0.0 109.169 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.88 -38.14 87.99 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.951 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -65.25 -37.06 86.06 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-N 118.513 0.597 . . . . 0.0 112.28 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -66.25 -37.19 84.9 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 122.912 0.485 . . . . 0.0 109.754 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.7 mt -69.13 -40.19 80.31 Favored 'Isoleucine or valine' 0 C--N 1.356 0.859 0 C-N-CA 123.722 0.809 . . . . 0.0 109.734 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.5 t -66.08 -34.45 70.28 Favored 'Isoleucine or valine' 0 C--N 1.356 0.863 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -64.13 -39.13 93.36 Favored 'General case' 0 C--N 1.358 0.95 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.0 mt -66.4 -38.43 87.47 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 123.934 0.894 . . . . 0.0 109.825 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -60.2 -46.15 90.72 Favored 'General case' 0 C--N 1.364 1.204 0 C-N-CA 125.114 1.366 . . . . 0.0 108.097 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.91 -33.83 76.46 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 123.527 0.731 . . . . 0.0 111.271 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.4 m -74.95 -12.69 60.4 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 124.217 1.007 . . . . 0.0 112.972 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.61 -15.42 12.79 Favored Glycine 0 C--N 1.358 1.783 0 N-CA-C 116.76 1.464 . . . . 0.0 116.76 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.8 t -91.84 87.17 6.15 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 100.924 -3.732 . . . . 0.0 100.924 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.4 m -95.66 -73.43 0.59 Allowed 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 115.138 1.532 . . . . 0.0 115.138 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.2 mt -81.22 -24.03 37.69 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-O 119.555 -0.259 . . . . 0.0 111.572 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.78 -20.94 78.98 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.6 -49.45 4.01 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 117.901 0.851 . . . . 0.0 112.456 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.96 -48.81 84.46 Favored 'Isoleucine or valine' 0 C--N 1.358 0.974 0 CA-C-N 118.44 0.564 . . . . 0.0 111.865 -176.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.2 m -70.2 -35.1 73.69 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.87 -50.23 9.44 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -73.16 -51.09 19.17 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 94.8 mt -87.83 -55.99 3.53 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.978 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 66.65 -67.02 0.17 Allowed 'General case' 0 C--N 1.356 0.862 0 C-N-CA 125.853 1.661 . . . . 0.0 114.909 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.6 t -69.48 -53.79 12.19 Favored Pre-proline 0 C--N 1.358 0.967 0 CA-C-O 114.549 -2.643 . . . . 0.0 114.713 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -81.8 46.08 2.13 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 CA-C-N 126.132 3.226 . . . . 0.0 114.441 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -70.68 -35.08 72.64 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 118.962 -0.542 . . . . 0.0 110.892 -174.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.5 m -65.0 -43.31 92.98 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 93.0 p -67.47 -39.34 85.27 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 78.3 t -67.69 -36.33 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 117.862 -1.066 . . . . 0.0 109.31 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.62 -36.75 84.84 Favored 'General case' 0 C--N 1.361 1.082 0 CA-C-N 119.656 1.116 . . . . 0.0 110.923 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 95.3 m -65.4 -40.95 94.05 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 123.351 0.66 . . . . 0.0 109.23 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.87 -40.78 81.63 Favored 'Isoleucine or valine' 0 C--N 1.356 0.889 0 C-N-CA 124.687 1.195 . . . . 0.0 110.08 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.1 t -61.6 -39.56 83.54 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 C-N-CA 125.773 1.629 . . . . 0.0 110.149 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -62.23 -38.85 90.78 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 118.424 0.556 . . . . 0.0 111.127 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -68.8 -42.45 77.29 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 123.921 0.888 . . . . 0.0 108.922 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . 0.259 28.8 m-85 -70.42 -23.2 62.7 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -66.3 -38.88 88.75 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -65.34 -42.69 92.63 Favored 'General case' 0 C--N 1.363 1.153 0 C-N-CA 124.404 1.082 . . . . 0.0 108.414 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -70.63 -25.04 62.85 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.31 -32.34 68.55 Favored Glycine 0 C--N 1.356 1.657 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.9 m -78.46 -50.01 12.41 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 83.3 m -140.3 106.07 5.15 Favored 'General case' 0 C--N 1.359 1.003 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -75.87 133.21 40.62 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -108.41 136.89 47.3 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 . . . . . 0 C--O 1.259 1.595 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 179.218 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.243 0 CA-C-O 121.559 0.695 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.6 t -80.98 110.67 16.74 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 106.225 -1.768 . . . . 0.0 106.225 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 97.8 mtp -128.01 -17.4 4.39 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.2 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.43 -91.66 1.37 Allowed Glycine 0 C--N 1.36 1.874 0 N-CA-C 106.37 -2.692 . . . . 0.0 106.37 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -88.45 102.61 15.06 Favored 'General case' 0 CA--C 1.497 -1.096 1 N-CA-C 98.96 -4.459 . . . . 0.0 98.96 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.1 m -76.26 -49.82 16.03 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -145.0 148.95 34.31 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -80.01 159.07 26.35 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 127.146 2.178 . . . . 0.0 109.343 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.4 mt -83.53 -40.56 16.09 Favored 'Isoleucine or valine' 0 C--N 1.355 0.835 0 C-N-CA 124.467 1.107 . . . . 0.0 110.886 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 90.8 p -58.4 -30.31 66.74 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 118.081 2.623 . . . . 0.0 118.081 -176.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -56.14 -41.72 75.82 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -67.41 -41.36 85.03 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 118.797 0.726 . . . . 0.0 111.629 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.05 -42.4 76.33 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 123.922 0.889 . . . . 0.0 110.345 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -66.7 -37.74 85.33 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-O 118.675 -0.678 . . . . 0.0 111.091 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -65.47 -34.7 78.89 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 119.018 -0.515 . . . . 0.0 111.476 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -66.51 -38.72 87.83 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.3 mt -67.65 -40.05 83.33 Favored 'Isoleucine or valine' 0 C--N 1.359 1.003 0 C-N-CA 123.851 0.86 . . . . 0.0 109.505 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.5 -36.48 77.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.826 0 C-N-CA 124.197 0.999 . . . . 0.0 108.985 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.06 -37.29 87.07 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.17 -36.37 79.53 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 123.66 0.784 . . . . 0.0 110.15 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -61.09 -45.38 94.97 Favored 'General case' 0 C--N 1.367 1.341 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.64 -36.44 84.28 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 125.262 1.425 . . . . 0.0 110.546 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.2 m -74.12 -18.26 60.82 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.226 1.011 . . . . 0.0 113.326 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.28 -14.34 8.85 Favored Glycine 0 C--N 1.357 1.704 0 CA-C-O 118.255 -1.303 . . . . 0.0 116.057 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.9 m -91.74 82.74 5.23 Favored 'General case' 0 C--N 1.356 0.853 1 N-CA-C 100.194 -4.002 . . . . 0.0 100.194 177.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.4 m -94.72 -81.01 0.4 Allowed 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 -175.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.3 mt -79.46 -23.66 42.94 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 118.371 0.532 . . . . 0.0 111.867 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.18 -25.48 75.41 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.74 -46.84 6.43 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 117.668 0.734 . . . . 0.0 112.707 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -66.62 -46.69 85.42 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 CA-C-N 118.124 0.42 . . . . 0.0 111.614 -177.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.8 m -69.25 -34.57 74.99 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -82.62 -47.25 12.29 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -74.69 -52.52 11.39 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 93.3 mt -84.33 -54.06 5.04 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 119.46 -0.305 . . . . 0.0 111.797 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 67.08 -66.92 0.18 Allowed 'General case' 0 C--N 1.358 0.969 0 C-N-CA 126.238 1.815 . . . . 0.0 115.328 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.8 t -72.91 -52.77 5.59 Favored Pre-proline 0 N--CA 1.442 -0.86 0 CA-C-O 114.963 -2.446 . . . . 0.0 114.764 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -81.51 43.92 1.63 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 125.789 3.103 . . . . 0.0 115.101 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -67.95 -33.38 74.55 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-O 118.55 -0.738 . . . . 0.0 112.803 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.3 m -65.72 -43.43 89.08 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 123.291 0.637 . . . . 0.0 111.683 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.8 m -66.42 -41.95 88.49 Favored 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 123.646 0.778 . . . . 0.0 109.657 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 78.9 t -67.34 -40.48 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-O 117.82 -1.086 . . . . 0.0 109.927 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -64.22 -30.81 71.85 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 119.652 1.115 . . . . 0.0 112.955 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 97.5 m -66.34 -40.51 89.89 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.3 mt -71.58 -40.68 71.56 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 C-N-CA 125.145 1.378 . . . . 0.0 109.511 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.73 -37.22 77.53 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 C-N-CA 125.754 1.621 . . . . 0.0 111.057 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 95.5 mtm-85 -63.33 -39.59 94.95 Favored 'General case' 0 C--N 1.357 0.926 0 CA-C-N 119.605 1.093 . . . . 0.0 110.91 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -68.6 -41.04 80.13 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 123.501 0.72 . . . . 0.0 109.071 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -69.98 -25.09 63.45 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -66.85 -38.13 85.78 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -65.41 -41.17 93.91 Favored 'General case' 0 C--N 1.362 1.122 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -69.55 -26.38 64.46 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.07 -31.03 71.93 Favored Glycine 0 C--N 1.357 1.704 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.2 m -75.34 -52.99 9.5 Favored 'General case' 0 C--N 1.359 1.008 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 76.8 m -147.88 105.83 3.72 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -75.59 131.48 40.03 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 123.487 0.715 . . . . 0.0 109.544 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -100.21 130.3 46.33 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 18.2 m80 . . . . . 0 C--O 1.26 1.62 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -179.018 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 73.3 tp60 . . . . . 0 CA--C 1.505 -0.762 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -65.82 -38.46 88.97 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 122.726 0.411 . . . . 0.0 110.824 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.3 tp -67.1 -41.09 86.84 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 123.639 0.776 . . . . 0.0 109.037 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -62.38 -42.61 99.55 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 124.631 1.172 . . . . 0.0 109.595 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -65.18 -41.79 94.28 Favored 'General case' 0 CA--C 1.496 -1.119 0 C-N-CA 123.256 0.622 . . . . 0.0 111.122 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -64.44 -41.11 96.75 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 123.078 0.551 . . . . 0.0 111.57 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.9 mm -67.35 -45.83 85.04 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 CA-C-O 118.602 -0.714 . . . . 0.0 110.24 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.72 -37.12 79.2 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 C-N-CA 123.54 0.736 . . . . 0.0 111.166 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -64.38 -43.75 93.51 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 118.584 0.629 . . . . 0.0 110.514 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.0 mt -67.57 -38.7 84.47 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 123.63 0.772 . . . . 0.0 110.886 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 26' ' ' SER . 74.6 t80 -61.68 -46.65 88.8 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.806 2.042 . . . . 0.0 110.035 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -74.21 -37.36 63.89 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.2 p -80.93 -42.18 21.75 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 117.575 2.435 . . . . 0.0 117.575 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.14 -113.14 1.09 Allowed Glycine 0 CA--C 1.485 -1.84 0 C-N-CA 121.488 -0.386 . . . . 0.0 112.652 -177.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.9 t -66.4 122.9 18.56 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 121.9 0.857 . . . . 0.0 110.747 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 21' ' ' TYR . 73.4 m -91.72 -57.55 2.71 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 113.801 -1.545 . . . . 0.0 113.135 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.7 mt -98.92 -16.91 18.61 Favored 'General case' 0 CA--C 1.487 -1.455 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.721 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.21 -38.56 72.12 Favored Glycine 0 C--N 1.354 1.557 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.62 -38.84 84.5 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 123.486 0.715 . . . . 0.0 111.001 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.415 HG21 ' HB3' ' A' ' 37' ' ' PRO . 96.8 mt -72.37 -47.09 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.967 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 75.7 m -63.23 -37.96 89.28 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 124.035 0.934 . . . . 0.0 112.988 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -75.79 -46.01 33.04 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -86.74 -54.99 4.06 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.9 mt -81.42 -31.44 33.17 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 123.772 0.829 . . . . 0.0 112.949 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 31' ' ' SER . . . 77.44 -67.35 0.2 Allowed 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 128.26 2.624 . . . . 0.0 111.052 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.2 t -113.48 117.29 45.21 Favored Pre-proline 0 N--CA 1.44 -0.948 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.415 ' HB3' HG21 ' A' ' 30' ' ' ILE . 26.4 Cg_endo -67.33 -38.64 14.68 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 123.197 2.598 . . . . 0.0 114.241 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 56.67 -173.03 0.07 Allowed 'General case' 0 C--N 1.36 1.06 0 C-N-CA 124.863 1.265 . . . . 0.0 113.376 -172.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.3 p -66.1 -29.99 70.42 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 124.618 1.167 . . . . 0.0 110.721 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.3 m -61.07 -48.86 79.77 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.425 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.0 t -81.33 -38.26 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 118.901 0.773 . . . . 0.0 109.71 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.535 ' HA ' HG22 ' A' ' 45' ' ' VAL . 94.6 mm-40 -61.33 -38.86 88.43 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 97.7 m -68.12 -41.87 81.08 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 119.268 0.94 . . . . 0.0 109.901 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.3 mt -66.35 -43.78 91.2 Favored 'Isoleucine or valine' 0 C--N 1.356 0.888 0 C-N-CA 123.767 0.827 . . . . 0.0 109.734 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.535 HG22 ' HA ' ' A' ' 42' ' ' GLN 0.264 33.0 m -70.18 -32.49 51.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 CA-C-O 117.743 -1.122 . . . . 0.0 113.323 -179.026 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -62.53 -41.55 98.94 Favored 'General case' 0 C--N 1.362 1.111 0 CA-C-N 119.22 0.918 . . . . 0.0 111.616 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -70.48 -44.45 67.69 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 124.443 1.097 . . . . 0.0 109.192 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -66.13 -32.16 73.45 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.79 -39.42 90.95 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -64.3 -42.68 96.24 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 123.61 0.764 . . . . 0.0 109.531 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -70.24 -33.51 71.72 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.93 -31.12 67.24 Favored Glycine 0 C--N 1.355 1.588 0 C-N-CA 124.527 1.061 . . . . 0.0 110.857 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.0 m -78.94 -60.33 2.42 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.1 m . . . . . 0 C--N 1.358 0.975 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.754 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 . . . . . 0 CA--C 1.493 -1.221 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -57.77 -32.94 67.99 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.8 mt -64.19 -40.84 96.94 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 123.013 0.525 . . . . 0.0 111.789 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.75 -37.99 67.51 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 124.622 1.169 . . . . 0.0 109.915 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.526 ' HA ' HG22 ' A' ' 18' ' ' VAL . 97.5 mttt -61.33 -35.45 77.43 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 123.658 0.783 . . . . 0.0 111.691 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -65.47 -29.03 69.65 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.408 HD13 HD21 ' A' ' 34' ' ' LEU . 93.5 mt -74.81 -47.59 37.13 Favored 'Isoleucine or valine' 0 C--N 1.356 0.881 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.526 HG22 ' HA ' ' A' ' 15' ' ' LYS 0.282 31.9 m -67.42 -25.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.36 1.062 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -178.655 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -63.9 -32.99 74.71 Favored 'General case' 0 C--N 1.358 0.962 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.447 HD13 HH11 ' A' ' 33' ' ' ARG . 92.2 mt -68.91 -37.84 79.2 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 124.247 1.019 . . . . 0.0 108.478 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.413 ' CD1' ' HB2' ' A' ' 25' ' ' SER . 79.4 t80 -62.98 -42.05 99.73 Favored 'General case' 0 C--N 1.363 1.158 0 C-N-CA 124.238 1.015 . . . . 0.0 109.404 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -68.48 -37.62 80.29 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.207 1.003 . . . . 0.0 110.512 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.0 m -69.81 -29.86 67.25 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 123.655 0.782 . . . . 0.0 111.671 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.15 109.96 0.53 Allowed Glycine 0 CA--C 1.482 -2.025 0 N-CA-C 106.268 -2.733 . . . . 0.0 106.268 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.413 ' HB2' ' CD1' ' A' ' 21' ' ' TYR . 43.9 t -79.26 114.57 18.3 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.851 0.834 . . . . 0.0 108.877 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.6 m -104.27 115.58 30.64 Favored 'General case' 0 N--CA 1.431 -1.412 1 N-CA-C 97.568 -4.975 . . . . 0.0 97.568 176.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.0 mt -67.31 -35.89 80.36 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.43 -38.41 86.86 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.5 -41.82 54.36 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.1 mt -68.95 -38.99 79.27 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 CA-C-O 118.619 -0.705 . . . . 0.0 111.961 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.5 m -65.47 -38.17 89.01 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 118.621 0.646 . . . . 0.0 111.591 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.22 -37.19 74.97 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 118.106 0.412 . . . . 0.0 111.863 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.447 HH11 HD13 ' A' ' 20' ' ' LEU . 99.6 mtt180 -70.75 -46.4 63.03 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.507 HD13 ' HB3' ' A' ' 37' ' ' PRO . 95.9 mt -80.94 -41.77 22.39 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 75.6 -67.95 0.22 Allowed 'General case' 0 C--N 1.355 0.846 0 C-N-CA 127.63 2.372 . . . . 0.0 107.2 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.453 HG12 ' HG3' ' A' ' 38' ' ' ARG . 59.2 t -127.88 102.93 21.67 Favored Pre-proline 0 C--N 1.358 0.949 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 178.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.507 ' HB3' HD13 ' A' ' 34' ' ' LEU . 34.1 Cg_endo -66.11 -32.69 42.85 Favored 'Trans proline' 0 CA--C 1.499 -1.235 0 C-N-CA 123.986 3.124 . . . . 0.0 114.577 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.453 ' HG3' HG12 ' A' ' 36' ' ' VAL . 99.8 mtt180 65.04 174.39 0.21 Allowed 'General case' 0 C--N 1.355 0.836 0 C-N-CA 125.789 1.635 . . . . 0.0 112.969 -177.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.9 m -64.34 -35.31 80.47 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 124.484 1.114 . . . . 0.0 112.819 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.7 m -63.69 -48.53 76.78 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 77.0 t -71.65 -38.69 67.73 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 73.3 tp60 -60.26 -35.84 76.42 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 123.176 0.59 . . . . 0.0 112.431 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 99.2 m -67.44 -39.44 85.42 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.391 0.541 . . . . 0.0 110.282 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.504 HG22 HG11 ' A' ' 18' ' ' VAL . 96.4 mt -71.77 -36.64 59.49 Favored 'Isoleucine or valine' 0 C--N 1.359 1.015 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.39 -40.3 85.77 Favored 'Isoleucine or valine' 0 C--N 1.362 1.126 0 C-N-CA 125.26 1.424 . . . . 0.0 108.471 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 -63.72 -36.6 84.4 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 123.343 0.657 . . . . 0.0 112.104 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.89 -44.39 93.18 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -68.3 -36.04 78.75 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.88 -39.25 93.74 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 124.953 1.301 . . . . 0.0 109.619 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -63.45 -43.6 96.91 Favored 'General case' 0 C--N 1.357 0.927 0 C-N-CA 123.768 0.827 . . . . 0.0 110.275 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -81.62 -22.7 37.49 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.15 -11.57 85.42 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-O 118.783 -1.009 . . . . 0.0 112.426 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.0 m -72.25 -60.79 2.05 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 118.123 0.961 . . . . 0.0 108.851 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 80.6 m . . . . . 0 C--N 1.362 1.13 0 CA-C-N 119.093 0.86 . . . . 0.0 108.768 179.023 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 . . . . . 0 CA--C 1.496 -1.126 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.6 -35.08 79.34 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.739 1.216 . . . . 0.0 110.628 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.3 tp -65.83 -43.03 89.8 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.7 mtp85 -65.18 -38.6 91.01 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 122.845 0.458 . . . . 0.0 111.049 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.46 -41.8 96.31 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 92.4 mtm-85 -67.24 -29.35 68.96 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 123.962 0.905 . . . . 0.0 113.048 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.407 HD13 ' HG ' ' A' ' 34' ' ' LEU . 96.3 mt -70.05 -46.32 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 119.29 0.95 . . . . 0.0 109.0 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.7 t -68.48 -44.33 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 124.634 1.174 . . . . 0.0 111.344 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -68.79 -40.13 79.77 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 124.072 0.949 . . . . 0.0 112.555 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.5 mt -67.22 -33.27 75.0 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 118.836 -0.602 . . . . 0.0 110.817 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -62.49 -42.07 99.24 Favored 'General case' 0 C--N 1.362 1.12 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -66.32 -36.66 83.48 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 123.971 0.908 . . . . 0.0 109.978 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.8 m -70.72 -16.97 62.82 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 124.906 1.282 . . . . 0.0 112.978 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.53 1.16 3.52 Favored Glycine 0 C--N 1.36 1.901 0 N-CA-C 117.866 1.907 . . . . 0.0 117.866 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.6 m -77.18 154.77 32.8 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 119.972 1.886 . . . . 0.0 111.721 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.7 p -80.83 164.67 22.52 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 125.307 1.443 . . . . 0.0 112.623 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.45 HD23 HD12 ' A' ' 30' ' ' ILE . 86.2 mt -68.94 -22.45 64.13 Favored 'General case' 0 C--N 1.361 1.073 0 C-N-CA 124.07 0.948 . . . . 0.0 110.61 177.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.98 -35.66 92.28 Favored Glycine 0 C--N 1.359 1.861 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.11 -37.01 75.26 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 123.644 0.778 . . . . 0.0 110.184 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.45 HD12 HD23 ' A' ' 27' ' ' LEU . 96.3 mt -66.41 -43.15 91.3 Favored 'Isoleucine or valine' 0 C--N 1.365 1.244 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.2 m -63.09 -37.14 86.02 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.65 1.18 . . . . 0.0 110.498 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.68 -46.88 67.89 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -74.44 -49.28 23.04 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.407 ' HG ' HD13 ' A' ' 17' ' ' ILE . 90.4 mt -77.36 -33.72 55.27 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 115.721 1.748 . . . . 0.0 115.721 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 74.76 -68.3 0.22 Allowed 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 126.186 1.795 . . . . 0.0 111.527 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.6 t -122.48 94.7 47.53 Favored Pre-proline 0 C--N 1.36 1.061 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -70.77 -27.83 21.15 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 123.578 2.852 . . . . 0.0 113.328 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 60.31 -175.57 0.11 Allowed 'General case' 0 C--N 1.359 1.02 0 C-N-CA 124.846 1.258 . . . . 0.0 112.548 -170.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 92.8 p -67.98 -37.44 81.52 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 123.775 0.83 . . . . 0.0 112.821 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.7 m -63.86 -47.47 80.55 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -177.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.4 t -71.45 -37.92 66.42 Favored 'Isoleucine or valine' 0 C--N 1.359 0.981 0 CA-C-O 118.535 -0.745 . . . . 0.0 109.29 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -62.3 -37.77 86.81 Favored 'General case' 0 C--N 1.362 1.12 0 CA-C-N 118.573 0.624 . . . . 0.0 112.334 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 97.7 m -66.84 -41.39 87.48 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 123.346 0.658 . . . . 0.0 109.581 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.4 mt -66.4 -41.92 89.58 Favored 'Isoleucine or valine' 0 C--N 1.358 0.953 0 C-N-CA 123.495 0.718 . . . . 0.0 110.01 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.7 t -62.9 -40.13 87.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 C-N-CA 124.127 0.971 . . . . 0.0 110.744 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -65.53 -40.1 92.53 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.45 0.568 . . . . 0.0 112.245 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -68.29 -40.25 81.84 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 124.155 0.982 . . . . 0.0 109.783 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -66.62 -40.14 88.64 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.246 1.018 . . . . 0.0 110.317 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.0 -41.51 86.58 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -60.76 -28.74 68.94 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 125.941 1.696 . . . . 0.0 112.463 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -60.1 -27.94 67.43 Favored 'General case' 0 C--N 1.361 1.104 0 N-CA-C 112.71 0.634 . . . . 0.0 112.71 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.83 -28.87 71.43 Favored Glycine 0 C--N 1.359 1.854 0 CA-C-O 119.483 -0.62 . . . . 0.0 111.818 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.0 m -83.1 -58.36 2.89 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 81.6 m . . . . . 0 C--N 1.359 1.02 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -179.439 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.433 ' HG3' ' HE3' ' A' ' 15' ' ' LYS . 71.0 tp60 . . . . . 0 N--CA 1.439 -0.998 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -65.43 -40.09 92.89 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 119.278 0.945 . . . . 0.0 111.478 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.3 tp -66.79 -41.66 87.28 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -63.26 -41.89 99.09 Favored 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 123.596 0.758 . . . . 0.0 110.14 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.433 ' HE3' ' HG3' ' A' ' 11' ' ' GLN . 97.8 mttt -64.37 -42.86 95.97 Favored 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 123.963 0.905 . . . . 0.0 111.334 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -64.26 -41.89 96.72 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 123.557 0.743 . . . . 0.0 110.46 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.6 mt -68.72 -46.51 79.53 Favored 'Isoleucine or valine' 0 C--N 1.358 0.966 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.407 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.96 -39.97 87.48 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 C-N-CA 124.039 0.935 . . . . 0.0 112.039 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -62.82 -43.4 98.9 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 118.297 0.498 . . . . 0.0 110.692 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.9 mt -70.63 -37.79 73.83 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 123.068 0.547 . . . . 0.0 111.77 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 26' ' ' SER . 74.2 t80 -60.92 -44.92 96.51 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 126.724 2.01 . . . . 0.0 109.687 -178.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -74.77 -40.31 61.26 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.9 p -80.88 -43.51 19.79 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.27 -115.31 1.38 Allowed Glycine 0 CA--C 1.487 -1.691 0 CA-C-O 121.158 0.31 . . . . 0.0 112.835 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.0 t -66.66 122.27 17.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-O 122.203 1.001 . . . . 0.0 110.691 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 21' ' ' TYR . 70.1 m -93.65 -54.99 3.42 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 113.126 -1.852 . . . . 0.0 111.298 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.0 mt -87.96 -29.07 21.06 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.81 -36.45 91.17 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-O 119.656 -0.524 . . . . 0.0 112.525 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.81 -40.85 79.34 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 117.06 0.43 . . . . 0.0 111.0 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -71.02 -45.39 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 118.955 -0.545 . . . . 0.0 109.778 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.7 m -62.7 -38.32 89.95 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 124.143 0.977 . . . . 0.0 113.149 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -72.7 -48.4 39.21 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -83.69 -55.81 4.07 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.98 -33.43 24.6 Favored 'General case' 0 CA--C 1.494 -1.208 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 78.82 -66.08 0.2 Allowed 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 128.011 2.524 . . . . 0.0 108.653 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.6 t -115.75 118.97 38.25 Favored Pre-proline 0 C--N 1.357 0.911 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -66.76 -38.44 17.84 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 123.849 3.033 . . . . 0.0 114.967 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 55.82 -171.98 0.07 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 125.501 1.521 . . . . 0.0 113.532 -172.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 89.0 p -63.79 -32.32 73.78 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 124.897 1.279 . . . . 0.0 111.872 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.6 m -59.81 -47.09 87.1 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 124.325 1.05 . . . . 0.0 112.757 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 77.0 t -82.46 -38.02 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-O 118.873 -0.584 . . . . 0.0 110.459 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.478 ' HA ' HG22 ' A' ' 45' ' ' VAL . 94.5 mm-40 -60.62 -38.98 86.54 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -178.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 98.6 m -65.76 -42.93 90.27 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-N 118.803 0.729 . . . . 0.0 109.939 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.1 mt -67.11 -45.93 85.55 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 123.985 0.914 . . . . 0.0 110.176 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.478 HG22 ' HA ' ' A' ' 42' ' ' GLN 0.266 33.9 m -69.18 -33.52 58.7 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.388 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.123 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -64.58 -36.71 85.1 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 119.179 0.9 . . . . 0.0 113.158 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -71.47 -44.98 63.77 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -66.74 -30.56 70.82 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -65.85 -37.27 85.73 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.611 1.565 . . . . 0.0 108.762 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -65.75 -41.55 91.98 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -70.25 -32.49 70.36 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 122.755 0.422 . . . . 0.0 111.4 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.86 -34.05 59.49 Favored Glycine 0 C--N 1.356 1.668 0 C-N-CA 123.878 0.752 . . . . 0.0 111.424 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.7 m -74.94 -61.05 2.02 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 79.1 m . . . . . 0 C--N 1.362 1.12 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.298 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 . . . . . 0 N--CA 1.431 -1.378 0 CA-C-O 118.383 -0.818 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -60.15 -39.99 88.29 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 123.866 0.867 . . . . 0.0 112.932 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.15 -39.79 82.53 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -65.3 -39.61 92.72 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 123.397 0.679 . . . . 0.0 109.659 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.07 -40.09 95.51 Favored 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 124.684 1.193 . . . . 0.0 109.043 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.66 -39.03 93.31 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.949 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.36 -45.42 85.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.2 t -63.74 -46.23 95.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 C-N-CA 124.792 1.237 . . . . 0.0 111.318 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -65.25 -42.07 93.65 Favored 'General case' 0 CA--C 1.488 -1.422 0 C-N-CA 123.853 0.861 . . . . 0.0 111.546 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.9 mt -66.24 -38.7 88.51 Favored 'General case' 0 CA--C 1.496 -1.104 0 O-C-N 123.514 0.509 . . . . 0.0 110.521 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.481 ' HE2' ' HD2' ' A' ' 49' ' ' LYS . 90.8 t80 -60.84 -45.33 94.92 Favored 'General case' 0 C--N 1.361 1.087 0 CA-C-O 118.965 -0.54 . . . . 0.0 110.678 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.04 -38.25 82.29 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.874 1.27 . . . . 0.0 111.587 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.4 m -69.79 -28.68 65.94 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 124.161 0.985 . . . . 0.0 112.538 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.54 78.22 0.44 Allowed Glycine 0 CA--C 1.482 -2.002 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.6 p -96.01 -20.32 18.79 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.462 -0.869 . . . . 0.0 110.576 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.8 t 57.96 -119.23 1.12 Allowed 'General case' 0 C--N 1.368 1.376 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.3 mt -123.12 -31.89 3.54 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 119.187 0.903 . . . . 0.0 109.785 177.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.52 -40.19 94.19 Favored Glycine 0 C--N 1.358 1.767 0 N-CA-C 117.925 1.93 . . . . 0.0 117.925 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.88 -41.59 82.54 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 118.424 1.112 . . . . 0.0 110.96 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.0 mt -67.28 -40.46 84.95 Favored 'Isoleucine or valine' 0 C--N 1.362 1.109 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.2 m -61.59 -37.01 82.32 Favored 'General case' 0 C--N 1.359 1.009 0 CA-C-N 118.612 0.642 . . . . 0.0 112.563 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.62 -40.14 88.63 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 119.217 -0.421 . . . . 0.0 110.984 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 62.7 ttm-85 -72.16 -52.63 15.74 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-O 119.157 -0.449 . . . . 0.0 111.534 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.8 mt -142.0 110.17 5.94 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.34 -49.84 4.78 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.1 t -73.45 -52.72 4.94 Favored Pre-proline 0 C--N 1.356 0.888 0 CA-C-O 115.457 -2.211 . . . . 0.0 112.818 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.56 75.83 4.69 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 CA-C-N 124.321 2.579 . . . . 0.0 112.09 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 55.6 mmm-85 -93.53 -10.99 32.98 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.3 m -61.27 -43.42 98.9 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.8 p -72.13 -39.36 68.88 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 123.705 0.802 . . . . 0.0 110.976 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 78.3 t -62.3 -40.25 87.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.834 0 C-N-CA 125.39 1.476 . . . . 0.0 110.353 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.36 -38.34 89.17 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.652 0.781 . . . . 0.0 111.867 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 94.9 m -71.28 -45.57 62.83 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 123.858 0.863 . . . . 0.0 110.571 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.41 -43.66 97.03 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 C-N-CA 124.869 1.268 . . . . 0.0 111.618 -177.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.5 m -65.48 -36.83 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.128 0 CA-C-O 118.284 -0.865 . . . . 0.0 113.188 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -68.52 -44.51 74.46 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.14 -45.53 76.84 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 123.113 0.565 . . . . 0.0 111.417 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -69.97 -30.65 68.05 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.481 ' HD2' ' HE2' ' A' ' 21' ' ' TYR . 86.8 tttt -65.39 -39.81 92.7 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -63.27 -40.11 96.48 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.746 0.818 . . . . 0.0 109.82 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -69.69 -38.53 77.01 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 118.955 -0.545 . . . . 0.0 111.905 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.5 -32.89 61.57 Favored Glycine 0 C--N 1.358 1.754 0 CA-C-O 119.825 -0.431 . . . . 0.0 113.868 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.3 m -82.19 -48.06 11.75 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 117.208 0.504 . . . . 0.0 111.719 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.9 m . . . . . 0 N--CA 1.436 -1.161 0 N-CA-C 119.518 3.155 . . . . 0.0 119.518 -175.484 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 . . . . . 0 N--CA 1.437 -1.096 0 CA-C-O 119.313 -0.375 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -66.27 -38.96 89.05 Favored 'General case' 0 C--N 1.361 1.083 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.9 mt -66.91 -38.94 87.18 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.422 ' O ' HG23 ' A' ' 18' ' ' VAL . 78.1 mtt85 -61.98 -37.24 84.07 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 123.223 0.609 . . . . 0.0 111.176 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -60.52 -42.23 96.02 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 124.405 1.082 . . . . 0.0 109.391 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -69.71 -41.87 74.79 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.907 1.283 . . . . 0.0 110.387 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.536 HD13 HD11 ' A' ' 34' ' ' LEU . 88.9 mt -64.13 -38.1 81.6 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 125.9 1.68 . . . . 0.0 111.812 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 14' ' ' ARG . 60.9 t -62.4 -40.53 88.36 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -69.53 -40.25 77.0 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 123.528 0.517 . . . . 0.0 109.848 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.6 mt -60.7 -30.35 69.89 Favored 'General case' 0 CA--C 1.496 -1.126 0 C-N-CA 125.229 1.412 . . . . 0.0 112.774 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -56.16 -44.04 78.94 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 124.351 1.06 . . . . 0.0 110.16 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -84.75 -36.85 21.49 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 117.903 0.32 . . . . 0.0 111.156 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.8 m -60.54 -36.62 78.89 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 176.89 -176.05 47.87 Favored Glycine 0 CA--C 1.49 -1.517 0 C-N-CA 119.469 -1.348 . . . . 0.0 113.217 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.6 t 56.93 -149.67 0.46 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 128.242 2.617 . . . . 0.0 111.37 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.8 m -132.99 155.4 49.23 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.637 0.732 . . . . 0.0 109.14 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.7 tp -65.02 -32.07 73.61 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.473 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.15 -35.69 92.02 Favored Glycine 0 C--N 1.358 1.751 0 CA-C-O 119.275 -0.736 . . . . 0.0 111.51 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.9 -40.92 62.83 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-N 118.077 0.938 . . . . 0.0 111.303 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.59 -41.96 86.22 Favored 'Isoleucine or valine' 0 C--N 1.358 0.951 0 C-N-CA 123.776 0.83 . . . . 0.0 109.515 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.3 m -65.04 -38.85 92.2 Favored 'General case' 0 CA--C 1.496 -1.126 0 C-N-CA 124.397 1.079 . . . . 0.0 111.083 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.36 -39.07 85.69 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 92.0 mtm-85 -66.8 -42.41 85.98 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 122.599 0.36 . . . . 0.0 111.305 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.536 HD11 HD13 ' A' ' 17' ' ' ILE . 91.2 mt -73.09 -26.41 61.24 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 124.793 1.237 . . . . 0.0 111.993 178.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 79.49 -63.34 0.26 Allowed 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 128.212 2.605 . . . . 0.0 108.197 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.0 t -115.97 105.45 51.19 Favored Pre-proline 0 C--N 1.36 1.024 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -71.85 -27.02 18.31 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 123.762 2.975 . . . . 0.0 113.639 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 64.89 167.34 0.17 Allowed 'General case' 0 C--N 1.359 1.006 0 C-N-CA 125.949 1.699 . . . . 0.0 112.505 -166.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 88.8 p -77.2 -26.77 53.15 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 124.997 1.319 . . . . 0.0 110.338 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.2 m -61.56 -44.72 96.51 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.827 1.251 . . . . 0.0 113.421 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.0 t -67.16 -36.91 78.12 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.411 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 99.3 mm-40 -64.59 -40.36 95.38 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 123.549 0.74 . . . . 0.0 110.947 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 95.8 m -68.44 -41.84 79.73 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 123.548 0.739 . . . . 0.0 110.062 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.8 mt -67.52 -42.36 86.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.968 0 C-N-CA 122.927 0.491 . . . . 0.0 109.993 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.8 m -66.36 -33.31 62.67 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 CA-C-N 118.468 0.576 . . . . 0.0 111.753 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 95.7 mtt-85 -64.04 -39.2 93.57 Favored 'General case' 0 C--N 1.359 0.988 0 CA-C-N 118.321 0.509 . . . . 0.0 110.932 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -67.68 -39.6 84.44 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 124.201 1.0 . . . . 0.0 109.613 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -66.49 -37.22 84.61 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 124.249 1.019 . . . . 0.0 109.823 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -67.99 -41.2 82.67 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 124.907 1.283 . . . . 0.0 109.097 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -63.98 -35.03 79.36 Favored 'General case' 0 C--N 1.36 1.025 0 C-N-CA 124.617 1.167 . . . . 0.0 109.401 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -66.16 -25.46 66.97 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 123.812 0.845 . . . . 0.0 111.606 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.99 -35.02 77.85 Favored Glycine 0 C--N 1.36 1.88 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 84.8 m -79.28 -52.6 7.91 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.8 m . . . . . 0 C--N 1.359 1.004 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -179.713 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 . . . . . 0 N--CA 1.441 -0.91 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -65.77 -43.38 89.03 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 118.757 0.708 . . . . 0.0 110.213 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.3 tp -64.3 -45.59 87.29 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.706 1.202 . . . . 0.0 109.169 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.88 -38.14 87.99 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.951 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -65.25 -37.06 86.06 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-N 118.513 0.597 . . . . 0.0 112.28 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -66.25 -37.19 84.9 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 122.912 0.485 . . . . 0.0 109.754 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.7 mt -69.13 -40.19 80.31 Favored 'Isoleucine or valine' 0 C--N 1.356 0.859 0 C-N-CA 123.722 0.809 . . . . 0.0 109.734 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.5 t -66.08 -34.45 70.28 Favored 'Isoleucine or valine' 0 C--N 1.356 0.863 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -64.13 -39.13 93.36 Favored 'General case' 0 C--N 1.358 0.95 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.0 mt -66.4 -38.43 87.47 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 123.934 0.894 . . . . 0.0 109.825 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -60.2 -46.15 90.72 Favored 'General case' 0 C--N 1.364 1.204 0 C-N-CA 125.114 1.366 . . . . 0.0 108.097 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.91 -33.83 76.46 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 123.527 0.731 . . . . 0.0 111.271 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.4 m -74.95 -12.69 60.4 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 124.217 1.007 . . . . 0.0 112.972 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.61 -15.42 12.79 Favored Glycine 0 C--N 1.358 1.783 0 N-CA-C 116.76 1.464 . . . . 0.0 116.76 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.8 t -91.84 87.17 6.15 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 100.924 -3.732 . . . . 0.0 100.924 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.4 m -95.66 -73.43 0.59 Allowed 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 115.138 1.532 . . . . 0.0 115.138 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.2 mt -81.22 -24.03 37.69 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-O 119.555 -0.259 . . . . 0.0 111.572 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.78 -20.94 78.98 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.6 -49.45 4.01 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 117.901 0.851 . . . . 0.0 112.456 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.96 -48.81 84.46 Favored 'Isoleucine or valine' 0 C--N 1.358 0.974 0 CA-C-N 118.44 0.564 . . . . 0.0 111.865 -176.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.2 m -70.2 -35.1 73.69 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.87 -50.23 9.44 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -73.16 -51.09 19.17 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.447 HD13 HG21 ' A' ' 41' ' ' VAL . 94.8 mt -87.83 -55.99 3.53 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.978 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 66.65 -67.02 0.17 Allowed 'General case' 0 C--N 1.356 0.862 0 C-N-CA 125.853 1.661 . . . . 0.0 114.909 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.6 t -69.48 -53.79 12.19 Favored Pre-proline 0 C--N 1.358 0.967 0 CA-C-O 114.549 -2.643 . . . . 0.0 114.713 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -81.8 46.08 2.13 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 CA-C-N 126.132 3.226 . . . . 0.0 114.441 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -70.68 -35.08 72.64 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 118.962 -0.542 . . . . 0.0 110.892 -174.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.5 m -65.0 -43.31 92.98 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 93.0 p -67.47 -39.34 85.27 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.447 HG21 HD13 ' A' ' 34' ' ' LEU . 78.3 t -67.69 -36.33 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 117.862 -1.066 . . . . 0.0 109.31 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.62 -36.75 84.84 Favored 'General case' 0 C--N 1.361 1.082 0 CA-C-N 119.656 1.116 . . . . 0.0 110.923 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 95.3 m -65.4 -40.95 94.05 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 123.351 0.66 . . . . 0.0 109.23 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.87 -40.78 81.63 Favored 'Isoleucine or valine' 0 C--N 1.356 0.889 0 C-N-CA 124.687 1.195 . . . . 0.0 110.08 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.1 t -61.6 -39.56 83.54 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 C-N-CA 125.773 1.629 . . . . 0.0 110.149 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -62.23 -38.85 90.78 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 118.424 0.556 . . . . 0.0 111.127 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -68.8 -42.45 77.29 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 123.921 0.888 . . . . 0.0 108.922 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . 0.259 28.8 m-85 -70.42 -23.2 62.7 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -66.3 -38.88 88.75 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -65.34 -42.69 92.63 Favored 'General case' 0 C--N 1.363 1.153 0 C-N-CA 124.404 1.082 . . . . 0.0 108.414 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -70.63 -25.04 62.85 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.31 -32.34 68.55 Favored Glycine 0 C--N 1.356 1.657 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.9 m -78.46 -50.01 12.41 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 83.3 m . . . . . 0 C--N 1.359 1.003 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 -179.148 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 . . . . . 0 CA--C 1.496 -1.113 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -67.41 -41.36 85.03 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 118.797 0.726 . . . . 0.0 111.629 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.05 -42.4 76.33 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 123.922 0.889 . . . . 0.0 110.345 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -66.7 -37.74 85.33 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-O 118.675 -0.678 . . . . 0.0 111.091 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -65.47 -34.7 78.89 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 119.018 -0.515 . . . . 0.0 111.476 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -66.51 -38.72 87.83 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.3 mt -67.65 -40.05 83.33 Favored 'Isoleucine or valine' 0 C--N 1.359 1.003 0 C-N-CA 123.851 0.86 . . . . 0.0 109.505 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.5 -36.48 77.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.826 0 C-N-CA 124.197 0.999 . . . . 0.0 108.985 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.06 -37.29 87.07 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.17 -36.37 79.53 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 123.66 0.784 . . . . 0.0 110.15 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -61.09 -45.38 94.97 Favored 'General case' 0 C--N 1.367 1.341 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.64 -36.44 84.28 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 125.262 1.425 . . . . 0.0 110.546 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.2 m -74.12 -18.26 60.82 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.226 1.011 . . . . 0.0 113.326 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.28 -14.34 8.85 Favored Glycine 0 C--N 1.357 1.704 0 CA-C-O 118.255 -1.303 . . . . 0.0 116.057 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.9 m -91.74 82.74 5.23 Favored 'General case' 0 C--N 1.356 0.853 1 N-CA-C 100.194 -4.002 . . . . 0.0 100.194 177.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.4 m -94.72 -81.01 0.4 Allowed 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 -175.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.3 mt -79.46 -23.66 42.94 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 118.371 0.532 . . . . 0.0 111.867 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.18 -25.48 75.41 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.74 -46.84 6.43 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 117.668 0.734 . . . . 0.0 112.707 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -66.62 -46.69 85.42 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 CA-C-N 118.124 0.42 . . . . 0.0 111.614 -177.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.8 m -69.25 -34.57 74.99 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -82.62 -47.25 12.29 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -74.69 -52.52 11.39 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.487 HD13 HG21 ' A' ' 41' ' ' VAL . 93.3 mt -84.33 -54.06 5.04 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 119.46 -0.305 . . . . 0.0 111.797 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 67.08 -66.92 0.18 Allowed 'General case' 0 C--N 1.358 0.969 0 C-N-CA 126.238 1.815 . . . . 0.0 115.328 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.8 t -72.91 -52.77 5.59 Favored Pre-proline 0 N--CA 1.442 -0.86 0 CA-C-O 114.963 -2.446 . . . . 0.0 114.764 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -81.51 43.92 1.63 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 125.789 3.103 . . . . 0.0 115.101 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -67.95 -33.38 74.55 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-O 118.55 -0.738 . . . . 0.0 112.803 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.3 m -65.72 -43.43 89.08 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 123.291 0.637 . . . . 0.0 111.683 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.8 m -66.42 -41.95 88.49 Favored 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 123.646 0.778 . . . . 0.0 109.657 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.487 HG21 HD13 ' A' ' 34' ' ' LEU . 78.9 t -67.34 -40.48 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-O 117.82 -1.086 . . . . 0.0 109.927 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -64.22 -30.81 71.85 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 119.652 1.115 . . . . 0.0 112.955 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 97.5 m -66.34 -40.51 89.89 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.3 mt -71.58 -40.68 71.56 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 C-N-CA 125.145 1.378 . . . . 0.0 109.511 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.73 -37.22 77.53 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 C-N-CA 125.754 1.621 . . . . 0.0 111.057 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 95.5 mtm-85 -63.33 -39.59 94.95 Favored 'General case' 0 C--N 1.357 0.926 0 CA-C-N 119.605 1.093 . . . . 0.0 110.91 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -68.6 -41.04 80.13 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 123.501 0.72 . . . . 0.0 109.071 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -69.98 -25.09 63.45 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -66.85 -38.13 85.78 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -65.41 -41.17 93.91 Favored 'General case' 0 C--N 1.362 1.122 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -69.55 -26.38 64.46 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.07 -31.03 71.93 Favored Glycine 0 C--N 1.357 1.704 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.2 m -75.34 -52.99 9.5 Favored 'General case' 0 C--N 1.359 1.008 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 76.8 m . . . . . 0 C--N 1.36 1.063 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -179.958 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 123.297 1.522 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.3 p -110.59 -22.8 11.45 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.375 -1.739 . . . . 0.0 114.801 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 78.2 mtm -72.41 -24.97 61.31 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.578 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . -106.24 -125.0 5.4 Favored Glycine 0 C--N 1.355 1.637 0 N-CA-C 108.29 -1.924 . . . . 0.0 108.29 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . 0.271 99.1 mttt 58.31 106.35 0.02 OUTLIER 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 57.6 m 53.34 52.1 14.16 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.578 ' HE3' ' HA2' ' A' ' 4' ' ' GLY . 98.6 mttt -71.99 124.54 25.14 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 81.07 130.56 0.05 Allowed 'General case' 0 C--N 1.358 0.968 0 C-N-CA 127.149 2.18 . . . . 0.0 106.067 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.71 -41.78 93.63 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 124.702 1.201 . . . . 0.0 110.729 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.6 p -76.98 -9.49 58.73 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 73.3 tp60 -60.73 -39.98 90.67 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -65.82 -38.46 88.97 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 122.726 0.411 . . . . 0.0 110.824 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.3 tp -67.1 -41.09 86.84 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 123.639 0.776 . . . . 0.0 109.037 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -62.38 -42.61 99.55 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 124.631 1.172 . . . . 0.0 109.595 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -65.18 -41.79 94.28 Favored 'General case' 0 CA--C 1.496 -1.119 0 C-N-CA 123.256 0.622 . . . . 0.0 111.122 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -64.44 -41.11 96.75 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 123.078 0.551 . . . . 0.0 111.57 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.9 mm -67.35 -45.83 85.04 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 CA-C-O 118.602 -0.714 . . . . 0.0 110.24 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.72 -37.12 79.2 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 C-N-CA 123.54 0.736 . . . . 0.0 111.166 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -64.38 -43.75 93.51 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 118.584 0.629 . . . . 0.0 110.514 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.0 mt -67.57 -38.7 84.47 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 123.63 0.772 . . . . 0.0 110.886 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 26' ' ' SER . 74.6 t80 -61.68 -46.65 88.8 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.806 2.042 . . . . 0.0 110.035 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -74.21 -37.36 63.89 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.2 p -80.93 -42.18 21.75 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 117.575 2.435 . . . . 0.0 117.575 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.14 -113.14 1.09 Allowed Glycine 0 CA--C 1.485 -1.84 0 C-N-CA 121.488 -0.386 . . . . 0.0 112.652 -177.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.9 t -66.4 122.9 18.56 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 121.9 0.857 . . . . 0.0 110.747 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 21' ' ' TYR . 73.4 m -91.72 -57.55 2.71 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 113.801 -1.545 . . . . 0.0 113.135 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.7 mt -98.92 -16.91 18.61 Favored 'General case' 0 CA--C 1.487 -1.455 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.721 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.21 -38.56 72.12 Favored Glycine 0 C--N 1.354 1.557 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.62 -38.84 84.5 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 123.486 0.715 . . . . 0.0 111.001 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.415 HG21 ' HB3' ' A' ' 37' ' ' PRO . 96.8 mt -72.37 -47.09 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.967 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 75.7 m -63.23 -37.96 89.28 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 124.035 0.934 . . . . 0.0 112.988 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -75.79 -46.01 33.04 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -86.74 -54.99 4.06 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.9 mt -81.42 -31.44 33.17 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 123.772 0.829 . . . . 0.0 112.949 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 31' ' ' SER . . . 77.44 -67.35 0.2 Allowed 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 128.26 2.624 . . . . 0.0 111.052 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.2 t -113.48 117.29 45.21 Favored Pre-proline 0 N--CA 1.44 -0.948 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.415 ' HB3' HG21 ' A' ' 30' ' ' ILE . 26.4 Cg_endo -67.33 -38.64 14.68 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 123.197 2.598 . . . . 0.0 114.241 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 56.67 -173.03 0.07 Allowed 'General case' 0 C--N 1.36 1.06 0 C-N-CA 124.863 1.265 . . . . 0.0 113.376 -172.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.3 p -66.1 -29.99 70.42 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 124.618 1.167 . . . . 0.0 110.721 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.3 m -61.07 -48.86 79.77 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.425 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.0 t -81.33 -38.26 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 118.901 0.773 . . . . 0.0 109.71 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.535 ' HA ' HG22 ' A' ' 45' ' ' VAL . 94.6 mm-40 -61.33 -38.86 88.43 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 97.7 m -68.12 -41.87 81.08 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 119.268 0.94 . . . . 0.0 109.901 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.3 mt -66.35 -43.78 91.2 Favored 'Isoleucine or valine' 0 C--N 1.356 0.888 0 C-N-CA 123.767 0.827 . . . . 0.0 109.734 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.535 HG22 ' HA ' ' A' ' 42' ' ' GLN 0.264 33.0 m -70.18 -32.49 51.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 CA-C-O 117.743 -1.122 . . . . 0.0 113.323 -179.026 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -62.53 -41.55 98.94 Favored 'General case' 0 C--N 1.362 1.111 0 CA-C-N 119.22 0.918 . . . . 0.0 111.616 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -70.48 -44.45 67.69 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 124.443 1.097 . . . . 0.0 109.192 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -66.13 -32.16 73.45 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.79 -39.42 90.95 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -64.3 -42.68 96.24 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 123.61 0.764 . . . . 0.0 109.531 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -70.24 -33.51 71.72 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.93 -31.12 67.24 Favored Glycine 0 C--N 1.355 1.588 0 C-N-CA 124.527 1.061 . . . . 0.0 110.857 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.0 m -78.94 -60.33 2.42 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.1 m -153.27 108.1 3.17 Favored 'General case' 0 C--N 1.358 0.975 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -89.4 126.0 35.38 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -98.9 139.9 33.87 Favored 'General case' 0 CA--C 1.498 -1.03 0 C-N-CA 124.453 1.101 . . . . 0.0 110.593 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 56.9 m80 . . . . . 0 C--O 1.259 1.554 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 179.899 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.278 0 CA-C-O 121.65 0.738 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.9 t -80.94 137.96 36.11 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.205 -1.361 . . . . 0.0 109.409 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 99.1 mmm -104.76 -28.03 11.43 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.11 -141.6 9.79 Favored Glycine 0 CA--C 1.488 -1.632 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 72.93 -52.83 0.71 Allowed 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 127.394 2.278 . . . . 0.0 112.013 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.1 t -70.83 125.1 25.9 Favored 'General case' 0 C--N 1.36 1.03 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -122.48 161.07 24.26 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.05 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.4 mp0 54.76 40.62 32.03 Favored 'General case' 0 C--N 1.36 1.025 0 C-N-CA 127.275 2.23 . . . . 0.0 113.245 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.35 -47.21 90.57 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.0 p -80.07 -39.19 30.24 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 123.902 0.881 . . . . 0.0 113.092 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -61.61 -27.9 68.98 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -57.77 -32.94 67.99 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.8 mt -64.19 -40.84 96.94 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 123.013 0.525 . . . . 0.0 111.789 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.75 -37.99 67.51 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 124.622 1.169 . . . . 0.0 109.915 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.526 ' HA ' HG22 ' A' ' 18' ' ' VAL . 97.5 mttt -61.33 -35.45 77.43 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 123.658 0.783 . . . . 0.0 111.691 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -65.47 -29.03 69.65 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.408 HD13 HD21 ' A' ' 34' ' ' LEU . 93.5 mt -74.81 -47.59 37.13 Favored 'Isoleucine or valine' 0 C--N 1.356 0.881 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.526 HG22 ' HA ' ' A' ' 15' ' ' LYS 0.282 31.9 m -67.42 -25.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.36 1.062 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -178.655 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -63.9 -32.99 74.71 Favored 'General case' 0 C--N 1.358 0.962 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.447 HD13 HH11 ' A' ' 33' ' ' ARG . 92.2 mt -68.91 -37.84 79.2 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 124.247 1.019 . . . . 0.0 108.478 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.413 ' CD1' ' HB2' ' A' ' 25' ' ' SER . 79.4 t80 -62.98 -42.05 99.73 Favored 'General case' 0 C--N 1.363 1.158 0 C-N-CA 124.238 1.015 . . . . 0.0 109.404 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -68.48 -37.62 80.29 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.207 1.003 . . . . 0.0 110.512 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.0 m -69.81 -29.86 67.25 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 123.655 0.782 . . . . 0.0 111.671 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.15 109.96 0.53 Allowed Glycine 0 CA--C 1.482 -2.025 0 N-CA-C 106.268 -2.733 . . . . 0.0 106.268 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.413 ' HB2' ' CD1' ' A' ' 21' ' ' TYR . 43.9 t -79.26 114.57 18.3 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.851 0.834 . . . . 0.0 108.877 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.6 m -104.27 115.58 30.64 Favored 'General case' 0 N--CA 1.431 -1.412 1 N-CA-C 97.568 -4.975 . . . . 0.0 97.568 176.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.0 mt -67.31 -35.89 80.36 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.43 -38.41 86.86 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.5 -41.82 54.36 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.1 mt -68.95 -38.99 79.27 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 CA-C-O 118.619 -0.705 . . . . 0.0 111.961 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.5 m -65.47 -38.17 89.01 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 118.621 0.646 . . . . 0.0 111.591 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.22 -37.19 74.97 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 118.106 0.412 . . . . 0.0 111.863 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.447 HH11 HD13 ' A' ' 20' ' ' LEU . 99.6 mtt180 -70.75 -46.4 63.03 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.507 HD13 ' HB3' ' A' ' 37' ' ' PRO . 95.9 mt -80.94 -41.77 22.39 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 75.6 -67.95 0.22 Allowed 'General case' 0 C--N 1.355 0.846 0 C-N-CA 127.63 2.372 . . . . 0.0 107.2 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.453 HG12 ' HG3' ' A' ' 38' ' ' ARG . 59.2 t -127.88 102.93 21.67 Favored Pre-proline 0 C--N 1.358 0.949 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 178.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.507 ' HB3' HD13 ' A' ' 34' ' ' LEU . 34.1 Cg_endo -66.11 -32.69 42.85 Favored 'Trans proline' 0 CA--C 1.499 -1.235 0 C-N-CA 123.986 3.124 . . . . 0.0 114.577 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.453 ' HG3' HG12 ' A' ' 36' ' ' VAL . 99.8 mtt180 65.04 174.39 0.21 Allowed 'General case' 0 C--N 1.355 0.836 0 C-N-CA 125.789 1.635 . . . . 0.0 112.969 -177.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.9 m -64.34 -35.31 80.47 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 124.484 1.114 . . . . 0.0 112.819 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.7 m -63.69 -48.53 76.78 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 77.0 t -71.65 -38.69 67.73 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 73.3 tp60 -60.26 -35.84 76.42 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 123.176 0.59 . . . . 0.0 112.431 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 99.2 m -67.44 -39.44 85.42 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.391 0.541 . . . . 0.0 110.282 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.504 HG22 HG11 ' A' ' 18' ' ' VAL . 96.4 mt -71.77 -36.64 59.49 Favored 'Isoleucine or valine' 0 C--N 1.359 1.015 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.39 -40.3 85.77 Favored 'Isoleucine or valine' 0 C--N 1.362 1.126 0 C-N-CA 125.26 1.424 . . . . 0.0 108.471 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 -63.72 -36.6 84.4 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 123.343 0.657 . . . . 0.0 112.104 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.89 -44.39 93.18 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -68.3 -36.04 78.75 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.88 -39.25 93.74 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 124.953 1.301 . . . . 0.0 109.619 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -63.45 -43.6 96.91 Favored 'General case' 0 C--N 1.357 0.927 0 C-N-CA 123.768 0.827 . . . . 0.0 110.275 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -81.62 -22.7 37.49 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.15 -11.57 85.42 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-O 118.783 -1.009 . . . . 0.0 112.426 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.0 m -72.25 -60.79 2.05 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 118.123 0.961 . . . . 0.0 108.851 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 80.6 m -133.94 -69.05 0.54 Allowed 'General case' 0 C--N 1.362 1.13 0 CA-C-N 119.093 0.86 . . . . 0.0 108.768 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 67.34 -72.77 0.09 Allowed 'General case' 0 C--N 1.364 1.223 0 C-N-CA 128.079 2.552 . . . . 0.0 111.59 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -77.03 135.88 38.67 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 123.645 0.778 . . . . 0.0 112.786 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 . . . . . 0 C--O 1.26 1.645 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 179.872 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.1 m -85.62 -44.47 12.58 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.695 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.6 ttm -62.06 124.37 20.63 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 123.766 0.826 . . . . 0.0 111.776 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.04 -12.97 62.54 Favored Glycine 0 C--N 1.352 1.43 0 CA-C-N 114.482 -1.236 . . . . 0.0 112.552 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -114.72 2.61 14.5 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.12 0.968 . . . . 0.0 109.411 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.5 m -66.66 -25.82 66.75 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 126.945 2.098 . . . . 0.0 111.535 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.31 166.99 22.13 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 127.36 2.264 . . . . 0.0 112.778 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -67.5 169.03 9.82 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.876 1.67 . . . . 0.0 112.13 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.495 ' HA ' ' HB2' ' A' ' 12' ' ' ASP . 96.5 mt 81.96 -19.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.089 0 C-N-CA 128.89 2.876 . . . . 0.0 111.143 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 75.5 m -67.55 -48.99 65.35 Favored 'General case' 0 C--N 1.357 0.929 0 CA-C-N 119.25 0.932 . . . . 0.0 110.674 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -75.11 -36.24 61.67 Favored 'General case' 0 CA--C 1.496 -1.126 0 C-N-CA 124.466 1.106 . . . . 0.0 110.007 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.495 ' HB2' ' HA ' ' A' ' 9' ' ' ILE . 99.4 m-20 -63.6 -35.08 79.34 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.739 1.216 . . . . 0.0 110.628 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.3 tp -65.83 -43.03 89.8 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.7 mtp85 -65.18 -38.6 91.01 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 122.845 0.458 . . . . 0.0 111.049 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.46 -41.8 96.31 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 92.4 mtm-85 -67.24 -29.35 68.96 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 123.962 0.905 . . . . 0.0 113.048 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.407 HD13 ' HG ' ' A' ' 34' ' ' LEU . 96.3 mt -70.05 -46.32 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 119.29 0.95 . . . . 0.0 109.0 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.7 t -68.48 -44.33 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 124.634 1.174 . . . . 0.0 111.344 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -68.79 -40.13 79.77 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 124.072 0.949 . . . . 0.0 112.555 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.5 mt -67.22 -33.27 75.0 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 118.836 -0.602 . . . . 0.0 110.817 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -62.49 -42.07 99.24 Favored 'General case' 0 C--N 1.362 1.12 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -66.32 -36.66 83.48 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 123.971 0.908 . . . . 0.0 109.978 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.8 m -70.72 -16.97 62.82 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 124.906 1.282 . . . . 0.0 112.978 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.53 1.16 3.52 Favored Glycine 0 C--N 1.36 1.901 0 N-CA-C 117.866 1.907 . . . . 0.0 117.866 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.6 m -77.18 154.77 32.8 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 119.972 1.886 . . . . 0.0 111.721 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.7 p -80.83 164.67 22.52 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 125.307 1.443 . . . . 0.0 112.623 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.45 HD23 HD12 ' A' ' 30' ' ' ILE . 86.2 mt -68.94 -22.45 64.13 Favored 'General case' 0 C--N 1.361 1.073 0 C-N-CA 124.07 0.948 . . . . 0.0 110.61 177.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.98 -35.66 92.28 Favored Glycine 0 C--N 1.359 1.861 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.11 -37.01 75.26 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 123.644 0.778 . . . . 0.0 110.184 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.45 HD12 HD23 ' A' ' 27' ' ' LEU . 96.3 mt -66.41 -43.15 91.3 Favored 'Isoleucine or valine' 0 C--N 1.365 1.244 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.2 m -63.09 -37.14 86.02 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.65 1.18 . . . . 0.0 110.498 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.68 -46.88 67.89 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -74.44 -49.28 23.04 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.407 ' HG ' HD13 ' A' ' 17' ' ' ILE . 90.4 mt -77.36 -33.72 55.27 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 115.721 1.748 . . . . 0.0 115.721 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 74.76 -68.3 0.22 Allowed 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 126.186 1.795 . . . . 0.0 111.527 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.6 t -122.48 94.7 47.53 Favored Pre-proline 0 C--N 1.36 1.061 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -70.77 -27.83 21.15 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 123.578 2.852 . . . . 0.0 113.328 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 60.31 -175.57 0.11 Allowed 'General case' 0 C--N 1.359 1.02 0 C-N-CA 124.846 1.258 . . . . 0.0 112.548 -170.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 92.8 p -67.98 -37.44 81.52 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 123.775 0.83 . . . . 0.0 112.821 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.7 m -63.86 -47.47 80.55 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -177.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.4 t -71.45 -37.92 66.42 Favored 'Isoleucine or valine' 0 C--N 1.359 0.981 0 CA-C-O 118.535 -0.745 . . . . 0.0 109.29 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -62.3 -37.77 86.81 Favored 'General case' 0 C--N 1.362 1.12 0 CA-C-N 118.573 0.624 . . . . 0.0 112.334 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 97.7 m -66.84 -41.39 87.48 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 123.346 0.658 . . . . 0.0 109.581 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.4 mt -66.4 -41.92 89.58 Favored 'Isoleucine or valine' 0 C--N 1.358 0.953 0 C-N-CA 123.495 0.718 . . . . 0.0 110.01 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.7 t -62.9 -40.13 87.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 C-N-CA 124.127 0.971 . . . . 0.0 110.744 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -65.53 -40.1 92.53 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.45 0.568 . . . . 0.0 112.245 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -68.29 -40.25 81.84 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 124.155 0.982 . . . . 0.0 109.783 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -66.62 -40.14 88.64 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.246 1.018 . . . . 0.0 110.317 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.0 -41.51 86.58 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -60.76 -28.74 68.94 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 125.941 1.696 . . . . 0.0 112.463 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -60.1 -27.94 67.43 Favored 'General case' 0 C--N 1.361 1.104 0 N-CA-C 112.71 0.634 . . . . 0.0 112.71 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.83 -28.87 71.43 Favored Glycine 0 C--N 1.359 1.854 0 CA-C-O 119.483 -0.62 . . . . 0.0 111.818 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.0 m -83.1 -58.36 2.89 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 81.6 m -150.57 110.44 4.09 Favored 'General case' 0 C--N 1.359 1.02 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -82.52 -49.61 9.71 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.005 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -110.09 130.5 55.53 Favored 'General case' 0 CA--C 1.49 -1.336 0 CA-C-O 120.734 0.302 . . . . 0.0 110.626 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.1 m80 . . . . . 0 C--O 1.26 1.639 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 -179.525 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.146 0 CA-C-O 121.415 0.626 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.4 p -103.53 -3.14 25.69 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 125.179 1.392 . . . . 0.0 113.21 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 97.8 mmm -66.93 -31.61 72.31 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.79 -90.78 2.19 Favored Glycine 0 C--N 1.354 1.556 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . 0.279 95.7 mttt 56.23 56.82 5.46 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 117.129 2.27 . . . . 0.0 117.129 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.279 59.2 m 54.91 69.74 0.7 Allowed 'General case' 0 C--N 1.362 1.118 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 89.2 tttt -63.55 131.86 49.42 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 80.9 133.94 0.06 Allowed 'General case' 0 C--N 1.359 0.984 0 C-N-CA 128.604 2.762 . . . . 0.0 107.161 -177.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.44 -41.35 90.85 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 C-N-CA 124.037 0.935 . . . . 0.0 109.468 -178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 98.6 p -66.58 -21.44 66.14 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 126.06 1.744 . . . . 0.0 115.259 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.433 ' HG3' ' HE3' ' A' ' 15' ' ' LYS . 71.0 tp60 -59.02 -38.05 78.35 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -176.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -65.43 -40.09 92.89 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 119.278 0.945 . . . . 0.0 111.478 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.3 tp -66.79 -41.66 87.28 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -63.26 -41.89 99.09 Favored 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 123.596 0.758 . . . . 0.0 110.14 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.433 ' HE3' ' HG3' ' A' ' 11' ' ' GLN . 97.8 mttt -64.37 -42.86 95.97 Favored 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 123.963 0.905 . . . . 0.0 111.334 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -64.26 -41.89 96.72 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 123.557 0.743 . . . . 0.0 110.46 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.6 mt -68.72 -46.51 79.53 Favored 'Isoleucine or valine' 0 C--N 1.358 0.966 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.407 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.96 -39.97 87.48 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 C-N-CA 124.039 0.935 . . . . 0.0 112.039 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -62.82 -43.4 98.9 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 118.297 0.498 . . . . 0.0 110.692 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.9 mt -70.63 -37.79 73.83 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 123.068 0.547 . . . . 0.0 111.77 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 26' ' ' SER . 74.2 t80 -60.92 -44.92 96.51 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 126.724 2.01 . . . . 0.0 109.687 -178.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -74.77 -40.31 61.26 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.9 p -80.88 -43.51 19.79 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.27 -115.31 1.38 Allowed Glycine 0 CA--C 1.487 -1.691 0 CA-C-O 121.158 0.31 . . . . 0.0 112.835 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.0 t -66.66 122.27 17.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-O 122.203 1.001 . . . . 0.0 110.691 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 21' ' ' TYR . 70.1 m -93.65 -54.99 3.42 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 113.126 -1.852 . . . . 0.0 111.298 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.0 mt -87.96 -29.07 21.06 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.81 -36.45 91.17 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-O 119.656 -0.524 . . . . 0.0 112.525 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.81 -40.85 79.34 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 117.06 0.43 . . . . 0.0 111.0 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -71.02 -45.39 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 118.955 -0.545 . . . . 0.0 109.778 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.7 m -62.7 -38.32 89.95 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 124.143 0.977 . . . . 0.0 113.149 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -72.7 -48.4 39.21 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -83.69 -55.81 4.07 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.98 -33.43 24.6 Favored 'General case' 0 CA--C 1.494 -1.208 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 78.82 -66.08 0.2 Allowed 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 128.011 2.524 . . . . 0.0 108.653 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.6 t -115.75 118.97 38.25 Favored Pre-proline 0 C--N 1.357 0.911 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -66.76 -38.44 17.84 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 123.849 3.033 . . . . 0.0 114.967 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 55.82 -171.98 0.07 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 125.501 1.521 . . . . 0.0 113.532 -172.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 89.0 p -63.79 -32.32 73.78 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 124.897 1.279 . . . . 0.0 111.872 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.6 m -59.81 -47.09 87.1 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 124.325 1.05 . . . . 0.0 112.757 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 77.0 t -82.46 -38.02 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-O 118.873 -0.584 . . . . 0.0 110.459 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.478 ' HA ' HG22 ' A' ' 45' ' ' VAL . 94.5 mm-40 -60.62 -38.98 86.54 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -178.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 98.6 m -65.76 -42.93 90.27 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-N 118.803 0.729 . . . . 0.0 109.939 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.1 mt -67.11 -45.93 85.55 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 123.985 0.914 . . . . 0.0 110.176 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.478 HG22 ' HA ' ' A' ' 42' ' ' GLN 0.266 33.9 m -69.18 -33.52 58.7 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.388 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.123 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -64.58 -36.71 85.1 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 119.179 0.9 . . . . 0.0 113.158 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -71.47 -44.98 63.77 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -66.74 -30.56 70.82 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -65.85 -37.27 85.73 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.611 1.565 . . . . 0.0 108.762 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -65.75 -41.55 91.98 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -70.25 -32.49 70.36 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 122.755 0.422 . . . . 0.0 111.4 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.86 -34.05 59.49 Favored Glycine 0 C--N 1.356 1.668 0 C-N-CA 123.878 0.752 . . . . 0.0 111.424 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.7 m -74.94 -61.05 2.02 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 79.1 m -154.55 106.92 2.77 Favored 'General case' 0 C--N 1.362 1.12 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -85.81 131.93 34.22 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -84.22 140.64 31.56 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 124.54 1.136 . . . . 0.0 110.945 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 47.5 m80 . . . . . 0 C--O 1.261 1.672 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 179.595 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.173 0 CA-C-O 121.176 0.512 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.7 t -76.51 132.43 39.56 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.869 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 97.4 mmm -105.32 120.3 41.22 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.7 174.08 46.98 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -134.05 148.45 51.06 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 121.428 0.633 . . . . 0.0 111.969 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.1 p -90.7 168.17 11.96 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 124.85 1.26 . . . . 0.0 107.61 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt 58.27 60.21 2.73 Favored 'General case' 0 C--N 1.365 1.245 0 C-N-CA 124.56 1.144 . . . . 0.0 112.9 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -85.44 7.1 23.94 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.361 1.064 . . . . 0.0 113.622 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.2 mt -58.38 -41.19 80.78 Favored 'Isoleucine or valine' 0 C--N 1.357 0.921 0 C-N-CA 125.111 1.364 . . . . 0.0 111.27 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 88.6 p -66.84 -38.89 87.28 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 123.97 0.908 . . . . 0.0 111.96 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -67.41 -31.94 72.49 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 125.588 1.555 . . . . 0.0 110.853 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -60.15 -39.99 88.29 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 123.866 0.867 . . . . 0.0 112.932 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.15 -39.79 82.53 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -65.3 -39.61 92.72 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 123.397 0.679 . . . . 0.0 109.659 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.07 -40.09 95.51 Favored 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 124.684 1.193 . . . . 0.0 109.043 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.66 -39.03 93.31 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.949 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.36 -45.42 85.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.2 t -63.74 -46.23 95.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 C-N-CA 124.792 1.237 . . . . 0.0 111.318 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -65.25 -42.07 93.65 Favored 'General case' 0 CA--C 1.488 -1.422 0 C-N-CA 123.853 0.861 . . . . 0.0 111.546 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.9 mt -66.24 -38.7 88.51 Favored 'General case' 0 CA--C 1.496 -1.104 0 O-C-N 123.514 0.509 . . . . 0.0 110.521 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.481 ' HE2' ' HD2' ' A' ' 49' ' ' LYS . 90.8 t80 -60.84 -45.33 94.92 Favored 'General case' 0 C--N 1.361 1.087 0 CA-C-O 118.965 -0.54 . . . . 0.0 110.678 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.04 -38.25 82.29 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.874 1.27 . . . . 0.0 111.587 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.4 m -69.79 -28.68 65.94 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 124.161 0.985 . . . . 0.0 112.538 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.54 78.22 0.44 Allowed Glycine 0 CA--C 1.482 -2.002 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.6 p -96.01 -20.32 18.79 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.462 -0.869 . . . . 0.0 110.576 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.8 t 57.96 -119.23 1.12 Allowed 'General case' 0 C--N 1.368 1.376 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.3 mt -123.12 -31.89 3.54 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 119.187 0.903 . . . . 0.0 109.785 177.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.52 -40.19 94.19 Favored Glycine 0 C--N 1.358 1.767 0 N-CA-C 117.925 1.93 . . . . 0.0 117.925 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.88 -41.59 82.54 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 118.424 1.112 . . . . 0.0 110.96 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.0 mt -67.28 -40.46 84.95 Favored 'Isoleucine or valine' 0 C--N 1.362 1.109 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.2 m -61.59 -37.01 82.32 Favored 'General case' 0 C--N 1.359 1.009 0 CA-C-N 118.612 0.642 . . . . 0.0 112.563 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.62 -40.14 88.63 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 119.217 -0.421 . . . . 0.0 110.984 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 62.7 ttm-85 -72.16 -52.63 15.74 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-O 119.157 -0.449 . . . . 0.0 111.534 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.8 mt -142.0 110.17 5.94 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.34 -49.84 4.78 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.1 t -73.45 -52.72 4.94 Favored Pre-proline 0 C--N 1.356 0.888 0 CA-C-O 115.457 -2.211 . . . . 0.0 112.818 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.56 75.83 4.69 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 CA-C-N 124.321 2.579 . . . . 0.0 112.09 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 55.6 mmm-85 -93.53 -10.99 32.98 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.3 m -61.27 -43.42 98.9 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.8 p -72.13 -39.36 68.88 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 123.705 0.802 . . . . 0.0 110.976 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 78.3 t -62.3 -40.25 87.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.834 0 C-N-CA 125.39 1.476 . . . . 0.0 110.353 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.36 -38.34 89.17 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.652 0.781 . . . . 0.0 111.867 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 94.9 m -71.28 -45.57 62.83 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 123.858 0.863 . . . . 0.0 110.571 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.41 -43.66 97.03 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 C-N-CA 124.869 1.268 . . . . 0.0 111.618 -177.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.5 m -65.48 -36.83 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.128 0 CA-C-O 118.284 -0.865 . . . . 0.0 113.188 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -68.52 -44.51 74.46 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.14 -45.53 76.84 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 123.113 0.565 . . . . 0.0 111.417 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -69.97 -30.65 68.05 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.481 ' HD2' ' HE2' ' A' ' 21' ' ' TYR . 86.8 tttt -65.39 -39.81 92.7 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -63.27 -40.11 96.48 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.746 0.818 . . . . 0.0 109.82 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -69.69 -38.53 77.01 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 118.955 -0.545 . . . . 0.0 111.905 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.5 -32.89 61.57 Favored Glycine 0 C--N 1.358 1.754 0 CA-C-O 119.825 -0.431 . . . . 0.0 113.868 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.3 m -82.19 -48.06 11.75 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 117.208 0.504 . . . . 0.0 111.719 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.9 m -99.18 -52.81 3.42 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 119.518 3.155 . . . . 0.0 119.518 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -82.15 -55.6 4.45 Favored 'General case' 0 C--N 1.356 0.859 1 N-CA-C 122.874 4.398 . . . . 0.0 122.874 -174.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 66.9 m170 -78.39 144.98 35.45 Favored 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 125.163 1.385 . . . . 0.0 113.386 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 . . . . . 0 C--O 1.259 1.584 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 179.591 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 121.555 0.693 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.7 m -81.75 -40.47 22.62 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.762 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 76.8 mtm -60.97 138.78 58.15 Favored 'General case' 0 CA--C 1.497 -1.067 0 C-N-CA 125.554 1.541 . . . . 0.0 115.074 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.75 -175.57 43.27 Favored Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -86.73 -10.73 53.0 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.7 m -61.95 124.0 19.59 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.61 111.09 23.51 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 103.146 -2.909 . . . . 0.0 103.146 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . 0.314 96.0 mt-10 52.9 -106.61 0.3 Allowed 'General case' 0 C--N 1.357 0.93 0 C-N-CA 124.188 0.995 . . . . 0.0 112.888 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 86.9 mt 73.93 -64.59 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.324 0 C-N-CA 128.036 2.534 . . . . 0.0 109.325 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 98.7 p -64.8 -33.9 77.09 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 125.047 1.339 . . . . 0.0 111.055 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -63.65 -35.54 80.86 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 123.831 0.853 . . . . 0.0 111.144 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -66.27 -38.96 89.05 Favored 'General case' 0 C--N 1.361 1.083 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.9 mt -66.91 -38.94 87.18 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.422 ' O ' HG23 ' A' ' 18' ' ' VAL . 78.1 mtt85 -61.98 -37.24 84.07 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 123.223 0.609 . . . . 0.0 111.176 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -60.52 -42.23 96.02 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 124.405 1.082 . . . . 0.0 109.391 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -69.71 -41.87 74.79 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.907 1.283 . . . . 0.0 110.387 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.536 HD13 HD11 ' A' ' 34' ' ' LEU . 88.9 mt -64.13 -38.1 81.6 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 125.9 1.68 . . . . 0.0 111.812 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 14' ' ' ARG . 60.9 t -62.4 -40.53 88.36 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -69.53 -40.25 77.0 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 123.528 0.517 . . . . 0.0 109.848 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.6 mt -60.7 -30.35 69.89 Favored 'General case' 0 CA--C 1.496 -1.126 0 C-N-CA 125.229 1.412 . . . . 0.0 112.774 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -56.16 -44.04 78.94 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 124.351 1.06 . . . . 0.0 110.16 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -84.75 -36.85 21.49 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 117.903 0.32 . . . . 0.0 111.156 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.8 m -60.54 -36.62 78.89 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 176.89 -176.05 47.87 Favored Glycine 0 CA--C 1.49 -1.517 0 C-N-CA 119.469 -1.348 . . . . 0.0 113.217 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.6 t 56.93 -149.67 0.46 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 128.242 2.617 . . . . 0.0 111.37 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.8 m -132.99 155.4 49.23 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.637 0.732 . . . . 0.0 109.14 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.7 tp -65.02 -32.07 73.61 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.473 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.15 -35.69 92.02 Favored Glycine 0 C--N 1.358 1.751 0 CA-C-O 119.275 -0.736 . . . . 0.0 111.51 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.9 -40.92 62.83 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-N 118.077 0.938 . . . . 0.0 111.303 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.59 -41.96 86.22 Favored 'Isoleucine or valine' 0 C--N 1.358 0.951 0 C-N-CA 123.776 0.83 . . . . 0.0 109.515 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.3 m -65.04 -38.85 92.2 Favored 'General case' 0 CA--C 1.496 -1.126 0 C-N-CA 124.397 1.079 . . . . 0.0 111.083 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.36 -39.07 85.69 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 92.0 mtm-85 -66.8 -42.41 85.98 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 122.599 0.36 . . . . 0.0 111.305 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.536 HD11 HD13 ' A' ' 17' ' ' ILE . 91.2 mt -73.09 -26.41 61.24 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 124.793 1.237 . . . . 0.0 111.993 178.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 79.49 -63.34 0.26 Allowed 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 128.212 2.605 . . . . 0.0 108.197 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.0 t -115.97 105.45 51.19 Favored Pre-proline 0 C--N 1.36 1.024 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -71.85 -27.02 18.31 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 123.762 2.975 . . . . 0.0 113.639 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 64.89 167.34 0.17 Allowed 'General case' 0 C--N 1.359 1.006 0 C-N-CA 125.949 1.699 . . . . 0.0 112.505 -166.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 88.8 p -77.2 -26.77 53.15 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 124.997 1.319 . . . . 0.0 110.338 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.2 m -61.56 -44.72 96.51 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.827 1.251 . . . . 0.0 113.421 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.0 t -67.16 -36.91 78.12 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.411 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 99.3 mm-40 -64.59 -40.36 95.38 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 123.549 0.74 . . . . 0.0 110.947 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 95.8 m -68.44 -41.84 79.73 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 123.548 0.739 . . . . 0.0 110.062 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.8 mt -67.52 -42.36 86.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.968 0 C-N-CA 122.927 0.491 . . . . 0.0 109.993 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.8 m -66.36 -33.31 62.67 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 CA-C-N 118.468 0.576 . . . . 0.0 111.753 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 95.7 mtt-85 -64.04 -39.2 93.57 Favored 'General case' 0 C--N 1.359 0.988 0 CA-C-N 118.321 0.509 . . . . 0.0 110.932 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -67.68 -39.6 84.44 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 124.201 1.0 . . . . 0.0 109.613 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -66.49 -37.22 84.61 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 124.249 1.019 . . . . 0.0 109.823 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -67.99 -41.2 82.67 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 124.907 1.283 . . . . 0.0 109.097 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -63.98 -35.03 79.36 Favored 'General case' 0 C--N 1.36 1.025 0 C-N-CA 124.617 1.167 . . . . 0.0 109.401 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -66.16 -25.46 66.97 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 123.812 0.845 . . . . 0.0 111.606 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.99 -35.02 77.85 Favored Glycine 0 C--N 1.36 1.88 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 84.8 m -79.28 -52.6 7.91 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.8 m -147.49 108.09 4.14 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -85.31 -50.7 7.12 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.152 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 49.3 p-80 -142.08 153.61 44.3 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 121.167 0.508 . . . . 0.0 111.437 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 31.2 m80 . . . . . 0 C--O 1.257 1.48 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.715 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.232 0 CA-C-O 121.45 0.643 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.576 ' HB3' ' HA ' ' A' ' 6' ' ' SER . 72.3 m -71.47 121.61 18.95 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.249 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.7 mmm -123.22 -21.41 5.4 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.483 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.62 -95.46 1.64 Allowed Glycine 0 CA--C 1.484 -1.894 0 N-CA-C 106.096 -2.802 . . . . 0.0 106.096 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -89.9 96.95 10.91 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 102.43 -3.174 . . . . 0.0 102.43 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.576 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 47.1 t -85.75 -54.22 4.66 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.477 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -142.68 154.81 44.67 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 117.78 2.511 . . . . 0.0 117.78 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -81.86 155.09 25.52 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 127.328 2.251 . . . . 0.0 108.123 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -82.2 -38.41 15.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.829 0 C-N-CA 124.754 1.221 . . . . 0.0 111.303 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 97.9 p -59.21 -23.62 62.44 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 117.031 2.234 . . . . 0.0 117.031 -177.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -57.89 -37.85 74.74 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.515 1.526 . . . . 0.0 112.927 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -65.77 -43.38 89.03 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 118.757 0.708 . . . . 0.0 110.213 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.3 tp -64.3 -45.59 87.29 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.706 1.202 . . . . 0.0 109.169 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.88 -38.14 87.99 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.951 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -65.25 -37.06 86.06 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-N 118.513 0.597 . . . . 0.0 112.28 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -66.25 -37.19 84.9 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 122.912 0.485 . . . . 0.0 109.754 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.7 mt -69.13 -40.19 80.31 Favored 'Isoleucine or valine' 0 C--N 1.356 0.859 0 C-N-CA 123.722 0.809 . . . . 0.0 109.734 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.5 t -66.08 -34.45 70.28 Favored 'Isoleucine or valine' 0 C--N 1.356 0.863 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -64.13 -39.13 93.36 Favored 'General case' 0 C--N 1.358 0.95 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.0 mt -66.4 -38.43 87.47 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 123.934 0.894 . . . . 0.0 109.825 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -60.2 -46.15 90.72 Favored 'General case' 0 C--N 1.364 1.204 0 C-N-CA 125.114 1.366 . . . . 0.0 108.097 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.91 -33.83 76.46 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 123.527 0.731 . . . . 0.0 111.271 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.4 m -74.95 -12.69 60.4 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 124.217 1.007 . . . . 0.0 112.972 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.61 -15.42 12.79 Favored Glycine 0 C--N 1.358 1.783 0 N-CA-C 116.76 1.464 . . . . 0.0 116.76 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.8 t -91.84 87.17 6.15 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 100.924 -3.732 . . . . 0.0 100.924 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.4 m -95.66 -73.43 0.59 Allowed 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 115.138 1.532 . . . . 0.0 115.138 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.2 mt -81.22 -24.03 37.69 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-O 119.555 -0.259 . . . . 0.0 111.572 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.78 -20.94 78.98 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.6 -49.45 4.01 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 117.901 0.851 . . . . 0.0 112.456 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.96 -48.81 84.46 Favored 'Isoleucine or valine' 0 C--N 1.358 0.974 0 CA-C-N 118.44 0.564 . . . . 0.0 111.865 -176.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.2 m -70.2 -35.1 73.69 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.87 -50.23 9.44 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -73.16 -51.09 19.17 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.447 HD13 HG21 ' A' ' 41' ' ' VAL . 94.8 mt -87.83 -55.99 3.53 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.978 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 66.65 -67.02 0.17 Allowed 'General case' 0 C--N 1.356 0.862 0 C-N-CA 125.853 1.661 . . . . 0.0 114.909 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.6 t -69.48 -53.79 12.19 Favored Pre-proline 0 C--N 1.358 0.967 0 CA-C-O 114.549 -2.643 . . . . 0.0 114.713 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -81.8 46.08 2.13 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 CA-C-N 126.132 3.226 . . . . 0.0 114.441 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -70.68 -35.08 72.64 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 118.962 -0.542 . . . . 0.0 110.892 -174.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.5 m -65.0 -43.31 92.98 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 93.0 p -67.47 -39.34 85.27 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.447 HG21 HD13 ' A' ' 34' ' ' LEU . 78.3 t -67.69 -36.33 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 117.862 -1.066 . . . . 0.0 109.31 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.62 -36.75 84.84 Favored 'General case' 0 C--N 1.361 1.082 0 CA-C-N 119.656 1.116 . . . . 0.0 110.923 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 95.3 m -65.4 -40.95 94.05 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 123.351 0.66 . . . . 0.0 109.23 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.87 -40.78 81.63 Favored 'Isoleucine or valine' 0 C--N 1.356 0.889 0 C-N-CA 124.687 1.195 . . . . 0.0 110.08 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.1 t -61.6 -39.56 83.54 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 C-N-CA 125.773 1.629 . . . . 0.0 110.149 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -62.23 -38.85 90.78 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 118.424 0.556 . . . . 0.0 111.127 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -68.8 -42.45 77.29 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 123.921 0.888 . . . . 0.0 108.922 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . 0.259 28.8 m-85 -70.42 -23.2 62.7 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -66.3 -38.88 88.75 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -65.34 -42.69 92.63 Favored 'General case' 0 C--N 1.363 1.153 0 C-N-CA 124.404 1.082 . . . . 0.0 108.414 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -70.63 -25.04 62.85 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.31 -32.34 68.55 Favored Glycine 0 C--N 1.356 1.657 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.9 m -78.46 -50.01 12.41 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 83.3 m -140.3 106.07 5.15 Favored 'General case' 0 C--N 1.359 1.003 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -75.87 133.21 40.62 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -108.41 136.89 47.3 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 . . . . . 0 C--O 1.259 1.595 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 179.218 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.243 0 CA-C-O 121.559 0.695 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.482 ' OG ' ' HA ' ' A' ' 6' ' ' SER . 38.6 t -80.98 110.67 16.74 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 106.225 -1.768 . . . . 0.0 106.225 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 97.8 mtp -128.01 -17.4 4.39 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.2 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.43 -91.66 1.37 Allowed Glycine 0 C--N 1.36 1.874 0 N-CA-C 106.37 -2.692 . . . . 0.0 106.37 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -88.45 102.61 15.06 Favored 'General case' 0 CA--C 1.497 -1.096 1 N-CA-C 98.96 -4.459 . . . . 0.0 98.96 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.482 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 72.1 m -76.26 -49.82 16.03 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -177.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -145.0 148.95 34.31 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -80.01 159.07 26.35 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 127.146 2.178 . . . . 0.0 109.343 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.4 mt -83.53 -40.56 16.09 Favored 'Isoleucine or valine' 0 C--N 1.355 0.835 0 C-N-CA 124.467 1.107 . . . . 0.0 110.886 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 90.8 p -58.4 -30.31 66.74 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 118.081 2.623 . . . . 0.0 118.081 -176.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -56.14 -41.72 75.82 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -177.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -67.41 -41.36 85.03 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 118.797 0.726 . . . . 0.0 111.629 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.05 -42.4 76.33 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 123.922 0.889 . . . . 0.0 110.345 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -66.7 -37.74 85.33 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-O 118.675 -0.678 . . . . 0.0 111.091 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -65.47 -34.7 78.89 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 119.018 -0.515 . . . . 0.0 111.476 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -66.51 -38.72 87.83 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.3 mt -67.65 -40.05 83.33 Favored 'Isoleucine or valine' 0 C--N 1.359 1.003 0 C-N-CA 123.851 0.86 . . . . 0.0 109.505 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.5 -36.48 77.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.826 0 C-N-CA 124.197 0.999 . . . . 0.0 108.985 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.06 -37.29 87.07 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.17 -36.37 79.53 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 123.66 0.784 . . . . 0.0 110.15 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -61.09 -45.38 94.97 Favored 'General case' 0 C--N 1.367 1.341 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.64 -36.44 84.28 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 125.262 1.425 . . . . 0.0 110.546 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.2 m -74.12 -18.26 60.82 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.226 1.011 . . . . 0.0 113.326 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.28 -14.34 8.85 Favored Glycine 0 C--N 1.357 1.704 0 CA-C-O 118.255 -1.303 . . . . 0.0 116.057 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.9 m -91.74 82.74 5.23 Favored 'General case' 0 C--N 1.356 0.853 1 N-CA-C 100.194 -4.002 . . . . 0.0 100.194 177.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.4 m -94.72 -81.01 0.4 Allowed 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 -175.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.3 mt -79.46 -23.66 42.94 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 118.371 0.532 . . . . 0.0 111.867 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.18 -25.48 75.41 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.74 -46.84 6.43 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 117.668 0.734 . . . . 0.0 112.707 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -66.62 -46.69 85.42 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 CA-C-N 118.124 0.42 . . . . 0.0 111.614 -177.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.8 m -69.25 -34.57 74.99 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -82.62 -47.25 12.29 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -74.69 -52.52 11.39 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.487 HD13 HG21 ' A' ' 41' ' ' VAL . 93.3 mt -84.33 -54.06 5.04 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 119.46 -0.305 . . . . 0.0 111.797 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 67.08 -66.92 0.18 Allowed 'General case' 0 C--N 1.358 0.969 0 C-N-CA 126.238 1.815 . . . . 0.0 115.328 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.8 t -72.91 -52.77 5.59 Favored Pre-proline 0 N--CA 1.442 -0.86 0 CA-C-O 114.963 -2.446 . . . . 0.0 114.764 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -81.51 43.92 1.63 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 125.789 3.103 . . . . 0.0 115.101 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -67.95 -33.38 74.55 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-O 118.55 -0.738 . . . . 0.0 112.803 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.3 m -65.72 -43.43 89.08 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 123.291 0.637 . . . . 0.0 111.683 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.8 m -66.42 -41.95 88.49 Favored 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 123.646 0.778 . . . . 0.0 109.657 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.487 HG21 HD13 ' A' ' 34' ' ' LEU . 78.9 t -67.34 -40.48 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-O 117.82 -1.086 . . . . 0.0 109.927 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -64.22 -30.81 71.85 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 119.652 1.115 . . . . 0.0 112.955 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 97.5 m -66.34 -40.51 89.89 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.3 mt -71.58 -40.68 71.56 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 C-N-CA 125.145 1.378 . . . . 0.0 109.511 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.73 -37.22 77.53 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 C-N-CA 125.754 1.621 . . . . 0.0 111.057 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 95.5 mtm-85 -63.33 -39.59 94.95 Favored 'General case' 0 C--N 1.357 0.926 0 CA-C-N 119.605 1.093 . . . . 0.0 110.91 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -68.6 -41.04 80.13 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 123.501 0.72 . . . . 0.0 109.071 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -69.98 -25.09 63.45 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -66.85 -38.13 85.78 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -65.41 -41.17 93.91 Favored 'General case' 0 C--N 1.362 1.122 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -69.55 -26.38 64.46 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.07 -31.03 71.93 Favored Glycine 0 C--N 1.357 1.704 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.2 m -75.34 -52.99 9.5 Favored 'General case' 0 C--N 1.359 1.008 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 76.8 m -147.88 105.83 3.72 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -75.59 131.48 40.03 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 123.487 0.715 . . . . 0.0 109.544 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -100.21 130.3 46.33 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 18.2 m80 . . . . . 0 C--O 1.26 1.62 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -179.018 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 73.3 tp60 . . . . . 0 CA--C 1.505 -0.762 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -65.82 -38.46 88.97 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 122.726 0.411 . . . . 0.0 110.824 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.3 tp -67.1 -41.09 86.84 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 123.639 0.776 . . . . 0.0 109.037 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -62.38 -42.61 99.55 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 124.631 1.172 . . . . 0.0 109.595 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -65.18 -41.79 94.28 Favored 'General case' 0 CA--C 1.496 -1.119 0 C-N-CA 123.256 0.622 . . . . 0.0 111.122 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -64.44 -41.11 96.75 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 123.078 0.551 . . . . 0.0 111.57 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.9 mm -67.35 -45.83 85.04 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 CA-C-O 118.602 -0.714 . . . . 0.0 110.24 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.72 -37.12 79.2 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 C-N-CA 123.54 0.736 . . . . 0.0 111.166 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -64.38 -43.75 93.51 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 118.584 0.629 . . . . 0.0 110.514 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.0 mt -67.57 -38.7 84.47 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 123.63 0.772 . . . . 0.0 110.886 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 26' ' ' SER . 74.6 t80 -61.68 -46.65 88.8 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.806 2.042 . . . . 0.0 110.035 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -74.21 -37.36 63.89 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.2 p -80.93 -42.18 21.75 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 117.575 2.435 . . . . 0.0 117.575 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.14 -113.14 1.09 Allowed Glycine 0 CA--C 1.485 -1.84 0 C-N-CA 121.488 -0.386 . . . . 0.0 112.652 -177.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.9 t -66.4 122.9 18.56 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 121.9 0.857 . . . . 0.0 110.747 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 21' ' ' TYR . 73.4 m -91.72 -57.55 2.71 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 113.801 -1.545 . . . . 0.0 113.135 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.7 mt -98.92 -16.91 18.61 Favored 'General case' 0 CA--C 1.487 -1.455 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.721 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.21 -38.56 72.12 Favored Glycine 0 C--N 1.354 1.557 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.62 -38.84 84.5 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 123.486 0.715 . . . . 0.0 111.001 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.415 HG21 ' HB3' ' A' ' 37' ' ' PRO . 96.8 mt -72.37 -47.09 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.967 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 75.7 m -63.23 -37.96 89.28 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 124.035 0.934 . . . . 0.0 112.988 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -75.79 -46.01 33.04 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -86.74 -54.99 4.06 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.9 mt -81.42 -31.44 33.17 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 123.772 0.829 . . . . 0.0 112.949 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 31' ' ' SER . . . 77.44 -67.35 0.2 Allowed 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 128.26 2.624 . . . . 0.0 111.052 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.2 t -113.48 117.29 45.21 Favored Pre-proline 0 N--CA 1.44 -0.948 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.415 ' HB3' HG21 ' A' ' 30' ' ' ILE . 26.4 Cg_endo -67.33 -38.64 14.68 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 123.197 2.598 . . . . 0.0 114.241 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 56.67 -173.03 0.07 Allowed 'General case' 0 C--N 1.36 1.06 0 C-N-CA 124.863 1.265 . . . . 0.0 113.376 -172.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.3 p -66.1 -29.99 70.42 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 124.618 1.167 . . . . 0.0 110.721 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.3 m -61.07 -48.86 79.77 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.425 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.0 t -81.33 -38.26 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 118.901 0.773 . . . . 0.0 109.71 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.535 ' HA ' HG22 ' A' ' 45' ' ' VAL . 94.6 mm-40 -61.33 -38.86 88.43 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 97.7 m -68.12 -41.87 81.08 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 119.268 0.94 . . . . 0.0 109.901 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.3 mt -66.35 -43.78 91.2 Favored 'Isoleucine or valine' 0 C--N 1.356 0.888 0 C-N-CA 123.767 0.827 . . . . 0.0 109.734 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.535 HG22 ' HA ' ' A' ' 42' ' ' GLN 0.264 33.0 m -70.18 -32.49 51.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 CA-C-O 117.743 -1.122 . . . . 0.0 113.323 -179.026 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -62.53 -41.55 98.94 Favored 'General case' 0 C--N 1.362 1.111 0 CA-C-N 119.22 0.918 . . . . 0.0 111.616 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -70.48 -44.45 67.69 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 124.443 1.097 . . . . 0.0 109.192 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -66.13 -32.16 73.45 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.79 -39.42 90.95 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -64.3 -42.68 96.24 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 123.61 0.764 . . . . 0.0 109.531 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -70.24 -33.51 71.72 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.93 -31.12 67.24 Favored Glycine 0 C--N 1.355 1.588 0 C-N-CA 124.527 1.061 . . . . 0.0 110.857 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.0 m -78.94 -60.33 2.42 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.1 m . . . . . 0 C--N 1.358 0.975 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.754 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 . . . . . 0 CA--C 1.493 -1.221 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -57.77 -32.94 67.99 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.8 mt -64.19 -40.84 96.94 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 123.013 0.525 . . . . 0.0 111.789 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.75 -37.99 67.51 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 124.622 1.169 . . . . 0.0 109.915 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.526 ' HA ' HG22 ' A' ' 18' ' ' VAL . 97.5 mttt -61.33 -35.45 77.43 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 123.658 0.783 . . . . 0.0 111.691 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -65.47 -29.03 69.65 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.408 HD13 HD21 ' A' ' 34' ' ' LEU . 93.5 mt -74.81 -47.59 37.13 Favored 'Isoleucine or valine' 0 C--N 1.356 0.881 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.526 HG22 ' HA ' ' A' ' 15' ' ' LYS 0.282 31.9 m -67.42 -25.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.36 1.062 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -178.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -63.9 -32.99 74.71 Favored 'General case' 0 C--N 1.358 0.962 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.447 HD13 HH11 ' A' ' 33' ' ' ARG . 92.2 mt -68.91 -37.84 79.2 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 124.247 1.019 . . . . 0.0 108.478 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.413 ' CD1' ' HB2' ' A' ' 25' ' ' SER . 79.4 t80 -62.98 -42.05 99.73 Favored 'General case' 0 C--N 1.363 1.158 0 C-N-CA 124.238 1.015 . . . . 0.0 109.404 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -68.48 -37.62 80.29 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.207 1.003 . . . . 0.0 110.512 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.0 m -69.81 -29.86 67.25 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 123.655 0.782 . . . . 0.0 111.671 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.15 109.96 0.53 Allowed Glycine 0 CA--C 1.482 -2.025 0 N-CA-C 106.268 -2.733 . . . . 0.0 106.268 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.413 ' HB2' ' CD1' ' A' ' 21' ' ' TYR . 43.9 t -79.26 114.57 18.3 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.851 0.834 . . . . 0.0 108.877 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.6 m -104.27 115.58 30.64 Favored 'General case' 0 N--CA 1.431 -1.412 1 N-CA-C 97.568 -4.975 . . . . 0.0 97.568 176.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.0 mt -67.31 -35.89 80.36 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.43 -38.41 86.86 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.5 -41.82 54.36 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.1 mt -68.95 -38.99 79.27 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 CA-C-O 118.619 -0.705 . . . . 0.0 111.961 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.5 m -65.47 -38.17 89.01 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 118.621 0.646 . . . . 0.0 111.591 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.22 -37.19 74.97 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 118.106 0.412 . . . . 0.0 111.863 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.447 HH11 HD13 ' A' ' 20' ' ' LEU . 99.6 mtt180 -70.75 -46.4 63.03 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.507 HD13 ' HB3' ' A' ' 37' ' ' PRO . 95.9 mt -80.94 -41.77 22.39 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 75.6 -67.95 0.22 Allowed 'General case' 0 C--N 1.355 0.846 0 C-N-CA 127.63 2.372 . . . . 0.0 107.2 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.453 HG12 ' HG3' ' A' ' 38' ' ' ARG . 59.2 t -127.88 102.93 21.67 Favored Pre-proline 0 C--N 1.358 0.949 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 178.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.507 ' HB3' HD13 ' A' ' 34' ' ' LEU . 34.1 Cg_endo -66.11 -32.69 42.85 Favored 'Trans proline' 0 CA--C 1.499 -1.235 0 C-N-CA 123.986 3.124 . . . . 0.0 114.577 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.453 ' HG3' HG12 ' A' ' 36' ' ' VAL . 99.8 mtt180 65.04 174.39 0.21 Allowed 'General case' 0 C--N 1.355 0.836 0 C-N-CA 125.789 1.635 . . . . 0.0 112.969 -177.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.9 m -64.34 -35.31 80.47 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 124.484 1.114 . . . . 0.0 112.819 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.7 m -63.69 -48.53 76.78 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 77.0 t -71.65 -38.69 67.73 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 73.3 tp60 -60.26 -35.84 76.42 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 123.176 0.59 . . . . 0.0 112.431 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 99.2 m -67.44 -39.44 85.42 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.391 0.541 . . . . 0.0 110.282 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.504 HG22 HG11 ' A' ' 18' ' ' VAL . 96.4 mt -71.77 -36.64 59.49 Favored 'Isoleucine or valine' 0 C--N 1.359 1.015 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.39 -40.3 85.77 Favored 'Isoleucine or valine' 0 C--N 1.362 1.126 0 C-N-CA 125.26 1.424 . . . . 0.0 108.471 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 -63.72 -36.6 84.4 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 123.343 0.657 . . . . 0.0 112.104 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.89 -44.39 93.18 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -68.3 -36.04 78.75 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.88 -39.25 93.74 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 124.953 1.301 . . . . 0.0 109.619 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -63.45 -43.6 96.91 Favored 'General case' 0 C--N 1.357 0.927 0 C-N-CA 123.768 0.827 . . . . 0.0 110.275 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -81.62 -22.7 37.49 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.15 -11.57 85.42 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-O 118.783 -1.009 . . . . 0.0 112.426 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.0 m -72.25 -60.79 2.05 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 118.123 0.961 . . . . 0.0 108.851 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 80.6 m . . . . . 0 C--N 1.362 1.13 0 CA-C-N 119.093 0.86 . . . . 0.0 108.768 179.023 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 . . . . . 0 CA--C 1.496 -1.126 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.6 -35.08 79.34 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.739 1.216 . . . . 0.0 110.628 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.3 tp -65.83 -43.03 89.8 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.7 mtp85 -65.18 -38.6 91.01 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 122.845 0.458 . . . . 0.0 111.049 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.46 -41.8 96.31 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 92.4 mtm-85 -67.24 -29.35 68.96 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 123.962 0.905 . . . . 0.0 113.048 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.407 HD13 ' HG ' ' A' ' 34' ' ' LEU . 96.3 mt -70.05 -46.32 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 119.29 0.95 . . . . 0.0 109.0 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.7 t -68.48 -44.33 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 124.634 1.174 . . . . 0.0 111.344 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -68.79 -40.13 79.77 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 124.072 0.949 . . . . 0.0 112.555 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.5 mt -67.22 -33.27 75.0 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 118.836 -0.602 . . . . 0.0 110.817 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -62.49 -42.07 99.24 Favored 'General case' 0 C--N 1.362 1.12 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -66.32 -36.66 83.48 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 123.971 0.908 . . . . 0.0 109.978 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.8 m -70.72 -16.97 62.82 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 124.906 1.282 . . . . 0.0 112.978 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.53 1.16 3.52 Favored Glycine 0 C--N 1.36 1.901 0 N-CA-C 117.866 1.907 . . . . 0.0 117.866 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.6 m -77.18 154.77 32.8 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 119.972 1.886 . . . . 0.0 111.721 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.7 p -80.83 164.67 22.52 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 125.307 1.443 . . . . 0.0 112.623 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.45 HD23 HD12 ' A' ' 30' ' ' ILE . 86.2 mt -68.94 -22.45 64.13 Favored 'General case' 0 C--N 1.361 1.073 0 C-N-CA 124.07 0.948 . . . . 0.0 110.61 177.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.98 -35.66 92.28 Favored Glycine 0 C--N 1.359 1.861 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.11 -37.01 75.26 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 123.644 0.778 . . . . 0.0 110.184 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.45 HD12 HD23 ' A' ' 27' ' ' LEU . 96.3 mt -66.41 -43.15 91.3 Favored 'Isoleucine or valine' 0 C--N 1.365 1.244 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.2 m -63.09 -37.14 86.02 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.65 1.18 . . . . 0.0 110.498 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.68 -46.88 67.89 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -74.44 -49.28 23.04 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.407 ' HG ' HD13 ' A' ' 17' ' ' ILE . 90.4 mt -77.36 -33.72 55.27 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 115.721 1.748 . . . . 0.0 115.721 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 74.76 -68.3 0.22 Allowed 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 126.186 1.795 . . . . 0.0 111.527 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.6 t -122.48 94.7 47.53 Favored Pre-proline 0 C--N 1.36 1.061 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -70.77 -27.83 21.15 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 123.578 2.852 . . . . 0.0 113.328 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 60.31 -175.57 0.11 Allowed 'General case' 0 C--N 1.359 1.02 0 C-N-CA 124.846 1.258 . . . . 0.0 112.548 -170.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 92.8 p -67.98 -37.44 81.52 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 123.775 0.83 . . . . 0.0 112.821 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.7 m -63.86 -47.47 80.55 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -177.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.4 t -71.45 -37.92 66.42 Favored 'Isoleucine or valine' 0 C--N 1.359 0.981 0 CA-C-O 118.535 -0.745 . . . . 0.0 109.29 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -62.3 -37.77 86.81 Favored 'General case' 0 C--N 1.362 1.12 0 CA-C-N 118.573 0.624 . . . . 0.0 112.334 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 97.7 m -66.84 -41.39 87.48 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 123.346 0.658 . . . . 0.0 109.581 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.4 mt -66.4 -41.92 89.58 Favored 'Isoleucine or valine' 0 C--N 1.358 0.953 0 C-N-CA 123.495 0.718 . . . . 0.0 110.01 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.7 t -62.9 -40.13 87.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 C-N-CA 124.127 0.971 . . . . 0.0 110.744 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -65.53 -40.1 92.53 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.45 0.568 . . . . 0.0 112.245 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -68.29 -40.25 81.84 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 124.155 0.982 . . . . 0.0 109.783 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -66.62 -40.14 88.64 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.246 1.018 . . . . 0.0 110.317 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.0 -41.51 86.58 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -60.76 -28.74 68.94 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 125.941 1.696 . . . . 0.0 112.463 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -60.1 -27.94 67.43 Favored 'General case' 0 C--N 1.361 1.104 0 N-CA-C 112.71 0.634 . . . . 0.0 112.71 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.83 -28.87 71.43 Favored Glycine 0 C--N 1.359 1.854 0 CA-C-O 119.483 -0.62 . . . . 0.0 111.818 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.0 m -83.1 -58.36 2.89 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 81.6 m . . . . . 0 C--N 1.359 1.02 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -179.439 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.433 ' HG3' ' HE3' ' A' ' 15' ' ' LYS . 71.0 tp60 . . . . . 0 N--CA 1.439 -0.998 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -65.43 -40.09 92.89 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 119.278 0.945 . . . . 0.0 111.478 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.3 tp -66.79 -41.66 87.28 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -63.26 -41.89 99.09 Favored 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 123.596 0.758 . . . . 0.0 110.14 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.433 ' HE3' ' HG3' ' A' ' 11' ' ' GLN . 97.8 mttt -64.37 -42.86 95.97 Favored 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 123.963 0.905 . . . . 0.0 111.334 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -64.26 -41.89 96.72 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 123.557 0.743 . . . . 0.0 110.46 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.6 mt -68.72 -46.51 79.53 Favored 'Isoleucine or valine' 0 C--N 1.358 0.966 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.407 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.96 -39.97 87.48 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 C-N-CA 124.039 0.935 . . . . 0.0 112.039 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -62.82 -43.4 98.9 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 118.297 0.498 . . . . 0.0 110.692 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.9 mt -70.63 -37.79 73.83 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 123.068 0.547 . . . . 0.0 111.77 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 26' ' ' SER . 74.2 t80 -60.92 -44.92 96.51 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 126.724 2.01 . . . . 0.0 109.687 -178.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -74.77 -40.31 61.26 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.9 p -80.88 -43.51 19.79 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.27 -115.31 1.38 Allowed Glycine 0 CA--C 1.487 -1.691 0 CA-C-O 121.158 0.31 . . . . 0.0 112.835 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.0 t -66.66 122.27 17.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-O 122.203 1.001 . . . . 0.0 110.691 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 21' ' ' TYR . 70.1 m -93.65 -54.99 3.42 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 113.126 -1.852 . . . . 0.0 111.298 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.0 mt -87.96 -29.07 21.06 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.81 -36.45 91.17 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-O 119.656 -0.524 . . . . 0.0 112.525 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.81 -40.85 79.34 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 117.06 0.43 . . . . 0.0 111.0 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -71.02 -45.39 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 118.955 -0.545 . . . . 0.0 109.778 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.7 m -62.7 -38.32 89.95 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 124.143 0.977 . . . . 0.0 113.149 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -72.7 -48.4 39.21 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -83.69 -55.81 4.07 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.98 -33.43 24.6 Favored 'General case' 0 CA--C 1.494 -1.208 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 78.82 -66.08 0.2 Allowed 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 128.011 2.524 . . . . 0.0 108.653 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.6 t -115.75 118.97 38.25 Favored Pre-proline 0 C--N 1.357 0.911 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -66.76 -38.44 17.84 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 123.849 3.033 . . . . 0.0 114.967 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 55.82 -171.98 0.07 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 125.501 1.521 . . . . 0.0 113.532 -172.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 89.0 p -63.79 -32.32 73.78 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 124.897 1.279 . . . . 0.0 111.872 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.6 m -59.81 -47.09 87.1 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 124.325 1.05 . . . . 0.0 112.757 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 77.0 t -82.46 -38.02 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-O 118.873 -0.584 . . . . 0.0 110.459 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.478 ' HA ' HG22 ' A' ' 45' ' ' VAL . 94.5 mm-40 -60.62 -38.98 86.54 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -178.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 98.6 m -65.76 -42.93 90.27 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-N 118.803 0.729 . . . . 0.0 109.939 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.1 mt -67.11 -45.93 85.55 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 123.985 0.914 . . . . 0.0 110.176 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.478 HG22 ' HA ' ' A' ' 42' ' ' GLN 0.266 33.9 m -69.18 -33.52 58.7 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.388 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.123 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -64.58 -36.71 85.1 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 119.179 0.9 . . . . 0.0 113.158 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -71.47 -44.98 63.77 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -66.74 -30.56 70.82 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -65.85 -37.27 85.73 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.611 1.565 . . . . 0.0 108.762 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -65.75 -41.55 91.98 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -70.25 -32.49 70.36 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 122.755 0.422 . . . . 0.0 111.4 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.86 -34.05 59.49 Favored Glycine 0 C--N 1.356 1.668 0 C-N-CA 123.878 0.752 . . . . 0.0 111.424 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.7 m -74.94 -61.05 2.02 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 79.1 m . . . . . 0 C--N 1.362 1.12 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.298 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 . . . . . 0 N--CA 1.431 -1.378 0 CA-C-O 118.383 -0.818 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -60.15 -39.99 88.29 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 123.866 0.867 . . . . 0.0 112.932 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.15 -39.79 82.53 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -65.3 -39.61 92.72 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 123.397 0.679 . . . . 0.0 109.659 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.07 -40.09 95.51 Favored 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 124.684 1.193 . . . . 0.0 109.043 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.66 -39.03 93.31 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.949 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.36 -45.42 85.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.2 t -63.74 -46.23 95.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 C-N-CA 124.792 1.237 . . . . 0.0 111.318 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -65.25 -42.07 93.65 Favored 'General case' 0 CA--C 1.488 -1.422 0 C-N-CA 123.853 0.861 . . . . 0.0 111.546 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.9 mt -66.24 -38.7 88.51 Favored 'General case' 0 CA--C 1.496 -1.104 0 O-C-N 123.514 0.509 . . . . 0.0 110.521 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.481 ' HE2' ' HD2' ' A' ' 49' ' ' LYS . 90.8 t80 -60.84 -45.33 94.92 Favored 'General case' 0 C--N 1.361 1.087 0 CA-C-O 118.965 -0.54 . . . . 0.0 110.678 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.04 -38.25 82.29 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.874 1.27 . . . . 0.0 111.587 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.4 m -69.79 -28.68 65.94 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 124.161 0.985 . . . . 0.0 112.538 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.54 78.22 0.44 Allowed Glycine 0 CA--C 1.482 -2.002 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.6 p -96.01 -20.32 18.79 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.462 -0.869 . . . . 0.0 110.576 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.8 t 57.96 -119.23 1.12 Allowed 'General case' 0 C--N 1.368 1.376 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.3 mt -123.12 -31.89 3.54 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 119.187 0.903 . . . . 0.0 109.785 177.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.52 -40.19 94.19 Favored Glycine 0 C--N 1.358 1.767 0 N-CA-C 117.925 1.93 . . . . 0.0 117.925 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.88 -41.59 82.54 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 118.424 1.112 . . . . 0.0 110.96 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.0 mt -67.28 -40.46 84.95 Favored 'Isoleucine or valine' 0 C--N 1.362 1.109 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.2 m -61.59 -37.01 82.32 Favored 'General case' 0 C--N 1.359 1.009 0 CA-C-N 118.612 0.642 . . . . 0.0 112.563 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.62 -40.14 88.63 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 119.217 -0.421 . . . . 0.0 110.984 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 62.7 ttm-85 -72.16 -52.63 15.74 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-O 119.157 -0.449 . . . . 0.0 111.534 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.8 mt -142.0 110.17 5.94 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.34 -49.84 4.78 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.1 t -73.45 -52.72 4.94 Favored Pre-proline 0 C--N 1.356 0.888 0 CA-C-O 115.457 -2.211 . . . . 0.0 112.818 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.56 75.83 4.69 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 CA-C-N 124.321 2.579 . . . . 0.0 112.09 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 55.6 mmm-85 -93.53 -10.99 32.98 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.3 m -61.27 -43.42 98.9 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.8 p -72.13 -39.36 68.88 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 123.705 0.802 . . . . 0.0 110.976 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 78.3 t -62.3 -40.25 87.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.834 0 C-N-CA 125.39 1.476 . . . . 0.0 110.353 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.36 -38.34 89.17 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.652 0.781 . . . . 0.0 111.867 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 94.9 m -71.28 -45.57 62.83 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 123.858 0.863 . . . . 0.0 110.571 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.41 -43.66 97.03 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 C-N-CA 124.869 1.268 . . . . 0.0 111.618 -177.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.5 m -65.48 -36.83 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.128 0 CA-C-O 118.284 -0.865 . . . . 0.0 113.188 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -68.52 -44.51 74.46 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.14 -45.53 76.84 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 123.113 0.565 . . . . 0.0 111.417 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -69.97 -30.65 68.05 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.481 ' HD2' ' HE2' ' A' ' 21' ' ' TYR . 86.8 tttt -65.39 -39.81 92.7 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -63.27 -40.11 96.48 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.746 0.818 . . . . 0.0 109.82 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -69.69 -38.53 77.01 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 118.955 -0.545 . . . . 0.0 111.905 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.5 -32.89 61.57 Favored Glycine 0 C--N 1.358 1.754 0 CA-C-O 119.825 -0.431 . . . . 0.0 113.868 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.3 m -82.19 -48.06 11.75 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 117.208 0.504 . . . . 0.0 111.719 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.9 m . . . . . 0 N--CA 1.436 -1.161 0 N-CA-C 119.518 3.155 . . . . 0.0 119.518 -175.484 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 . . . . . 0 N--CA 1.437 -1.096 0 CA-C-O 119.313 -0.375 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -66.27 -38.96 89.05 Favored 'General case' 0 C--N 1.361 1.083 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.9 mt -66.91 -38.94 87.18 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.422 ' O ' HG23 ' A' ' 18' ' ' VAL . 78.1 mtt85 -61.98 -37.24 84.07 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 123.223 0.609 . . . . 0.0 111.176 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -60.52 -42.23 96.02 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 124.405 1.082 . . . . 0.0 109.391 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -69.71 -41.87 74.79 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.907 1.283 . . . . 0.0 110.387 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.536 HD13 HD11 ' A' ' 34' ' ' LEU . 88.9 mt -64.13 -38.1 81.6 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 125.9 1.68 . . . . 0.0 111.812 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 14' ' ' ARG . 60.9 t -62.4 -40.53 88.36 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -69.53 -40.25 77.0 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 123.528 0.517 . . . . 0.0 109.848 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.6 mt -60.7 -30.35 69.89 Favored 'General case' 0 CA--C 1.496 -1.126 0 C-N-CA 125.229 1.412 . . . . 0.0 112.774 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -56.16 -44.04 78.94 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 124.351 1.06 . . . . 0.0 110.16 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -84.75 -36.85 21.49 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 117.903 0.32 . . . . 0.0 111.156 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.8 m -60.54 -36.62 78.89 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 176.89 -176.05 47.87 Favored Glycine 0 CA--C 1.49 -1.517 0 C-N-CA 119.469 -1.348 . . . . 0.0 113.217 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.6 t 56.93 -149.67 0.46 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 128.242 2.617 . . . . 0.0 111.37 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.8 m -132.99 155.4 49.23 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.637 0.732 . . . . 0.0 109.14 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.7 tp -65.02 -32.07 73.61 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.473 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.15 -35.69 92.02 Favored Glycine 0 C--N 1.358 1.751 0 CA-C-O 119.275 -0.736 . . . . 0.0 111.51 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.9 -40.92 62.83 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-N 118.077 0.938 . . . . 0.0 111.303 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.59 -41.96 86.22 Favored 'Isoleucine or valine' 0 C--N 1.358 0.951 0 C-N-CA 123.776 0.83 . . . . 0.0 109.515 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.3 m -65.04 -38.85 92.2 Favored 'General case' 0 CA--C 1.496 -1.126 0 C-N-CA 124.397 1.079 . . . . 0.0 111.083 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.36 -39.07 85.69 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 92.0 mtm-85 -66.8 -42.41 85.98 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 122.599 0.36 . . . . 0.0 111.305 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.536 HD11 HD13 ' A' ' 17' ' ' ILE . 91.2 mt -73.09 -26.41 61.24 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 124.793 1.237 . . . . 0.0 111.993 178.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 79.49 -63.34 0.26 Allowed 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 128.212 2.605 . . . . 0.0 108.197 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.0 t -115.97 105.45 51.19 Favored Pre-proline 0 C--N 1.36 1.024 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -71.85 -27.02 18.31 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 123.762 2.975 . . . . 0.0 113.639 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 64.89 167.34 0.17 Allowed 'General case' 0 C--N 1.359 1.006 0 C-N-CA 125.949 1.699 . . . . 0.0 112.505 -166.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 88.8 p -77.2 -26.77 53.15 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 124.997 1.319 . . . . 0.0 110.338 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.2 m -61.56 -44.72 96.51 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.827 1.251 . . . . 0.0 113.421 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.0 t -67.16 -36.91 78.12 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.411 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 99.3 mm-40 -64.59 -40.36 95.38 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 123.549 0.74 . . . . 0.0 110.947 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 95.8 m -68.44 -41.84 79.73 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 123.548 0.739 . . . . 0.0 110.062 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.8 mt -67.52 -42.36 86.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.968 0 C-N-CA 122.927 0.491 . . . . 0.0 109.993 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.8 m -66.36 -33.31 62.67 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 CA-C-N 118.468 0.576 . . . . 0.0 111.753 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 95.7 mtt-85 -64.04 -39.2 93.57 Favored 'General case' 0 C--N 1.359 0.988 0 CA-C-N 118.321 0.509 . . . . 0.0 110.932 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -67.68 -39.6 84.44 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 124.201 1.0 . . . . 0.0 109.613 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -66.49 -37.22 84.61 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 124.249 1.019 . . . . 0.0 109.823 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -67.99 -41.2 82.67 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 124.907 1.283 . . . . 0.0 109.097 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -63.98 -35.03 79.36 Favored 'General case' 0 C--N 1.36 1.025 0 C-N-CA 124.617 1.167 . . . . 0.0 109.401 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -66.16 -25.46 66.97 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 123.812 0.845 . . . . 0.0 111.606 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.99 -35.02 77.85 Favored Glycine 0 C--N 1.36 1.88 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 84.8 m -79.28 -52.6 7.91 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.8 m . . . . . 0 C--N 1.359 1.004 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -179.713 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 . . . . . 0 N--CA 1.441 -0.91 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -65.77 -43.38 89.03 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 118.757 0.708 . . . . 0.0 110.213 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.3 tp -64.3 -45.59 87.29 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.706 1.202 . . . . 0.0 109.169 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.88 -38.14 87.99 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.951 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -65.25 -37.06 86.06 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-N 118.513 0.597 . . . . 0.0 112.28 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -66.25 -37.19 84.9 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 122.912 0.485 . . . . 0.0 109.754 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.7 mt -69.13 -40.19 80.31 Favored 'Isoleucine or valine' 0 C--N 1.356 0.859 0 C-N-CA 123.722 0.809 . . . . 0.0 109.734 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.5 t -66.08 -34.45 70.28 Favored 'Isoleucine or valine' 0 C--N 1.356 0.863 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -64.13 -39.13 93.36 Favored 'General case' 0 C--N 1.358 0.95 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.0 mt -66.4 -38.43 87.47 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 123.934 0.894 . . . . 0.0 109.825 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -60.2 -46.15 90.72 Favored 'General case' 0 C--N 1.364 1.204 0 C-N-CA 125.114 1.366 . . . . 0.0 108.097 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.91 -33.83 76.46 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 123.527 0.731 . . . . 0.0 111.271 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.4 m -74.95 -12.69 60.4 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 124.217 1.007 . . . . 0.0 112.972 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.61 -15.42 12.79 Favored Glycine 0 C--N 1.358 1.783 0 N-CA-C 116.76 1.464 . . . . 0.0 116.76 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.8 t -91.84 87.17 6.15 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 100.924 -3.732 . . . . 0.0 100.924 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.4 m -95.66 -73.43 0.59 Allowed 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 115.138 1.532 . . . . 0.0 115.138 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.2 mt -81.22 -24.03 37.69 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-O 119.555 -0.259 . . . . 0.0 111.572 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.78 -20.94 78.98 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.6 -49.45 4.01 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 117.901 0.851 . . . . 0.0 112.456 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.96 -48.81 84.46 Favored 'Isoleucine or valine' 0 C--N 1.358 0.974 0 CA-C-N 118.44 0.564 . . . . 0.0 111.865 -176.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.2 m -70.2 -35.1 73.69 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.87 -50.23 9.44 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -73.16 -51.09 19.17 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.447 HD13 HG21 ' A' ' 41' ' ' VAL . 94.8 mt -87.83 -55.99 3.53 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.978 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 66.65 -67.02 0.17 Allowed 'General case' 0 C--N 1.356 0.862 0 C-N-CA 125.853 1.661 . . . . 0.0 114.909 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.6 t -69.48 -53.79 12.19 Favored Pre-proline 0 C--N 1.358 0.967 0 CA-C-O 114.549 -2.643 . . . . 0.0 114.713 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -81.8 46.08 2.13 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 CA-C-N 126.132 3.226 . . . . 0.0 114.441 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -70.68 -35.08 72.64 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 118.962 -0.542 . . . . 0.0 110.892 -174.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.5 m -65.0 -43.31 92.98 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 93.0 p -67.47 -39.34 85.27 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.447 HG21 HD13 ' A' ' 34' ' ' LEU . 78.3 t -67.69 -36.33 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 117.862 -1.066 . . . . 0.0 109.31 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.62 -36.75 84.84 Favored 'General case' 0 C--N 1.361 1.082 0 CA-C-N 119.656 1.116 . . . . 0.0 110.923 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 95.3 m -65.4 -40.95 94.05 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 123.351 0.66 . . . . 0.0 109.23 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.87 -40.78 81.63 Favored 'Isoleucine or valine' 0 C--N 1.356 0.889 0 C-N-CA 124.687 1.195 . . . . 0.0 110.08 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.1 t -61.6 -39.56 83.54 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 C-N-CA 125.773 1.629 . . . . 0.0 110.149 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -62.23 -38.85 90.78 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 118.424 0.556 . . . . 0.0 111.127 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -68.8 -42.45 77.29 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 123.921 0.888 . . . . 0.0 108.922 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . 0.259 28.8 m-85 -70.42 -23.2 62.7 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -66.3 -38.88 88.75 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -65.34 -42.69 92.63 Favored 'General case' 0 C--N 1.363 1.153 0 C-N-CA 124.404 1.082 . . . . 0.0 108.414 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -70.63 -25.04 62.85 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.31 -32.34 68.55 Favored Glycine 0 C--N 1.356 1.657 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.9 m -78.46 -50.01 12.41 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 83.3 m . . . . . 0 C--N 1.359 1.003 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 -179.148 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 . . . . . 0 CA--C 1.496 -1.113 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -67.41 -41.36 85.03 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 118.797 0.726 . . . . 0.0 111.629 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.05 -42.4 76.33 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 123.922 0.889 . . . . 0.0 110.345 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -66.7 -37.74 85.33 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-O 118.675 -0.678 . . . . 0.0 111.091 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -65.47 -34.7 78.89 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 119.018 -0.515 . . . . 0.0 111.476 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -66.51 -38.72 87.83 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.3 mt -67.65 -40.05 83.33 Favored 'Isoleucine or valine' 0 C--N 1.359 1.003 0 C-N-CA 123.851 0.86 . . . . 0.0 109.505 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.5 -36.48 77.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.826 0 C-N-CA 124.197 0.999 . . . . 0.0 108.985 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.06 -37.29 87.07 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.17 -36.37 79.53 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 123.66 0.784 . . . . 0.0 110.15 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -61.09 -45.38 94.97 Favored 'General case' 0 C--N 1.367 1.341 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.64 -36.44 84.28 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 125.262 1.425 . . . . 0.0 110.546 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.2 m -74.12 -18.26 60.82 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.226 1.011 . . . . 0.0 113.326 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.28 -14.34 8.85 Favored Glycine 0 C--N 1.357 1.704 0 CA-C-O 118.255 -1.303 . . . . 0.0 116.057 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.9 m -91.74 82.74 5.23 Favored 'General case' 0 C--N 1.356 0.853 1 N-CA-C 100.194 -4.002 . . . . 0.0 100.194 177.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.4 m -94.72 -81.01 0.4 Allowed 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 -175.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.3 mt -79.46 -23.66 42.94 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 118.371 0.532 . . . . 0.0 111.867 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.18 -25.48 75.41 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.74 -46.84 6.43 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 117.668 0.734 . . . . 0.0 112.707 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -66.62 -46.69 85.42 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 CA-C-N 118.124 0.42 . . . . 0.0 111.614 -177.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.8 m -69.25 -34.57 74.99 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -82.62 -47.25 12.29 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -74.69 -52.52 11.39 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.487 HD13 HG21 ' A' ' 41' ' ' VAL . 93.3 mt -84.33 -54.06 5.04 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 119.46 -0.305 . . . . 0.0 111.797 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 67.08 -66.92 0.18 Allowed 'General case' 0 C--N 1.358 0.969 0 C-N-CA 126.238 1.815 . . . . 0.0 115.328 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.8 t -72.91 -52.77 5.59 Favored Pre-proline 0 N--CA 1.442 -0.86 0 CA-C-O 114.963 -2.446 . . . . 0.0 114.764 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -81.51 43.92 1.63 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 125.789 3.103 . . . . 0.0 115.101 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -67.95 -33.38 74.55 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-O 118.55 -0.738 . . . . 0.0 112.803 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.3 m -65.72 -43.43 89.08 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 123.291 0.637 . . . . 0.0 111.683 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.8 m -66.42 -41.95 88.49 Favored 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 123.646 0.778 . . . . 0.0 109.657 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.487 HG21 HD13 ' A' ' 34' ' ' LEU . 78.9 t -67.34 -40.48 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-O 117.82 -1.086 . . . . 0.0 109.927 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -64.22 -30.81 71.85 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 119.652 1.115 . . . . 0.0 112.955 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 97.5 m -66.34 -40.51 89.89 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.3 mt -71.58 -40.68 71.56 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 C-N-CA 125.145 1.378 . . . . 0.0 109.511 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.73 -37.22 77.53 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 C-N-CA 125.754 1.621 . . . . 0.0 111.057 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 95.5 mtm-85 -63.33 -39.59 94.95 Favored 'General case' 0 C--N 1.357 0.926 0 CA-C-N 119.605 1.093 . . . . 0.0 110.91 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -68.6 -41.04 80.13 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 123.501 0.72 . . . . 0.0 109.071 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -69.98 -25.09 63.45 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -66.85 -38.13 85.78 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -65.41 -41.17 93.91 Favored 'General case' 0 C--N 1.362 1.122 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -69.55 -26.38 64.46 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.07 -31.03 71.93 Favored Glycine 0 C--N 1.357 1.704 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.2 m -75.34 -52.99 9.5 Favored 'General case' 0 C--N 1.359 1.008 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 76.8 m . . . . . 0 C--N 1.36 1.063 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -179.958 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 123.297 1.522 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.3 p -110.59 -22.8 11.45 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.375 -1.739 . . . . 0.0 114.801 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 78.2 mtm -72.41 -24.97 61.31 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.578 ' HA2' ' HE3' ' A' ' 7' ' ' LYS . . . -106.24 -125.0 5.4 Favored Glycine 0 C--N 1.355 1.637 0 N-CA-C 108.29 -1.924 . . . . 0.0 108.29 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . 0.271 99.1 mttt 58.31 106.35 0.02 OUTLIER 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 57.6 m 53.34 52.1 14.16 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.578 ' HE3' ' HA2' ' A' ' 4' ' ' GLY . 98.6 mttt -71.99 124.54 25.14 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 81.07 130.56 0.05 Allowed 'General case' 0 C--N 1.358 0.968 0 C-N-CA 127.149 2.18 . . . . 0.0 106.067 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.71 -41.78 93.63 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 124.702 1.201 . . . . 0.0 110.729 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.6 p -76.98 -9.49 58.73 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 73.3 tp60 -60.73 -39.98 90.67 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -65.82 -38.46 88.97 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 122.726 0.411 . . . . 0.0 110.824 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.3 tp -67.1 -41.09 86.84 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 123.639 0.776 . . . . 0.0 109.037 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -62.38 -42.61 99.55 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 124.631 1.172 . . . . 0.0 109.595 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -65.18 -41.79 94.28 Favored 'General case' 0 CA--C 1.496 -1.119 0 C-N-CA 123.256 0.622 . . . . 0.0 111.122 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -64.44 -41.11 96.75 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 123.078 0.551 . . . . 0.0 111.57 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.9 mm -67.35 -45.83 85.04 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 CA-C-O 118.602 -0.714 . . . . 0.0 110.24 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.8 t -65.72 -37.12 79.2 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 C-N-CA 123.54 0.736 . . . . 0.0 111.166 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -64.38 -43.75 93.51 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 118.584 0.629 . . . . 0.0 110.514 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.0 mt -67.57 -38.7 84.47 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 123.63 0.772 . . . . 0.0 110.886 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 26' ' ' SER . 74.6 t80 -61.68 -46.65 88.8 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.806 2.042 . . . . 0.0 110.035 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -74.21 -37.36 63.89 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.2 p -80.93 -42.18 21.75 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 117.575 2.435 . . . . 0.0 117.575 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.14 -113.14 1.09 Allowed Glycine 0 CA--C 1.485 -1.84 0 C-N-CA 121.488 -0.386 . . . . 0.0 112.652 -177.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.9 t -66.4 122.9 18.56 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 121.9 0.857 . . . . 0.0 110.747 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 21' ' ' TYR . 73.4 m -91.72 -57.55 2.71 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 113.801 -1.545 . . . . 0.0 113.135 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.7 mt -98.92 -16.91 18.61 Favored 'General case' 0 CA--C 1.487 -1.455 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.721 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.21 -38.56 72.12 Favored Glycine 0 C--N 1.354 1.557 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.62 -38.84 84.5 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 123.486 0.715 . . . . 0.0 111.001 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.415 HG21 ' HB3' ' A' ' 37' ' ' PRO . 96.8 mt -72.37 -47.09 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.967 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 75.7 m -63.23 -37.96 89.28 Favored 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 124.035 0.934 . . . . 0.0 112.988 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -75.79 -46.01 33.04 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -86.74 -54.99 4.06 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.9 mt -81.42 -31.44 33.17 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 123.772 0.829 . . . . 0.0 112.949 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 31' ' ' SER . . . 77.44 -67.35 0.2 Allowed 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 128.26 2.624 . . . . 0.0 111.052 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.2 t -113.48 117.29 45.21 Favored Pre-proline 0 N--CA 1.44 -0.948 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.415 ' HB3' HG21 ' A' ' 30' ' ' ILE . 26.4 Cg_endo -67.33 -38.64 14.68 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 123.197 2.598 . . . . 0.0 114.241 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 56.67 -173.03 0.07 Allowed 'General case' 0 C--N 1.36 1.06 0 C-N-CA 124.863 1.265 . . . . 0.0 113.376 -172.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.3 p -66.1 -29.99 70.42 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 124.618 1.167 . . . . 0.0 110.721 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.3 m -61.07 -48.86 79.77 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.425 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.0 t -81.33 -38.26 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 118.901 0.773 . . . . 0.0 109.71 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.535 ' HA ' HG22 ' A' ' 45' ' ' VAL . 94.6 mm-40 -61.33 -38.86 88.43 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 97.7 m -68.12 -41.87 81.08 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 119.268 0.94 . . . . 0.0 109.901 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.3 mt -66.35 -43.78 91.2 Favored 'Isoleucine or valine' 0 C--N 1.356 0.888 0 C-N-CA 123.767 0.827 . . . . 0.0 109.734 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.535 HG22 ' HA ' ' A' ' 42' ' ' GLN 0.264 33.0 m -70.18 -32.49 51.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 CA-C-O 117.743 -1.122 . . . . 0.0 113.323 -179.026 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -62.53 -41.55 98.94 Favored 'General case' 0 C--N 1.362 1.111 0 CA-C-N 119.22 0.918 . . . . 0.0 111.616 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -70.48 -44.45 67.69 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 124.443 1.097 . . . . 0.0 109.192 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -66.13 -32.16 73.45 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.79 -39.42 90.95 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -64.3 -42.68 96.24 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 123.61 0.764 . . . . 0.0 109.531 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -70.24 -33.51 71.72 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.93 -31.12 67.24 Favored Glycine 0 C--N 1.355 1.588 0 C-N-CA 124.527 1.061 . . . . 0.0 110.857 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.0 m -78.94 -60.33 2.42 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.1 m -153.27 108.1 3.17 Favored 'General case' 0 C--N 1.358 0.975 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -89.4 126.0 35.38 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -98.9 139.9 33.87 Favored 'General case' 0 CA--C 1.498 -1.03 0 C-N-CA 124.453 1.101 . . . . 0.0 110.593 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 56.9 m80 . . . . . 0 C--O 1.259 1.554 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 179.899 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.278 0 CA-C-O 121.65 0.738 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.9 t -80.94 137.96 36.11 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.205 -1.361 . . . . 0.0 109.409 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 99.1 mmm -104.76 -28.03 11.43 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.11 -141.6 9.79 Favored Glycine 0 CA--C 1.488 -1.632 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt 72.93 -52.83 0.71 Allowed 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 127.394 2.278 . . . . 0.0 112.013 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.1 t -70.83 125.1 25.9 Favored 'General case' 0 C--N 1.36 1.03 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -122.48 161.07 24.26 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.05 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.4 mp0 54.76 40.62 32.03 Favored 'General case' 0 C--N 1.36 1.025 0 C-N-CA 127.275 2.23 . . . . 0.0 113.245 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.35 -47.21 90.57 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.0 p -80.07 -39.19 30.24 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 123.902 0.881 . . . . 0.0 113.092 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -61.61 -27.9 68.98 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 117.864 2.542 . . . . 0.0 117.864 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -57.77 -32.94 67.99 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.8 mt -64.19 -40.84 96.94 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 123.013 0.525 . . . . 0.0 111.789 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.75 -37.99 67.51 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 124.622 1.169 . . . . 0.0 109.915 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.526 ' HA ' HG22 ' A' ' 18' ' ' VAL . 97.5 mttt -61.33 -35.45 77.43 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 123.658 0.783 . . . . 0.0 111.691 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -65.47 -29.03 69.65 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.408 HD13 HD21 ' A' ' 34' ' ' LEU . 93.5 mt -74.81 -47.59 37.13 Favored 'Isoleucine or valine' 0 C--N 1.356 0.881 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.526 HG22 ' HA ' ' A' ' 15' ' ' LYS 0.282 31.9 m -67.42 -25.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.36 1.062 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -178.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -63.9 -32.99 74.71 Favored 'General case' 0 C--N 1.358 0.962 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.447 HD13 HH11 ' A' ' 33' ' ' ARG . 92.2 mt -68.91 -37.84 79.2 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 124.247 1.019 . . . . 0.0 108.478 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.413 ' CD1' ' HB2' ' A' ' 25' ' ' SER . 79.4 t80 -62.98 -42.05 99.73 Favored 'General case' 0 C--N 1.363 1.158 0 C-N-CA 124.238 1.015 . . . . 0.0 109.404 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -68.48 -37.62 80.29 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.207 1.003 . . . . 0.0 110.512 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.0 m -69.81 -29.86 67.25 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 123.655 0.782 . . . . 0.0 111.671 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.15 109.96 0.53 Allowed Glycine 0 CA--C 1.482 -2.025 0 N-CA-C 106.268 -2.733 . . . . 0.0 106.268 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.413 ' HB2' ' CD1' ' A' ' 21' ' ' TYR . 43.9 t -79.26 114.57 18.3 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.851 0.834 . . . . 0.0 108.877 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.6 m -104.27 115.58 30.64 Favored 'General case' 0 N--CA 1.431 -1.412 1 N-CA-C 97.568 -4.975 . . . . 0.0 97.568 176.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.0 mt -67.31 -35.89 80.36 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.43 -38.41 86.86 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.5 -41.82 54.36 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.1 mt -68.95 -38.99 79.27 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 CA-C-O 118.619 -0.705 . . . . 0.0 111.961 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.5 m -65.47 -38.17 89.01 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 118.621 0.646 . . . . 0.0 111.591 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.22 -37.19 74.97 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 118.106 0.412 . . . . 0.0 111.863 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.447 HH11 HD13 ' A' ' 20' ' ' LEU . 99.6 mtt180 -70.75 -46.4 63.03 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.507 HD13 ' HB3' ' A' ' 37' ' ' PRO . 95.9 mt -80.94 -41.77 22.39 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 75.6 -67.95 0.22 Allowed 'General case' 0 C--N 1.355 0.846 0 C-N-CA 127.63 2.372 . . . . 0.0 107.2 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.453 HG12 ' HG3' ' A' ' 38' ' ' ARG . 59.2 t -127.88 102.93 21.67 Favored Pre-proline 0 C--N 1.358 0.949 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 178.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.507 ' HB3' HD13 ' A' ' 34' ' ' LEU . 34.1 Cg_endo -66.11 -32.69 42.85 Favored 'Trans proline' 0 CA--C 1.499 -1.235 0 C-N-CA 123.986 3.124 . . . . 0.0 114.577 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.453 ' HG3' HG12 ' A' ' 36' ' ' VAL . 99.8 mtt180 65.04 174.39 0.21 Allowed 'General case' 0 C--N 1.355 0.836 0 C-N-CA 125.789 1.635 . . . . 0.0 112.969 -177.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.9 m -64.34 -35.31 80.47 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 124.484 1.114 . . . . 0.0 112.819 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.7 m -63.69 -48.53 76.78 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 77.0 t -71.65 -38.69 67.73 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 73.3 tp60 -60.26 -35.84 76.42 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 123.176 0.59 . . . . 0.0 112.431 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 99.2 m -67.44 -39.44 85.42 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.391 0.541 . . . . 0.0 110.282 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.504 HG22 HG11 ' A' ' 18' ' ' VAL . 96.4 mt -71.77 -36.64 59.49 Favored 'Isoleucine or valine' 0 C--N 1.359 1.015 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.39 -40.3 85.77 Favored 'Isoleucine or valine' 0 C--N 1.362 1.126 0 C-N-CA 125.26 1.424 . . . . 0.0 108.471 178.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 -63.72 -36.6 84.4 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 123.343 0.657 . . . . 0.0 112.104 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.89 -44.39 93.18 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -68.3 -36.04 78.75 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.88 -39.25 93.74 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 124.953 1.301 . . . . 0.0 109.619 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -63.45 -43.6 96.91 Favored 'General case' 0 C--N 1.357 0.927 0 C-N-CA 123.768 0.827 . . . . 0.0 110.275 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -81.62 -22.7 37.49 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.15 -11.57 85.42 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-O 118.783 -1.009 . . . . 0.0 112.426 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.0 m -72.25 -60.79 2.05 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 118.123 0.961 . . . . 0.0 108.851 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 80.6 m -133.94 -69.05 0.54 Allowed 'General case' 0 C--N 1.362 1.13 0 CA-C-N 119.093 0.86 . . . . 0.0 108.768 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 67.34 -72.77 0.09 Allowed 'General case' 0 C--N 1.364 1.223 0 C-N-CA 128.079 2.552 . . . . 0.0 111.59 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -77.03 135.88 38.67 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 123.645 0.778 . . . . 0.0 112.786 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 . . . . . 0 C--O 1.26 1.645 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 179.872 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.1 m -85.62 -44.47 12.58 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.844 -1.071 . . . . 0.0 112.695 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.6 ttm -62.06 124.37 20.63 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 123.766 0.826 . . . . 0.0 111.776 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.04 -12.97 62.54 Favored Glycine 0 C--N 1.352 1.43 0 CA-C-N 114.482 -1.236 . . . . 0.0 112.552 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -114.72 2.61 14.5 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.12 0.968 . . . . 0.0 109.411 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.5 m -66.66 -25.82 66.75 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 126.945 2.098 . . . . 0.0 111.535 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.31 166.99 22.13 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 127.36 2.264 . . . . 0.0 112.778 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -67.5 169.03 9.82 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.876 1.67 . . . . 0.0 112.13 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.495 ' HA ' ' HB2' ' A' ' 12' ' ' ASP . 96.5 mt 81.96 -19.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.089 0 C-N-CA 128.89 2.876 . . . . 0.0 111.143 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 75.5 m -67.55 -48.99 65.35 Favored 'General case' 0 C--N 1.357 0.929 0 CA-C-N 119.25 0.932 . . . . 0.0 110.674 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -75.11 -36.24 61.67 Favored 'General case' 0 CA--C 1.496 -1.126 0 C-N-CA 124.466 1.106 . . . . 0.0 110.007 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.495 ' HB2' ' HA ' ' A' ' 9' ' ' ILE . 99.4 m-20 -63.6 -35.08 79.34 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.739 1.216 . . . . 0.0 110.628 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.3 tp -65.83 -43.03 89.8 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.7 mtp85 -65.18 -38.6 91.01 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 122.845 0.458 . . . . 0.0 111.049 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.46 -41.8 96.31 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 92.4 mtm-85 -67.24 -29.35 68.96 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 123.962 0.905 . . . . 0.0 113.048 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.407 HD13 ' HG ' ' A' ' 34' ' ' LEU . 96.3 mt -70.05 -46.32 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 119.29 0.95 . . . . 0.0 109.0 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.7 t -68.48 -44.33 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 124.634 1.174 . . . . 0.0 111.344 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -68.79 -40.13 79.77 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 124.072 0.949 . . . . 0.0 112.555 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.5 mt -67.22 -33.27 75.0 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 118.836 -0.602 . . . . 0.0 110.817 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -62.49 -42.07 99.24 Favored 'General case' 0 C--N 1.362 1.12 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -66.32 -36.66 83.48 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 123.971 0.908 . . . . 0.0 109.978 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.8 m -70.72 -16.97 62.82 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 124.906 1.282 . . . . 0.0 112.978 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.53 1.16 3.52 Favored Glycine 0 C--N 1.36 1.901 0 N-CA-C 117.866 1.907 . . . . 0.0 117.866 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.6 m -77.18 154.77 32.8 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 119.972 1.886 . . . . 0.0 111.721 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.7 p -80.83 164.67 22.52 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 125.307 1.443 . . . . 0.0 112.623 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.45 HD23 HD12 ' A' ' 30' ' ' ILE . 86.2 mt -68.94 -22.45 64.13 Favored 'General case' 0 C--N 1.361 1.073 0 C-N-CA 124.07 0.948 . . . . 0.0 110.61 177.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.98 -35.66 92.28 Favored Glycine 0 C--N 1.359 1.861 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.11 -37.01 75.26 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 123.644 0.778 . . . . 0.0 110.184 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.45 HD12 HD23 ' A' ' 27' ' ' LEU . 96.3 mt -66.41 -43.15 91.3 Favored 'Isoleucine or valine' 0 C--N 1.365 1.244 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.2 m -63.09 -37.14 86.02 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.65 1.18 . . . . 0.0 110.498 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.68 -46.88 67.89 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -74.44 -49.28 23.04 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.407 ' HG ' HD13 ' A' ' 17' ' ' ILE . 90.4 mt -77.36 -33.72 55.27 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 115.721 1.748 . . . . 0.0 115.721 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 74.76 -68.3 0.22 Allowed 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 126.186 1.795 . . . . 0.0 111.527 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.6 t -122.48 94.7 47.53 Favored Pre-proline 0 C--N 1.36 1.061 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -70.77 -27.83 21.15 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 123.578 2.852 . . . . 0.0 113.328 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 60.31 -175.57 0.11 Allowed 'General case' 0 C--N 1.359 1.02 0 C-N-CA 124.846 1.258 . . . . 0.0 112.548 -170.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 92.8 p -67.98 -37.44 81.52 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 123.775 0.83 . . . . 0.0 112.821 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.7 m -63.86 -47.47 80.55 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -177.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 70.4 t -71.45 -37.92 66.42 Favored 'Isoleucine or valine' 0 C--N 1.359 0.981 0 CA-C-O 118.535 -0.745 . . . . 0.0 109.29 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -62.3 -37.77 86.81 Favored 'General case' 0 C--N 1.362 1.12 0 CA-C-N 118.573 0.624 . . . . 0.0 112.334 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 97.7 m -66.84 -41.39 87.48 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 123.346 0.658 . . . . 0.0 109.581 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.4 mt -66.4 -41.92 89.58 Favored 'Isoleucine or valine' 0 C--N 1.358 0.953 0 C-N-CA 123.495 0.718 . . . . 0.0 110.01 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.7 t -62.9 -40.13 87.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 C-N-CA 124.127 0.971 . . . . 0.0 110.744 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -65.53 -40.1 92.53 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.45 0.568 . . . . 0.0 112.245 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -68.29 -40.25 81.84 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 124.155 0.982 . . . . 0.0 109.783 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -66.62 -40.14 88.64 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.246 1.018 . . . . 0.0 110.317 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.0 -41.51 86.58 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -60.76 -28.74 68.94 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 125.941 1.696 . . . . 0.0 112.463 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -60.1 -27.94 67.43 Favored 'General case' 0 C--N 1.361 1.104 0 N-CA-C 112.71 0.634 . . . . 0.0 112.71 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.83 -28.87 71.43 Favored Glycine 0 C--N 1.359 1.854 0 CA-C-O 119.483 -0.62 . . . . 0.0 111.818 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.0 m -83.1 -58.36 2.89 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 81.6 m -150.57 110.44 4.09 Favored 'General case' 0 C--N 1.359 1.02 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -82.52 -49.61 9.71 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.005 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -110.09 130.5 55.53 Favored 'General case' 0 CA--C 1.49 -1.336 0 CA-C-O 120.734 0.302 . . . . 0.0 110.626 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.1 m80 . . . . . 0 C--O 1.26 1.639 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 -179.525 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.146 0 CA-C-O 121.415 0.626 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.4 p -103.53 -3.14 25.69 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 125.179 1.392 . . . . 0.0 113.21 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 97.8 mmm -66.93 -31.61 72.31 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.79 -90.78 2.19 Favored Glycine 0 C--N 1.354 1.556 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . 0.279 95.7 mttt 56.23 56.82 5.46 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 117.129 2.27 . . . . 0.0 117.129 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.279 59.2 m 54.91 69.74 0.7 Allowed 'General case' 0 C--N 1.362 1.118 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 89.2 tttt -63.55 131.86 49.42 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 80.9 133.94 0.06 Allowed 'General case' 0 C--N 1.359 0.984 0 C-N-CA 128.604 2.762 . . . . 0.0 107.161 -177.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.44 -41.35 90.85 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 C-N-CA 124.037 0.935 . . . . 0.0 109.468 -178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 98.6 p -66.58 -21.44 66.14 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 126.06 1.744 . . . . 0.0 115.259 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.433 ' HG3' ' HE3' ' A' ' 15' ' ' LYS . 71.0 tp60 -59.02 -38.05 78.35 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -176.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -65.43 -40.09 92.89 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 119.278 0.945 . . . . 0.0 111.478 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.3 tp -66.79 -41.66 87.28 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -63.26 -41.89 99.09 Favored 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 123.596 0.758 . . . . 0.0 110.14 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.433 ' HE3' ' HG3' ' A' ' 11' ' ' GLN . 97.8 mttt -64.37 -42.86 95.97 Favored 'General case' 0 CA--C 1.493 -1.241 0 C-N-CA 123.963 0.905 . . . . 0.0 111.334 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -64.26 -41.89 96.72 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 123.557 0.743 . . . . 0.0 110.46 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.6 mt -68.72 -46.51 79.53 Favored 'Isoleucine or valine' 0 C--N 1.358 0.966 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.407 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.96 -39.97 87.48 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 C-N-CA 124.039 0.935 . . . . 0.0 112.039 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -62.82 -43.4 98.9 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 118.297 0.498 . . . . 0.0 110.692 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.9 mt -70.63 -37.79 73.83 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 123.068 0.547 . . . . 0.0 111.77 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 26' ' ' SER . 74.2 t80 -60.92 -44.92 96.51 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 126.724 2.01 . . . . 0.0 109.687 -178.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -74.77 -40.31 61.26 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.9 p -80.88 -43.51 19.79 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.27 -115.31 1.38 Allowed Glycine 0 CA--C 1.487 -1.691 0 CA-C-O 121.158 0.31 . . . . 0.0 112.835 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.0 t -66.66 122.27 17.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-O 122.203 1.001 . . . . 0.0 110.691 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 21' ' ' TYR . 70.1 m -93.65 -54.99 3.42 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 113.126 -1.852 . . . . 0.0 111.298 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.0 mt -87.96 -29.07 21.06 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.81 -36.45 91.17 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-O 119.656 -0.524 . . . . 0.0 112.525 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.81 -40.85 79.34 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 117.06 0.43 . . . . 0.0 111.0 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -71.02 -45.39 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 118.955 -0.545 . . . . 0.0 109.778 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.7 m -62.7 -38.32 89.95 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 124.143 0.977 . . . . 0.0 113.149 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -72.7 -48.4 39.21 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -83.69 -55.81 4.07 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.98 -33.43 24.6 Favored 'General case' 0 CA--C 1.494 -1.208 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 78.82 -66.08 0.2 Allowed 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 128.011 2.524 . . . . 0.0 108.653 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.6 t -115.75 118.97 38.25 Favored Pre-proline 0 C--N 1.357 0.911 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -66.76 -38.44 17.84 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 123.849 3.033 . . . . 0.0 114.967 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 55.82 -171.98 0.07 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 125.501 1.521 . . . . 0.0 113.532 -172.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 89.0 p -63.79 -32.32 73.78 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 124.897 1.279 . . . . 0.0 111.872 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.6 m -59.81 -47.09 87.1 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 124.325 1.05 . . . . 0.0 112.757 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 77.0 t -82.46 -38.02 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-O 118.873 -0.584 . . . . 0.0 110.459 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.478 ' HA ' HG22 ' A' ' 45' ' ' VAL . 94.5 mm-40 -60.62 -38.98 86.54 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -178.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 98.6 m -65.76 -42.93 90.27 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-N 118.803 0.729 . . . . 0.0 109.939 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.1 mt -67.11 -45.93 85.55 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 123.985 0.914 . . . . 0.0 110.176 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.478 HG22 ' HA ' ' A' ' 42' ' ' GLN 0.266 33.9 m -69.18 -33.52 58.7 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.388 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.123 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -64.58 -36.71 85.1 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 119.179 0.9 . . . . 0.0 113.158 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -71.47 -44.98 63.77 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -66.74 -30.56 70.82 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -65.85 -37.27 85.73 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.611 1.565 . . . . 0.0 108.762 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -65.75 -41.55 91.98 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -70.25 -32.49 70.36 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 122.755 0.422 . . . . 0.0 111.4 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.86 -34.05 59.49 Favored Glycine 0 C--N 1.356 1.668 0 C-N-CA 123.878 0.752 . . . . 0.0 111.424 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.7 m -74.94 -61.05 2.02 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 79.1 m -154.55 106.92 2.77 Favored 'General case' 0 C--N 1.362 1.12 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -85.81 131.93 34.22 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -84.22 140.64 31.56 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 124.54 1.136 . . . . 0.0 110.945 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 47.5 m80 . . . . . 0 C--O 1.261 1.672 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 179.595 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.173 0 CA-C-O 121.176 0.512 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.7 t -76.51 132.43 39.56 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.869 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 97.4 mmm -105.32 120.3 41.22 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.7 174.08 46.98 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -134.05 148.45 51.06 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 121.428 0.633 . . . . 0.0 111.969 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.1 p -90.7 168.17 11.96 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 124.85 1.26 . . . . 0.0 107.61 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt 58.27 60.21 2.73 Favored 'General case' 0 C--N 1.365 1.245 0 C-N-CA 124.56 1.144 . . . . 0.0 112.9 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -85.44 7.1 23.94 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.361 1.064 . . . . 0.0 113.622 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.2 mt -58.38 -41.19 80.78 Favored 'Isoleucine or valine' 0 C--N 1.357 0.921 0 C-N-CA 125.111 1.364 . . . . 0.0 111.27 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 88.6 p -66.84 -38.89 87.28 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 123.97 0.908 . . . . 0.0 111.96 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -67.41 -31.94 72.49 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 125.588 1.555 . . . . 0.0 110.853 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -60.15 -39.99 88.29 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 123.866 0.867 . . . . 0.0 112.932 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.15 -39.79 82.53 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -65.3 -39.61 92.72 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 123.397 0.679 . . . . 0.0 109.659 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.07 -40.09 95.51 Favored 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 124.684 1.193 . . . . 0.0 109.043 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -63.66 -39.03 93.31 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.949 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.36 -45.42 85.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.2 t -63.74 -46.23 95.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 C-N-CA 124.792 1.237 . . . . 0.0 111.318 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -65.25 -42.07 93.65 Favored 'General case' 0 CA--C 1.488 -1.422 0 C-N-CA 123.853 0.861 . . . . 0.0 111.546 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.9 mt -66.24 -38.7 88.51 Favored 'General case' 0 CA--C 1.496 -1.104 0 O-C-N 123.514 0.509 . . . . 0.0 110.521 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.481 ' HE2' ' HD2' ' A' ' 49' ' ' LYS . 90.8 t80 -60.84 -45.33 94.92 Favored 'General case' 0 C--N 1.361 1.087 0 CA-C-O 118.965 -0.54 . . . . 0.0 110.678 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.04 -38.25 82.29 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.874 1.27 . . . . 0.0 111.587 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.4 m -69.79 -28.68 65.94 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 124.161 0.985 . . . . 0.0 112.538 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.54 78.22 0.44 Allowed Glycine 0 CA--C 1.482 -2.002 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.6 p -96.01 -20.32 18.79 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.462 -0.869 . . . . 0.0 110.576 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.8 t 57.96 -119.23 1.12 Allowed 'General case' 0 C--N 1.368 1.376 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.3 mt -123.12 -31.89 3.54 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 119.187 0.903 . . . . 0.0 109.785 177.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.52 -40.19 94.19 Favored Glycine 0 C--N 1.358 1.767 0 N-CA-C 117.925 1.93 . . . . 0.0 117.925 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.88 -41.59 82.54 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 118.424 1.112 . . . . 0.0 110.96 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.0 mt -67.28 -40.46 84.95 Favored 'Isoleucine or valine' 0 C--N 1.362 1.109 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.2 m -61.59 -37.01 82.32 Favored 'General case' 0 C--N 1.359 1.009 0 CA-C-N 118.612 0.642 . . . . 0.0 112.563 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.62 -40.14 88.63 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 119.217 -0.421 . . . . 0.0 110.984 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 62.7 ttm-85 -72.16 -52.63 15.74 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-O 119.157 -0.449 . . . . 0.0 111.534 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.8 mt -142.0 110.17 5.94 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.34 -49.84 4.78 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.1 t -73.45 -52.72 4.94 Favored Pre-proline 0 C--N 1.356 0.888 0 CA-C-O 115.457 -2.211 . . . . 0.0 112.818 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.56 75.83 4.69 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 CA-C-N 124.321 2.579 . . . . 0.0 112.09 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 55.6 mmm-85 -93.53 -10.99 32.98 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.3 m -61.27 -43.42 98.9 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.8 p -72.13 -39.36 68.88 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 123.705 0.802 . . . . 0.0 110.976 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 78.3 t -62.3 -40.25 87.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.834 0 C-N-CA 125.39 1.476 . . . . 0.0 110.353 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.36 -38.34 89.17 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.652 0.781 . . . . 0.0 111.867 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 94.9 m -71.28 -45.57 62.83 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 123.858 0.863 . . . . 0.0 110.571 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.41 -43.66 97.03 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 C-N-CA 124.869 1.268 . . . . 0.0 111.618 -177.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.5 m -65.48 -36.83 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.128 0 CA-C-O 118.284 -0.865 . . . . 0.0 113.188 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -68.52 -44.51 74.46 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.14 -45.53 76.84 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 123.113 0.565 . . . . 0.0 111.417 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -69.97 -30.65 68.05 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.481 ' HD2' ' HE2' ' A' ' 21' ' ' TYR . 86.8 tttt -65.39 -39.81 92.7 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -63.27 -40.11 96.48 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.746 0.818 . . . . 0.0 109.82 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -69.69 -38.53 77.01 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 118.955 -0.545 . . . . 0.0 111.905 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.5 -32.89 61.57 Favored Glycine 0 C--N 1.358 1.754 0 CA-C-O 119.825 -0.431 . . . . 0.0 113.868 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.3 m -82.19 -48.06 11.75 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 117.208 0.504 . . . . 0.0 111.719 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.9 m -99.18 -52.81 3.42 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 119.518 3.155 . . . . 0.0 119.518 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -82.15 -55.6 4.45 Favored 'General case' 0 C--N 1.356 0.859 1 N-CA-C 122.874 4.398 . . . . 0.0 122.874 -174.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 66.9 m170 -78.39 144.98 35.45 Favored 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 125.163 1.385 . . . . 0.0 113.386 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 . . . . . 0 C--O 1.259 1.584 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 179.591 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 121.555 0.693 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.7 m -81.75 -40.47 22.62 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.762 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 76.8 mtm -60.97 138.78 58.15 Favored 'General case' 0 CA--C 1.497 -1.067 0 C-N-CA 125.554 1.541 . . . . 0.0 115.074 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.75 -175.57 43.27 Favored Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -86.73 -10.73 53.0 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.7 m -61.95 124.0 19.59 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.61 111.09 23.51 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 103.146 -2.909 . . . . 0.0 103.146 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . 0.314 96.0 mt-10 52.9 -106.61 0.3 Allowed 'General case' 0 C--N 1.357 0.93 0 C-N-CA 124.188 0.995 . . . . 0.0 112.888 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 86.9 mt 73.93 -64.59 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.324 0 C-N-CA 128.036 2.534 . . . . 0.0 109.325 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 98.7 p -64.8 -33.9 77.09 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 125.047 1.339 . . . . 0.0 111.055 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -63.65 -35.54 80.86 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 123.831 0.853 . . . . 0.0 111.144 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -66.27 -38.96 89.05 Favored 'General case' 0 C--N 1.361 1.083 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.9 mt -66.91 -38.94 87.18 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.422 ' O ' HG23 ' A' ' 18' ' ' VAL . 78.1 mtt85 -61.98 -37.24 84.07 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 123.223 0.609 . . . . 0.0 111.176 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -60.52 -42.23 96.02 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 124.405 1.082 . . . . 0.0 109.391 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -69.71 -41.87 74.79 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.907 1.283 . . . . 0.0 110.387 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.536 HD13 HD11 ' A' ' 34' ' ' LEU . 88.9 mt -64.13 -38.1 81.6 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 125.9 1.68 . . . . 0.0 111.812 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 14' ' ' ARG . 60.9 t -62.4 -40.53 88.36 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -69.53 -40.25 77.0 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 123.528 0.517 . . . . 0.0 109.848 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.6 mt -60.7 -30.35 69.89 Favored 'General case' 0 CA--C 1.496 -1.126 0 C-N-CA 125.229 1.412 . . . . 0.0 112.774 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -56.16 -44.04 78.94 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 124.351 1.06 . . . . 0.0 110.16 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -84.75 -36.85 21.49 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 117.903 0.32 . . . . 0.0 111.156 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.8 m -60.54 -36.62 78.89 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 176.89 -176.05 47.87 Favored Glycine 0 CA--C 1.49 -1.517 0 C-N-CA 119.469 -1.348 . . . . 0.0 113.217 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.6 t 56.93 -149.67 0.46 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 128.242 2.617 . . . . 0.0 111.37 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.8 m -132.99 155.4 49.23 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.637 0.732 . . . . 0.0 109.14 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.7 tp -65.02 -32.07 73.61 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.473 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.15 -35.69 92.02 Favored Glycine 0 C--N 1.358 1.751 0 CA-C-O 119.275 -0.736 . . . . 0.0 111.51 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.9 -40.92 62.83 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-N 118.077 0.938 . . . . 0.0 111.303 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -67.59 -41.96 86.22 Favored 'Isoleucine or valine' 0 C--N 1.358 0.951 0 C-N-CA 123.776 0.83 . . . . 0.0 109.515 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.3 m -65.04 -38.85 92.2 Favored 'General case' 0 CA--C 1.496 -1.126 0 C-N-CA 124.397 1.079 . . . . 0.0 111.083 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.36 -39.07 85.69 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 92.0 mtm-85 -66.8 -42.41 85.98 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 122.599 0.36 . . . . 0.0 111.305 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.536 HD11 HD13 ' A' ' 17' ' ' ILE . 91.2 mt -73.09 -26.41 61.24 Favored 'General case' 0 CA--C 1.497 -1.09 0 C-N-CA 124.793 1.237 . . . . 0.0 111.993 178.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 79.49 -63.34 0.26 Allowed 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 128.212 2.605 . . . . 0.0 108.197 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.0 t -115.97 105.45 51.19 Favored Pre-proline 0 C--N 1.36 1.024 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -71.85 -27.02 18.31 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 123.762 2.975 . . . . 0.0 113.639 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 64.89 167.34 0.17 Allowed 'General case' 0 C--N 1.359 1.006 0 C-N-CA 125.949 1.699 . . . . 0.0 112.505 -166.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 88.8 p -77.2 -26.77 53.15 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 124.997 1.319 . . . . 0.0 110.338 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.2 m -61.56 -44.72 96.51 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.827 1.251 . . . . 0.0 113.421 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.0 t -67.16 -36.91 78.12 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.411 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 99.3 mm-40 -64.59 -40.36 95.38 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 123.549 0.74 . . . . 0.0 110.947 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 95.8 m -68.44 -41.84 79.73 Favored 'General case' 0 C--N 1.354 0.761 0 C-N-CA 123.548 0.739 . . . . 0.0 110.062 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.8 mt -67.52 -42.36 86.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.968 0 C-N-CA 122.927 0.491 . . . . 0.0 109.993 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.8 m -66.36 -33.31 62.67 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 CA-C-N 118.468 0.576 . . . . 0.0 111.753 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 95.7 mtt-85 -64.04 -39.2 93.57 Favored 'General case' 0 C--N 1.359 0.988 0 CA-C-N 118.321 0.509 . . . . 0.0 110.932 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -67.68 -39.6 84.44 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 124.201 1.0 . . . . 0.0 109.613 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -66.49 -37.22 84.61 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 124.249 1.019 . . . . 0.0 109.823 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -67.99 -41.2 82.67 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 124.907 1.283 . . . . 0.0 109.097 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -63.98 -35.03 79.36 Favored 'General case' 0 C--N 1.36 1.025 0 C-N-CA 124.617 1.167 . . . . 0.0 109.401 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -66.16 -25.46 66.97 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 123.812 0.845 . . . . 0.0 111.606 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.99 -35.02 77.85 Favored Glycine 0 C--N 1.36 1.88 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 84.8 m -79.28 -52.6 7.91 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.8 m -147.49 108.09 4.14 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -85.31 -50.7 7.12 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.152 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 49.3 p-80 -142.08 153.61 44.3 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 121.167 0.508 . . . . 0.0 111.437 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 31.2 m80 . . . . . 0 C--O 1.257 1.48 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.715 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.232 0 CA-C-O 121.45 0.643 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.576 ' HB3' ' HA ' ' A' ' 6' ' ' SER . 72.3 m -71.47 121.61 18.95 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.249 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.7 mmm -123.22 -21.41 5.4 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.483 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.62 -95.46 1.64 Allowed Glycine 0 CA--C 1.484 -1.894 0 N-CA-C 106.096 -2.802 . . . . 0.0 106.096 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -89.9 96.95 10.91 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 102.43 -3.174 . . . . 0.0 102.43 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.576 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 47.1 t -85.75 -54.22 4.66 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.477 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -142.68 154.81 44.67 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 117.78 2.511 . . . . 0.0 117.78 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -81.86 155.09 25.52 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 127.328 2.251 . . . . 0.0 108.123 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -82.2 -38.41 15.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.829 0 C-N-CA 124.754 1.221 . . . . 0.0 111.303 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 97.9 p -59.21 -23.62 62.44 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 117.031 2.234 . . . . 0.0 117.031 -177.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -57.89 -37.85 74.74 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.515 1.526 . . . . 0.0 112.927 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -65.77 -43.38 89.03 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 118.757 0.708 . . . . 0.0 110.213 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.3 tp -64.3 -45.59 87.29 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.706 1.202 . . . . 0.0 109.169 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.88 -38.14 87.99 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.951 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -65.25 -37.06 86.06 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-N 118.513 0.597 . . . . 0.0 112.28 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -66.25 -37.19 84.9 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 122.912 0.485 . . . . 0.0 109.754 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.7 mt -69.13 -40.19 80.31 Favored 'Isoleucine or valine' 0 C--N 1.356 0.859 0 C-N-CA 123.722 0.809 . . . . 0.0 109.734 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.5 t -66.08 -34.45 70.28 Favored 'Isoleucine or valine' 0 C--N 1.356 0.863 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -64.13 -39.13 93.36 Favored 'General case' 0 C--N 1.358 0.95 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.0 mt -66.4 -38.43 87.47 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 123.934 0.894 . . . . 0.0 109.825 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -60.2 -46.15 90.72 Favored 'General case' 0 C--N 1.364 1.204 0 C-N-CA 125.114 1.366 . . . . 0.0 108.097 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.91 -33.83 76.46 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 123.527 0.731 . . . . 0.0 111.271 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.4 m -74.95 -12.69 60.4 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 124.217 1.007 . . . . 0.0 112.972 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.61 -15.42 12.79 Favored Glycine 0 C--N 1.358 1.783 0 N-CA-C 116.76 1.464 . . . . 0.0 116.76 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.8 t -91.84 87.17 6.15 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 100.924 -3.732 . . . . 0.0 100.924 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.4 m -95.66 -73.43 0.59 Allowed 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 115.138 1.532 . . . . 0.0 115.138 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.2 mt -81.22 -24.03 37.69 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-O 119.555 -0.259 . . . . 0.0 111.572 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.78 -20.94 78.98 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.6 -49.45 4.01 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 117.901 0.851 . . . . 0.0 112.456 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.96 -48.81 84.46 Favored 'Isoleucine or valine' 0 C--N 1.358 0.974 0 CA-C-N 118.44 0.564 . . . . 0.0 111.865 -176.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.2 m -70.2 -35.1 73.69 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.87 -50.23 9.44 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -73.16 -51.09 19.17 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.447 HD13 HG21 ' A' ' 41' ' ' VAL . 94.8 mt -87.83 -55.99 3.53 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.978 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 66.65 -67.02 0.17 Allowed 'General case' 0 C--N 1.356 0.862 0 C-N-CA 125.853 1.661 . . . . 0.0 114.909 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.6 t -69.48 -53.79 12.19 Favored Pre-proline 0 C--N 1.358 0.967 0 CA-C-O 114.549 -2.643 . . . . 0.0 114.713 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -81.8 46.08 2.13 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 CA-C-N 126.132 3.226 . . . . 0.0 114.441 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -70.68 -35.08 72.64 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 118.962 -0.542 . . . . 0.0 110.892 -174.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.5 m -65.0 -43.31 92.98 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 93.0 p -67.47 -39.34 85.27 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.447 HG21 HD13 ' A' ' 34' ' ' LEU . 78.3 t -67.69 -36.33 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-O 117.862 -1.066 . . . . 0.0 109.31 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.62 -36.75 84.84 Favored 'General case' 0 C--N 1.361 1.082 0 CA-C-N 119.656 1.116 . . . . 0.0 110.923 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 95.3 m -65.4 -40.95 94.05 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 123.351 0.66 . . . . 0.0 109.23 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.87 -40.78 81.63 Favored 'Isoleucine or valine' 0 C--N 1.356 0.889 0 C-N-CA 124.687 1.195 . . . . 0.0 110.08 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.1 t -61.6 -39.56 83.54 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 C-N-CA 125.773 1.629 . . . . 0.0 110.149 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -62.23 -38.85 90.78 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 118.424 0.556 . . . . 0.0 111.127 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -68.8 -42.45 77.29 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 123.921 0.888 . . . . 0.0 108.922 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . 0.259 28.8 m-85 -70.42 -23.2 62.7 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -66.3 -38.88 88.75 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -65.34 -42.69 92.63 Favored 'General case' 0 C--N 1.363 1.153 0 C-N-CA 124.404 1.082 . . . . 0.0 108.414 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -70.63 -25.04 62.85 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.31 -32.34 68.55 Favored Glycine 0 C--N 1.356 1.657 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.9 m -78.46 -50.01 12.41 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 83.3 m -140.3 106.07 5.15 Favored 'General case' 0 C--N 1.359 1.003 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -75.87 133.21 40.62 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -108.41 136.89 47.3 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 . . . . . 0 C--O 1.259 1.595 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 179.218 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.243 0 CA-C-O 121.559 0.695 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.482 ' OG ' ' HA ' ' A' ' 6' ' ' SER . 38.6 t -80.98 110.67 16.74 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 106.225 -1.768 . . . . 0.0 106.225 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 97.8 mtp -128.01 -17.4 4.39 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.2 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.43 -91.66 1.37 Allowed Glycine 0 C--N 1.36 1.874 0 N-CA-C 106.37 -2.692 . . . . 0.0 106.37 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -88.45 102.61 15.06 Favored 'General case' 0 CA--C 1.497 -1.096 1 N-CA-C 98.96 -4.459 . . . . 0.0 98.96 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.482 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 72.1 m -76.26 -49.82 16.03 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -177.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -145.0 148.95 34.31 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -80.01 159.07 26.35 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 127.146 2.178 . . . . 0.0 109.343 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.4 mt -83.53 -40.56 16.09 Favored 'Isoleucine or valine' 0 C--N 1.355 0.835 0 C-N-CA 124.467 1.107 . . . . 0.0 110.886 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 90.8 p -58.4 -30.31 66.74 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 118.081 2.623 . . . . 0.0 118.081 -176.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -56.14 -41.72 75.82 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -177.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -67.41 -41.36 85.03 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 118.797 0.726 . . . . 0.0 111.629 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.05 -42.4 76.33 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 123.922 0.889 . . . . 0.0 110.345 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -66.7 -37.74 85.33 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-O 118.675 -0.678 . . . . 0.0 111.091 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -65.47 -34.7 78.89 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 119.018 -0.515 . . . . 0.0 111.476 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -66.51 -38.72 87.83 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.3 mt -67.65 -40.05 83.33 Favored 'Isoleucine or valine' 0 C--N 1.359 1.003 0 C-N-CA 123.851 0.86 . . . . 0.0 109.505 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.5 -36.48 77.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.826 0 C-N-CA 124.197 0.999 . . . . 0.0 108.985 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.06 -37.29 87.07 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.17 -36.37 79.53 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 123.66 0.784 . . . . 0.0 110.15 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -61.09 -45.38 94.97 Favored 'General case' 0 C--N 1.367 1.341 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.64 -36.44 84.28 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 125.262 1.425 . . . . 0.0 110.546 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.2 m -74.12 -18.26 60.82 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.226 1.011 . . . . 0.0 113.326 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.28 -14.34 8.85 Favored Glycine 0 C--N 1.357 1.704 0 CA-C-O 118.255 -1.303 . . . . 0.0 116.057 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.9 m -91.74 82.74 5.23 Favored 'General case' 0 C--N 1.356 0.853 1 N-CA-C 100.194 -4.002 . . . . 0.0 100.194 177.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.4 m -94.72 -81.01 0.4 Allowed 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 -175.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.3 mt -79.46 -23.66 42.94 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 118.371 0.532 . . . . 0.0 111.867 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.18 -25.48 75.41 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.74 -46.84 6.43 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 117.668 0.734 . . . . 0.0 112.707 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -66.62 -46.69 85.42 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 CA-C-N 118.124 0.42 . . . . 0.0 111.614 -177.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.8 m -69.25 -34.57 74.99 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -82.62 -47.25 12.29 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -74.69 -52.52 11.39 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.487 HD13 HG21 ' A' ' 41' ' ' VAL . 93.3 mt -84.33 -54.06 5.04 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 119.46 -0.305 . . . . 0.0 111.797 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 67.08 -66.92 0.18 Allowed 'General case' 0 C--N 1.358 0.969 0 C-N-CA 126.238 1.815 . . . . 0.0 115.328 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.8 t -72.91 -52.77 5.59 Favored Pre-proline 0 N--CA 1.442 -0.86 0 CA-C-O 114.963 -2.446 . . . . 0.0 114.764 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -81.51 43.92 1.63 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 125.789 3.103 . . . . 0.0 115.101 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -67.95 -33.38 74.55 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-O 118.55 -0.738 . . . . 0.0 112.803 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.3 m -65.72 -43.43 89.08 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 123.291 0.637 . . . . 0.0 111.683 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.8 m -66.42 -41.95 88.49 Favored 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 123.646 0.778 . . . . 0.0 109.657 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.487 HG21 HD13 ' A' ' 34' ' ' LEU . 78.9 t -67.34 -40.48 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-O 117.82 -1.086 . . . . 0.0 109.927 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -64.22 -30.81 71.85 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 119.652 1.115 . . . . 0.0 112.955 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 97.5 m -66.34 -40.51 89.89 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.3 mt -71.58 -40.68 71.56 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 C-N-CA 125.145 1.378 . . . . 0.0 109.511 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.73 -37.22 77.53 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 C-N-CA 125.754 1.621 . . . . 0.0 111.057 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 95.5 mtm-85 -63.33 -39.59 94.95 Favored 'General case' 0 C--N 1.357 0.926 0 CA-C-N 119.605 1.093 . . . . 0.0 110.91 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -68.6 -41.04 80.13 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 123.501 0.72 . . . . 0.0 109.071 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -69.98 -25.09 63.45 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -66.85 -38.13 85.78 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -65.41 -41.17 93.91 Favored 'General case' 0 C--N 1.362 1.122 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -69.55 -26.38 64.46 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.07 -31.03 71.93 Favored Glycine 0 C--N 1.357 1.704 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.2 m -75.34 -52.99 9.5 Favored 'General case' 0 C--N 1.359 1.008 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 76.8 m -147.88 105.83 3.72 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -75.59 131.48 40.03 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 123.487 0.715 . . . . 0.0 109.544 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -100.21 130.3 46.33 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 18.2 m80 . . . . . 0 C--O 1.26 1.62 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -179.018 . . . . . . . . 0 0 . 1 stop_ save_